<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft10{font-size:9px;font-family:Times;color:#010202;}
	.ft11{font-size:29px;font-family:Times;color:#bfbfbf;}
	.ft12{font-size:41px;font-family:Times;color:#dbdbdb;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft13{font-size:-1px;font-family:Times;color:#ffffff;}
	.ft14{font-size:-1px;font-family:Times;color:#ffffff;}
	.ft15{font-size:0px;font-family:Times;color:#ffffff;}
	.ft16{font-size:9px;font-family:Times;color:#000000;}
	.ft17{font-size:14px;font-family:Times;color:#000000;}
	.ft18{font-size:8px;font-family:Times;color:#000000;}
	.ft19{font-size:7px;font-family:Times;color:#000000;}
	.ft110{font-size:11px;font-family:Times;color:#000000;}
	.ft111{font-size:9px;font-family:Times;color:#000000;}
	.ft112{font-size:8px;font-family:Times;color:#000000;}
	.ft113{font-size:8px;font-family:Times;color:#000000;}
	.ft114{font-size:7px;font-family:Times;color:#000000;}
	.ft115{font-size:9px;font-family:Times;color:#000000;}
	.ft116{font-size:11px;font-family:Times;color:#000000;}
	.ft117{font-size:11px;font-family:Times;color:#000000;}
	.ft118{font-size:11px;font-family:Times;color:#000000;}
	.ft119{font-size:9px;font-family:Times;color:#000000;}
	.ft120{font-size:13px;font-family:Times;color:#000000;}
	.ft121{font-size:12px;font-family:Times;color:#000000;}
	.ft122{font-size:16px;font-family:Times;color:#000000;}
	.ft123{font-size:11px;line-height:15px;font-family:Times;color:#000000;}
	.ft124{font-size:11px;line-height:18px;font-family:Times;color:#000000;}
	.ft125{font-size:7px;line-height:10px;font-family:Times;color:#000000;}
	.ft126{font-size:7px;line-height:10px;font-family:Times;color:#000000;}
	.ft127{font-size:9px;line-height:12px;font-family:Times;color:#000000;}
	.ft128{font-size:9px;line-height:13px;font-family:Times;color:#000000;}
	.ft129{font-size:11px;line-height:15px;font-family:Times;color:#000000;}
	.ft130{font-size:11px;line-height:15px;font-family:Times;color:#000000;}
	.ft131{font-size:11px;line-height:14px;font-family:Times;color:#000000;}
	.ft132{font-size:11px;line-height:17px;font-family:Times;color:#000000;}
	.ft133{font-size:16px;line-height:19px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page1-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:82px;left:129px;white-space:nowrap" class="ft10"><i><b>&#160;</b></i></p>
<p style="position:absolute;top:12px;left:110px;white-space:nowrap" class="ft11">&#160;</p>
<p style="position:absolute;top:1110px;left:39px;white-space:nowrap" class="ft12"><i>Current Pharmaceutical Design</i></p>
<p style="position:absolute;top:167px;left:887px;white-space:nowrap" class="ft13">Impact</p>
<p style="position:absolute;top:169px;left:887px;white-space:nowrap" class="ft13">Factor:</p>
<p style="position:absolute;top:170px;left:888px;white-space:nowrap" class="ft13">2.611</p>
<p style="position:absolute;top:98px;left:827px;white-space:nowrap" class="ft14"><b>ISSN: 1381-6128</b></p>
<p style="position:absolute;top:99px;left:826px;white-space:nowrap" class="ft14"><b>eISSN: 1873-4286</b></p>
<p style="position:absolute;top:192px;left:887px;white-space:nowrap" class="ft13">BENTHAM</p>
<p style="position:absolute;top:193px;left:887px;white-space:nowrap" class="ft13">SCIENCE</p>
<p style="position:absolute;top:137px;left:889px;white-space:nowrap" class="ft15"><i><b>no.</b></i></p>
<p style="position:absolute;top:1139px;left:80px;white-space:nowrap" class="ft16"><b>&#160;</b></p>
<p style="position:absolute;top:234px;left:80px;white-space:nowrap" class="ft17">Jack Tuszynski</p>
<p style="position:absolute;top:230px;left:182px;white-space:nowrap" class="ft18">1,2,&#160;Tatiana&#160;M.&#160;Tilli3&#160;and&#160;Michael&#160;Levin4,*&#160;</p>
<p style="position:absolute;top:276px;left:80px;white-space:nowrap" class="ft123"><i>1Department&#160;of&#160;Oncology,&#160;Faculty&#160;of&#160;Medicine&#160;&amp;&#160;Dentistry,&#160;University&#160;of&#160;Alberta,&#160;Edmonton,&#160;Alberta,&#160;Canada T6G&#160;1Z2;&#160;<br/>2Department&#160;of&#160;Physics,&#160;University&#160;of&#160;Alberta,&#160;Edmonton,&#160;Alberta,&#160;Canada T6G&#160;2E1;&#160;3Laboratory&#160;of&#160;Biological&#160;System&#160;Modeling,&#160;<br/>National&#160;Institute&#160;for&#160;Science&#160;and Technology&#160;on&#160;Innovation&#160;in Neglected Diseases&#160;(INCT/IDN),&#160;Center&#160;for&#160;Technological&#160;Develop-<br/>ment&#160;in Health (CDTS),&#160;Oswaldo Cruz&#160;Foundation (Fiocruz),&#160;Rio de&#160;Janeiro,&#160;Brazil;&#160;</i></p>
<p style="position:absolute;top:322px;left:567px;white-space:nowrap" class="ft19"><i>4Biology&#160;Department,&#160;and Allen Discovery&#160;&#160;</i></p>
<p style="position:absolute;top:341px;left:80px;white-space:nowrap" class="ft110"><i>Center,&#160;Tufts&#160;University,&#160;Medford,&#160;MA,&#160;02155,&#160;USA&#160;</i></p>
<p style="position:absolute;top:374px;left:161px;white-space:nowrap" class="ft111"><i>&#160;</i></p>
<p style="position:absolute;top:477px;left:89px;white-space:nowrap" class="ft112"><b>A&#160;R&#160;T&#160;I C&#160;L&#160;E &#160;H&#160;I S&#160;T O&#160;R&#160;Y</b><i>&#160;</i></p>
<p style="position:absolute;top:497px;left:89px;white-space:nowrap" class="ft126">&#160;<br/>Received:&#160;April&#160;13,&#160;2017&#160;<br/>Accepted:&#160;May&#160;23,&#160;2017&#160;<br/>&#160;<br/><i>&#160;<br/>DOI:&#160;</i></p>
<p style="position:absolute;top:565px;left:89px;white-space:nowrap" class="ft19"><i>10.2174/1381612823666170530105837</i></p>
<p style="position:absolute;top:562px;left:233px;white-space:nowrap" class="ft19"><i></i></p>
<p style="position:absolute;top:374px;left:251px;white-space:nowrap" class="ft128"><b>Abstract:&#160;</b>The&#160;activities&#160;of&#160;individual cells&#160;must be&#160;tightly&#160;coordinated&#160;in&#160;order&#160;to&#160;build&#160;and&#160;maintain&#160;complex&#160;3-<br/>dimensional&#160;body structures&#160;during embryogenesis&#160;and&#160;regeneration.&#160;Thus,&#160;one way to&#160;view&#160;cancer&#160;is&#160;within&#160;<br/>systems&#160;biology&#160;as&#160;a&#160;network&#160;disorder&#160;affecting&#160;the&#160;ability&#160;of&#160;cells&#160;to&#160;properly&#160;interact&#160;with&#160;a&#160;morphodynamic&#160;<br/>field of&#160;instructive signals&#160;that&#160;keeps&#160;proliferation and migration&#160;orchestrated toward&#160;the anatomical&#160;needs&#160;of&#160;the&#160;<br/>host organism. One&#160;layer&#160;of&#160;this&#160;set of&#160;instructive&#160;microenvironmental cues&#160;is&#160;bioelectrical. Voltage&#160;gradients&#160;<br/>among&#160;all&#160;somatic&#160;cells&#160;(not&#160;just&#160;excitable nerve and muscle)&#160;control&#160;cell&#160;behavior,&#160;and the ionic coupling&#160;of&#160;cells&#160;<br/>into&#160;networks<i>&#160;via</i>&#160;electrochemical&#160;synapses&#160;allows&#160;them to&#160;implement&#160;tissue-level&#160;patterning decisions.&#160;These&#160;<br/>gradients&#160;have been increasingly implicated in&#160;the induction and suppression&#160;of&#160;tumorigenesis&#160;and metastasis,&#160;in&#160;</p>
<p style="position:absolute;top:482px;left:250px;white-space:nowrap" class="ft128">the&#160;emerging&#160;links&#160;between&#160;developmental bioelectricity&#160;to&#160;the&#160;cancer&#160;problem.&#160;Consistent with&#160;the&#160;well-known&#160;<br/>role&#160;of&#160;neurotransmitter&#160;molecules&#160;in&#160;transducing&#160;electrical activity&#160;to&#160;downstream cascades&#160;in&#160;the brain,&#160;seroton-<br/>ergic signaling has&#160;likewise been implicated in&#160;cancer.&#160;Here,&#160;we review these recent&#160;data&#160;and propose new ap-<br/>proaches&#160;for&#160;manipulating&#160;bioelectric&#160;and&#160;neurotransmitter&#160;pathways&#160;in&#160;cancer&#160;biology&#160;based&#160;on&#160;a&#160;bioelectric&#160;<br/>view&#160;of&#160;cancer.&#160;To&#160;support&#160;this&#160;methodology,&#160;we&#160;present&#160;new&#160;data&#160;on the effects&#160;of&#160;the&#160;SSRI&#160;Prozac and&#160;its&#160;ana-<br/>log (ZINC&#160;ID&#160;= ZINC06811610)&#160;on survival&#160;of&#160;both cancer&#160;(MCF7)&#160;and normal&#160;(MCF10A)&#160;breast&#160;cells&#160;exposed&#160;<br/>to&#160;these compounds.&#160;We&#160;found&#160;an IC50&#160;concentration (25&#160;</p>
<p style="position:absolute;top:560px;left:538px;white-space:nowrap" class="ft115">μM&#160;for&#160;Prozac&#160;and 100&#160;μM&#160;for&#160;the Prozac&#160;analog)&#160;at&#160;</p>
<p style="position:absolute;top:576px;left:250px;white-space:nowrap" class="ft128">which&#160;these&#160;compounds&#160;inhibited&#160;tumor&#160;cell survival and&#160;proliferation.&#160;Additionally, at these&#160;concentrations, we&#160;<br/>did&#160;not observe&#160;alterations&#160;in&#160;a&#160;non-tumoral cell line.&#160;This&#160;constitutes&#160;a&#160;proof-of-concept demonstration&#160;for&#160;our&#160;<br/>hypothesis&#160;that&#160;the&#160;use&#160;of&#160;both existing and novel&#160;drugs&#160;as&#160;electroceuticals&#160;could serve as&#160;an&#160;alternative to&#160;highly&#160;<br/>toxic&#160;chemotherapy&#160;strategies&#160;replacing&#160;or&#160;augmenting&#160;them&#160;with&#160;less&#160;toxic&#160;alternatives. We&#160;believe&#160;this&#160;new&#160;<br/>approach forms an exciting roadmap for&#160;future&#160;biomedical&#160;advances.&#160;</p>
<p style="position:absolute;top:648px;left:80px;white-space:nowrap" class="ft116"><b>Keywords:&#160;</b>Ion channels,&#160;serotonin,&#160;neurotransmitter,&#160;bioelectricity,&#160;biophysics,&#160;resting potential,&#160;Prozac,&#160;SSRI.&#160;</p>
<p style="position:absolute;top:687px;left:80px;white-space:nowrap" class="ft129"><b>1.&#160;INTRODUCTION:&#160;CANCER AS&#160;A DEVELOPMENTAL&#160;<br/>DISORDER&#160;</b></p>
<p style="position:absolute;top:722px;left:80px;white-space:nowrap" class="ft117">&#160;</p>
<p style="position:absolute;top:722px;left:102px;white-space:nowrap" class="ft117">A&#160;defining feature&#160;of&#160;multicellular life&#160;is&#160;pattern homeostasis:&#160;</p>
<p style="position:absolute;top:737px;left:81px;white-space:nowrap" class="ft128">the&#160;establishment&#160;and maintenance&#160;of&#160;a&#160;complex bodyplan during&#160;<br/>embryogenesis,&#160;and its&#160;upkeep during remodeling,&#160;wound healing,&#160;<br/>and aging.&#160;Some&#160;animals have developed&#160;this&#160;property&#160;to&#160;a&#160;remark-<br/>able degree, such&#160;as&#160;salamanders that&#160;fully&#160;regenerate&#160;amputated&#160;<br/>limbs, eyes, jaws, and&#160;spinal&#160;cords [1-3]. The&#160;single thread&#160;that&#160;<br/>connects&#160;all&#160;of&#160;these processes is&#160;the&#160;need&#160;to&#160;subjugate&#160;single cell&#160;<br/>activities&#160;to the&#160;anatomical&#160;needs&#160;of&#160;the&#160;host&#160;organism.&#160;Cell&#160;prolif-<br/>eration,&#160;differentiation,&#160;migration,&#160;apoptosis,&#160;and other&#160;functions&#160;<br/>are&#160;normally harnessed to large-scale&#160;morphogenesis&#160;by a&#160;complex&#160;<br/>system&#160;of instructive&#160;cues&#160;that&#160;functionally&#160;determines&#160;cell&#160;behav-<br/>ior.&#160;This&#160;morphodynamic&#160;field [4]&#160;is&#160;the&#160;sum&#160;total&#160;of&#160;signals&#160;that&#160;<br/>impinge&#160;upon cells&#160;<i>in&#160;vivo</i>, carrying&#160;information&#160;from&#160;distant re-<br/>gions&#160;that&#160;is&#160;necessary for&#160;cells&#160;to&#160;implement&#160;coordinated patterning&#160;<br/>at&#160;a&#160;large&#160;scale&#160;(Fig.&#160;<b>1</b>).&#160;It&#160;has long been&#160;recognized&#160;that&#160;such&#160;a&#160;<br/>process&#160;necessarily&#160;runs&#160;a&#160;risk&#160;of&#160;cells&#160;becoming unable&#160;to&#160;interact&#160;<br/>properly with&#160;the&#160;somatic&#160;bodyplan [5-7].&#160;This&#160;would&#160;result&#160;in&#160;cells&#160;<br/>reverting to&#160;a&#160;unicellular&#160;mode&#160;in which they survive&#160;and multiply&#160;<br/>as&#160;any&#160;life&#160;form&#160;tries&#160;to&#160;do, at&#160;the expense of&#160;the&#160;environment&#160;<br/>within which it&#160;lives&#160;[8,&#160;9].&#160;Thus,&#160;one&#160;view&#160;of&#160;cancer&#160;is&#160;as&#160;a&#160;devel-<br/>opmental&#160;disorder&#160;[7,&#160;10-13]:&#160;a&#160;network disease of&#160;the complex&#160;<br/>signaling pathways that&#160;normally&#160;keep&#160;cells&#160;away&#160;from&#160;<br/>&#160;<br/>*Address&#160;correspondence&#160;to&#160;this&#160;author&#160;at&#160;the&#160;200&#160;Boston&#160;Ave.,&#160;Suite&#160;4600,&#160;<br/>Medford,&#160;MA&#160;02155,&#160;USA;&#160;Tel:&#160;(617)&#160;627-6161;&#160;&#160;<br/>E-mail: michael.levin@tufts.edu</p>
<p style="position:absolute;top:1096px;left:237px;white-space:nowrap" class="ft117">&#160;</p>
<p style="position:absolute;top:687px;left:481px;white-space:nowrap" class="ft130">tumorigenesis and toward&#160;correct&#160;anatomical&#160;structure.&#160;Supporting&#160;<br/>this&#160;view&#160;is&#160;an&#160;evidence&#160;that&#160;regenerative and&#160;embryonic environ-<br/>ments,&#160;which feature&#160;very&#160;strong instructive&#160;patterning influences&#160;<br/>applied to&#160;cells,&#160;are&#160;well-known to&#160;be&#160;able&#160;to&#160;normalize&#160;tumor&#160;cells&#160;<br/>(Fig.&#160;<b>2</b>,&#160;[14-16]&#160;and&#160;[17]).&#160;</p>
<p style="position:absolute;top:766px;left:481px;white-space:nowrap" class="ft117">&#160;</p>
<p style="position:absolute;top:766px;left:502px;white-space:nowrap" class="ft117">Here,&#160;we&#160;focus&#160;on the&#160;role&#160;of&#160;one&#160;signaling modality&#160;that&#160;under-</p>
<p style="position:absolute;top:782px;left:481px;white-space:nowrap" class="ft130">lies this&#160;multiscale&#160;pattern&#160;regulation:&#160;non-neural bioelectricity&#160;[18-<br/>21].&#160; It&#160;is&#160;perhaps&#160;not&#160;widely&#160;appreciated that&#160;the&#160;use&#160;of&#160;electrical&#160;<br/>signaling by the&#160;brain is&#160;not&#160;an&#160;original&#160;invention:&#160;nervous&#160;systems&#160;<br/>evolved by exploiting ionic&#160;signaling that&#160;was&#160;ancient,&#160;and used by&#160;<br/>many kinds&#160;of&#160;cells&#160;to&#160;coordinate&#160;physiological signaling,&#160;aneural&#160;<br/>behavior&#160;patterns,&#160;and morphogenesis&#160;[22,&#160;23].&#160;Ion channels&#160;and&#160;<br/>electrical&#160;synapses&#160;(gap&#160;junctions,&#160;which function&#160;alongside&#160;the&#160;<br/>more&#160;familiar&#160;chemical&#160;synapses,&#160;especially&#160;outside the&#160;CNS)&#160;(Fig.&#160;<br/><b>3</b>)&#160;are&#160;widely-expressed&#160;throughout&#160;metazoan&#160;bodies,&#160;and the&#160;re-<br/>sulting&#160;electrical&#160;dynamics&#160;are&#160;an&#160;important&#160;regulatory modality&#160;for&#160;<br/>cell&#160;number,&#160;cell&#160;shape,&#160;differentiation,&#160;and morphogenesis&#160;[24].&#160;<br/>Differences&#160;in&#160;cells’&#160;resting potentials&#160;(Vmem) across&#160;anatomical&#160;<br/>distances (Fig.&#160;<b>4</b>)&#160;result&#160;in&#160;instructive&#160;physiological&#160;prepatterns&#160;that&#160;<br/>determine&#160;gene&#160;expression domains&#160;and subsequent&#160;morphogenesis,&#160;<br/>for example in&#160;craniofacial patterning&#160;[25,&#160;26]&#160;and&#160;axial polarity&#160;<br/>during regeneration [27,&#160;28].&#160;Crucially&#160;(Fig.&#160;<b>5</b>),&#160;bioelectric signals&#160;<br/>play&#160;a role&#160;in&#160;long-range&#160;coordination of growth&#160;and form,&#160;regulat-<br/>ing the&#160;size&#160;of&#160;brains&#160;[29],&#160;appendages&#160;[30],&#160;and even&#160;kickstarting&#160;<br/>the&#160;appearance&#160;of&#160;whole&#160;organs&#160;[31,&#160;32].&#160;Thus,&#160;many of&#160;the&#160;end-<br/>points&#160;that&#160;go awry&#160;in&#160;cancer,&#160;including overproliferation,&#160;dediffer-<br/>entiation,&#160;vascular&#160;patterns,&#160;chromatin changes,&#160;gene&#160;expression,&#160;<br/>and migratory behavior&#160;are&#160;all&#160;known to be&#160;downstream&#160;of&#160;the&#160;ac-</p>
<p style="position:absolute;top:1148px;left:330px;white-space:nowrap" class="ft16"><b>1873-4286/17 $58.00+.00&#160;</b></p>
<p style="position:absolute;top:1152px;left:482px;white-space:nowrap" class="ft16"><b>© 2017 Bentham&#160;Science Publishers&#160;</b></p>
<p style="position:absolute;top:13px;left:12px;white-space:nowrap" class="ft118"><i><b>Send&#160;Orders&#160;for Reprints&#160;to&#160;reprints@benthamscience.ae&#160;</b></i></p>
<p style="position:absolute;top:60px;left:140px;white-space:nowrap" class="ft119"><i><b>&#160;</b></i></p>
<p style="position:absolute;top:60px;left:360px;white-space:nowrap" class="ft119"><i><b>&#160;</b></i></p>
<p style="position:absolute;top:60px;left:390px;white-space:nowrap" class="ft119"><i><b>Current&#160;Pharmaceutical&#160;Design,&#160;</b></i><b>2017<i>,&#160;23,&#160;</i></b><b>4827-4841<i>&#160;</i></b></p>
<p style="position:absolute;top:11px;left:875px;white-space:nowrap" class="ft120"><b>4827&#160;</b></p>
<p style="position:absolute;top:74px;left:140px;white-space:nowrap" class="ft121"><b>REVIEW&#160;ARTICLE&#160;</b></p>
<p style="position:absolute;top:128px;left:141px;white-space:nowrap" class="ft133"><b>Ion&#160;Channel&#160;and&#160;Neurotransmitter Modulators&#160;as Electroceutical&#160;Approaches&#160;to&#160;the&#160;<br/>Control&#160;of&#160;Cancer&#160;</b></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft20{font-size:9px;font-family:Times;color:#000000;}
	.ft21{font-size:9px;font-family:Times;color:#000000;}
	.ft22{font-size:11px;font-family:Times;color:#000000;}
	.ft23{font-size:7px;font-family:Times;color:#000000;}
	.ft24{font-size:11px;font-family:Times;color:#000000;}
	.ft25{font-size:11px;font-family:Times;color:#000000;}
	.ft26{font-size:9px;font-family:Times;color:#000000;}
	.ft27{font-size:9px;font-family:Times;color:#000000;}
	.ft28{font-size:17px;font-family:Times;color:#000000;}
	.ft29{font-size:7px;font-family:Times;color:#000000;}
	.ft210{font-size:9px;font-family:Times;color:#ed2222;}
	.ft211{font-size:7px;font-family:Times;color:#9e9e9d;}
	.ft212{font-size:54px;font-family:Times;color:#000000;}
	.ft213{font-size:8px;font-family:Times;color:#000000;}
	.ft214{font-size:11px;line-height:14px;font-family:Times;color:#000000;}
	.ft215{font-size:11px;line-height:15px;font-family:Times;color:#000000;}
	.ft216{font-size:9px;line-height:14px;font-family:Times;color:#000000;}
	.ft217{font-size:9px;line-height:15px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page2-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft20"><b>4828 &#160; &#160;<i>Current&#160;Pharmaceutical&#160;Design,&#160;</i></b><b>2017<i>, Vol.&#160;23, No. 32&#160;</i></b></p>
<p style="position:absolute;top:57px;left:789px;white-space:nowrap" class="ft21"><i><b>Tuszynski&#160;et&#160;al.&#160;</b></i></p>
<p style="position:absolute;top:669px;left:96px;white-space:nowrap" class="ft214">tivity&#160;of&#160;bioelectric&#160;circuits&#160;during normal&#160;pattern regulation&#160;[18,&#160;<br/>21].&#160;</p>
<p style="position:absolute;top:704px;left:96px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:704px;left:117px;white-space:nowrap" class="ft22">Changes&#160;in&#160;the&#160;biophysical&#160;parameter&#160;Vmem&#160;can&#160;be&#160;transduced&#160;</p>
<p style="position:absolute;top:718px;left:96px;white-space:nowrap" class="ft215">into&#160;downstream&#160;transcriptional&#160;responses&#160;by the&#160;voltage-regulated&#160;<br/>movement&#160;of&#160;neurotransmitter&#160;molecules&#160;across&#160;cell&#160;membranes&#160;<br/>and between&#160;cells&#160;through gap junctions.&#160;These&#160;electrical&#160;synapses,&#160;<br/>like&#160;ion channels,&#160;are&#160;ancient&#160;and widely&#160;present&#160;outside&#160;the&#160;nerv-<br/>ous&#160;system&#160;[33,&#160;34].&#160;Molecules&#160;such&#160;as&#160;serotonin&#160;have&#160;pre-neural&#160;<br/>roles,&#160;such&#160;as&#160;in&#160;gastrulation,&#160;determination of left-right&#160;patterning,&#160;<br/>craniofacial&#160;development,&#160;and cardiac&#160;morphogenesis&#160;[35-42].&#160;To-<br/>gether,&#160;ion&#160;channels,&#160;gap junctions,&#160;and&#160;neurotransmitter&#160;signaling&#160;<br/>machinery&#160;form&#160;somatic&#160;bioelectric&#160;circuits&#160;that&#160;coordinate&#160;cell&#160;<br/>behaviors&#160;toward&#160;prescribed&#160;and limited&#160;tissue-level&#160;outcomes.&#160;One&#160;<br/>of&#160;the key&#160;aspects of&#160;this&#160;control system&#160;is&#160;that&#160;it&#160;is&#160;fundamentally&#160;<br/>epigenetic,&#160;operating at&#160;the&#160;level&#160;of&#160;ion flows&#160;and channel&#160;gating&#160;<br/>and invisible&#160;in&#160;fixed&#160;samples&#160;or&#160;from&#160;profiling of&#160;transcriptional&#160;or&#160;<br/>translational&#160;states.&#160;In some&#160;cases,&#160;this&#160;physiological&#160;layer&#160;domi-<br/>nates&#160;genomic&#160;defaults;&#160;appropriate&#160;bioelectric manipulation can&#160;<br/>rescue&#160;normal&#160;brain patterning despite&#160;defects&#160;in important&#160;neuro-<br/>genesis genes&#160;such&#160;as&#160;<i>Notch</i>&#160;[29],&#160;induce&#160;regeneration of&#160;spinal&#160;<br/>cord&#160;in&#160;non-regenerative animals&#160;[43,&#160;44],&#160;convert&#160;normally&#160;non-<br/>permissive&#160;tissue&#160;such&#160;as&#160;gut&#160;into&#160;complete&#160;eyes&#160;[32],&#160;and alter&#160;the&#160;<br/>shape [27]&#160;and number&#160;[45,&#160;46]&#160;of heads&#160;in&#160;regenerating animals.&#160;&#160;</p>
<p style="position:absolute;top:1023px;left:96px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:1023px;left:117px;white-space:nowrap" class="ft22">These&#160;data&#160;on multi-cellular&#160;reprogramming suggest&#160;that&#160;target-</p>
<p style="position:absolute;top:1038px;left:96px;white-space:nowrap" class="ft215">ing physiology,&#160;not&#160;only genetics,&#160;may be an&#160;effective&#160;and domi-<br/>nant&#160;strategy for&#160;diagnostics&#160;and control&#160;of&#160;cancer.&#160;The&#160;ability to&#160;<br/>trigger&#160;coherent&#160;change&#160;in&#160;thecell&#160;fields&#160;into&#160;a&#160;whole&#160;organ&#160;[32]&#160;or&#160;&#160;<br/>&#160;</p>
<p style="position:absolute;top:669px;left:496px;white-space:nowrap" class="ft215">starting the&#160;growth of&#160;a&#160;complex appendage&#160;with a&#160;simple&#160;gradient&#160;<br/>change&#160;[43,&#160;44]&#160;suggests&#160;that&#160;it&#160;may be&#160;possible&#160;to trigger&#160;modular&#160;<br/>patterning:&#160;exert&#160;organ-level&#160;control&#160;over&#160;a&#160;body region without&#160;<br/>having to&#160;micromanage each&#160;cell.&#160;Long-term,&#160;this&#160;may be part&#160;of&#160;a&#160;<br/>strategy&#160;to&#160;mimic&#160;the&#160;ability&#160;of&#160;regeneration or development&#160;to&#160;<br/>provide&#160;patterning cues&#160;that&#160;dominate&#160;individual&#160;cell&#160;fate&#160;and nor-<br/>malize&#160;tumors.&#160;Thus,&#160;we&#160;proposed the&#160;hypothesis&#160;that&#160;exploiting the&#160;<br/>bioelectrical&#160;system&#160;by which cells&#160;coordinate&#160;their&#160;constraints&#160;on&#160;<br/>growth&#160;could lead to&#160;advances&#160;in cancer&#160;biology.&#160;</p>
<p style="position:absolute;top:816px;left:496px;white-space:nowrap" class="ft25"><b>2.&#160;BIOELECTRICS AND CANCER&#160;</b></p>
<p style="position:absolute;top:835px;left:496px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:835px;left:517px;white-space:nowrap" class="ft22">Interestingly,&#160;while&#160;the&#160;importance&#160;of steady-state&#160;Vmem&#160;is&#160;only&#160;</p>
<p style="position:absolute;top:850px;left:496px;white-space:nowrap" class="ft215">recently&#160;becoming understood,&#160;true&#160;neural-like&#160;excitability&#160;in&#160;can-<br/>cer&#160;cells&#160;was&#160;discovered over&#160;20 years&#160;ago [47,&#160;48].&#160;Aside&#160;from&#160;<br/>spiking,&#160;steady-state&#160;resting potentials&#160;are&#160;an&#160;important&#160;regulatory&#160;<br/>factor (Fig.&#160;<b>6</b>): tumor cells tend&#160;to&#160;be&#160;more depolarized&#160;than&#160;their&#160;<br/>normal&#160;counterparts (complicated&#160;by the&#160;fact&#160;that&#160;Vmem&#160;tends to&#160;<br/>fluctuate&#160;somewhat&#160;during the&#160;mitotic phases,&#160;reviewed&#160;in&#160;[49]),&#160;<br/>and experimental&#160;modulation of&#160;resting potential&#160;can functionally&#160;<br/>normalize&#160;cells&#160;and prevent&#160;or&#160;reverse&#160;tumorigenesis&#160;[50-52].&#160;Re-<br/>cent&#160;work has&#160;extended this&#160;observation into testing roles&#160;of&#160;indi-<br/>vidual&#160;ion channels&#160;as&#160;<i>bona fide</i>&#160;oncogenes&#160;(Table&#160;<b>1</b>),&#160;ion channel&#160;<br/>expression profiles&#160;as&#160;markers&#160;[53,&#160;54],&#160;and drug approaches&#160;target-<br/>ing specific&#160;channels&#160;for&#160;cancer&#160;therapeutics&#160;[55].&#160;Role&#160;of&#160;gap junc-<br/>tions&#160;in cancer&#160;has&#160;been covered extensively [56,&#160;57],&#160;and these&#160;too&#160;<br/>are&#160;currently&#160;an&#160;exciting&#160;target&#160;for&#160;cancer&#160;therapies&#160;[58,&#160;59].&#160;</p>
<p style="position:absolute;top:1065px;left:496px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:1065px;left:517px;white-space:nowrap" class="ft22">Subsequent&#160;experiments&#160;suggested&#160;roles&#160;of&#160;resting potential&#160;per&#160;</p>
<p style="position:absolute;top:1080px;left:496px;white-space:nowrap" class="ft215">se&#160;(generated by one&#160;of&#160;any number&#160;of&#160;electrogenic&#160;proteins)&#160;in&#160;&#160;<br/>&#160;</p>
<p style="position:absolute;top:104px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:135px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:167px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:198px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:230px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:261px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:293px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:324px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:356px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:387px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:413px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:438px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:470px;left:98px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:502px;left:98px;white-space:nowrap" class="ft217"><b>Fig.&#160;(1).</b>&#160;Morphogenetic/morphostatic&#160;fields&#160;<br/>Each cell&#160;<i>in&#160;vivo</i>&#160;exists&#160;within&#160;a complex field of&#160;information imposed&#160;on it&#160;by the host&#160;organism.&#160;This&#160;set&#160;of&#160;signals,&#160;impinging on cells&#160;from&#160;3 dimensions&#160;<br/>and varying&#160;in&#160;time,&#160;is&#160;mediated&#160;by&#160;a number&#160;of&#160;physical&#160;properties,&#160;including&#160;gradients&#160;of&#160;diffusible&#160;chemical&#160;messengers,&#160;extracellular&#160;matrix&#160;properties&#160;<br/>(ECM),&#160;tensile/pressure forces,&#160;and&#160;bioelectric states.&#160;The sum total of&#160;these&#160;instructive&#160;cues&#160;are&#160;responsible&#160;for&#160;establishment&#160;of&#160;normal&#160;somatic&#160;pattern&#160;dur-<br/>ing&#160;embryogenesis,&#160;and&#160;for&#160;harnessing&#160;cell activity&#160;toward&#160;the&#160;anatomical needs&#160;of&#160;the&#160;host organism&#160;throughout its&#160;life.&#160;It guides&#160;cell&#160;behaviors&#160;during&#160;regen-<br/>eration,&#160;remodeling,&#160;and&#160;on-going&#160;pattern&#160;homeostasis; the&#160;interactions&#160;of&#160;cells&#160;with&#160;this&#160;guidance&#160;system&#160;reveals&#160;a&#160;key&#160;common&#160;feature among development,&#160;<br/>regeneration,&#160;and&#160;cancer,&#160;all&#160;of&#160;which are&#160;fundamentally&#160;problems&#160;of&#160;spatio-temporal&#160;organization&#160;and&#160;the imposition&#160;of&#160;global order&#160;on&#160;local cell activity. It&#160;<br/>may be that&#160;cancer&#160;can be efficiently&#160;understood as&#160;a disorder&#160;of&#160;cells’&#160;communication with&#160;this&#160;field (either&#160;because&#160;the signals&#160;become absent&#160;from a&#160;region&#160;<br/>of&#160;the&#160;environment, or&#160;because&#160;cells&#160;become&#160;inattentive&#160;to&#160;its&#160;informational influence);&#160;in&#160;turn,&#160;re-establishing&#160;correct morphogenetic&#160;cues&#160;and&#160;forcing cell&#160;<br/>communication with&#160;this&#160;set&#160;of&#160;cues&#160;may be a path&#160;forward for&#160;tumor&#160;normalization/reprogramming.&#160;</p>
<p style="position:absolute;top:135px;left:184px;white-space:nowrap" class="ft28"><b>Morphogenetic</b></p>
<p style="position:absolute;top:158px;left:186px;white-space:nowrap" class="ft28"><b>(morphostatic)</b></p>
<p style="position:absolute;top:180px;left:231px;white-space:nowrap" class="ft28"><b>Field</b></p>
<p style="position:absolute;top:320px;left:357px;white-space:nowrap" class="ft23">embryonic</p>
<p style="position:absolute;top:332px;left:352px;white-space:nowrap" class="ft23">development</p>
<p style="position:absolute;top:326px;left:456px;white-space:nowrap" class="ft23">remodeling</p>
<p style="position:absolute;top:326px;left:555px;white-space:nowrap" class="ft23">morphostasis</p>
<p style="position:absolute;top:326px;left:659px;white-space:nowrap" class="ft23">regeneration</p>
<p style="position:absolute;top:327px;left:746px;white-space:nowrap" class="ft29"><i>time</i></p>
<p style="position:absolute;top:392px;left:370px;white-space:nowrap" class="ft23">birth</p>
<p style="position:absolute;top:404px;left:364px;white-space:nowrap" class="ft23">defects</p>
<p style="position:absolute;top:393px;left:450px;white-space:nowrap" class="ft23">wear-and-tear</p>
<p style="position:absolute;top:404px;left:450px;white-space:nowrap" class="ft23">(microtrauma)</p>
<p style="position:absolute;top:392px;left:571px;white-space:nowrap" class="ft23">aging,</p>
<p style="position:absolute;top:404px;left:569px;white-space:nowrap" class="ft23">cancer</p>
<p style="position:absolute;top:392px;left:658px;white-space:nowrap" class="ft23">severe injury,</p>
<p style="position:absolute;top:404px;left:639px;white-space:nowrap" class="ft23">regenerative medicine</p>
<p style="position:absolute;top:174px;left:493px;white-space:nowrap" class="ft210"><b>bioelectrical</b></p>
<p style="position:absolute;top:131px;left:502px;white-space:nowrap" class="ft26">chemical,</p>
<p style="position:absolute;top:145px;left:512px;white-space:nowrap" class="ft26">ECM,</p>
<p style="position:absolute;top:159px;left:508px;white-space:nowrap" class="ft26">tension</p>
<p style="position:absolute;top:150px;left:601px;white-space:nowrap" class="ft26">signals</p>
<p style="position:absolute;top:189px;left:424px;white-space:nowrap" class="ft26">x,y,z,t</p>
<p style="position:absolute;top:203px;left:434px;white-space:nowrap" class="ft211"><i>00&#160;1&#160;1&#160;1</i></p>
<p style="position:absolute;top:188px;left:501px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:188px;left:525px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:203px;left:552px;white-space:nowrap" class="ft211"><i>1&#160;1&#160;1</i></p>
<p style="position:absolute;top:188px;left:601px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:188px;left:625px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:172px;left:666px;white-space:nowrap" class="ft211"><i>11</i></p>
<p style="position:absolute;top:157px;left:667px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:140px;left:652px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:125px;left:625px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:124px;left:601px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:109px;left:588px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:109px;left:572px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:109px;left:567px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:94px;left:499px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:109px;left:488px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:109px;left:472px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:109px;left:467px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:93px;left:467px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:125px;left:401px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:109px;left:388px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:109px;left:372px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:140px;left:352px;white-space:nowrap" class="ft211"><i>1&#160;1&#160;1</i></p>
<p style="position:absolute;top:156px;left:399px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:172px;left:388px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:172px;left:372px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:172px;left:367px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:93px;left:475px;white-space:nowrap" class="ft211"><i>000</i></p>
<p style="position:absolute;top:109px;left:453px;white-space:nowrap" class="ft211"><i>0</i></p>
<p style="position:absolute;top:125px;left:380px;white-space:nowrap" class="ft211"><i>0&#160;0</i></p>
<p style="position:absolute;top:157px;left:380px;white-space:nowrap" class="ft211"><i>00</i></p>
<p style="position:absolute;top:188px;left:380px;white-space:nowrap" class="ft211"><i>0&#160;0&#160;1</i></p>
<p style="position:absolute;top:203px;left:380px;white-space:nowrap" class="ft211"><i>1</i></p>
<p style="position:absolute;top:187px;left:412px;white-space:nowrap" class="ft211"><i>0</i></p>
<p style="position:absolute;top:188px;left:480px;white-space:nowrap" class="ft211"><i>0 0</i></p>
<p style="position:absolute;top:188px;left:512px;white-space:nowrap" class="ft211"><i>0</i></p>
<p style="position:absolute;top:203px;left:534px;white-space:nowrap" class="ft211"><i>00</i></p>
<p style="position:absolute;top:188px;left:580px;white-space:nowrap" class="ft211"><i>0 0</i></p>
<p style="position:absolute;top:188px;left:612px;white-space:nowrap" class="ft211"><i>0</i></p>
<p style="position:absolute;top:172px;left:653px;white-space:nowrap" class="ft211"><i>0</i></p>
<p style="position:absolute;top:157px;left:675px;white-space:nowrap" class="ft211"><i>0</i></p>
<p style="position:absolute;top:140px;left:634px;white-space:nowrap" class="ft211"><i>00</i></p>
<p style="position:absolute;top:109px;left:653px;white-space:nowrap" class="ft211"><i>0</i></p>
<p style="position:absolute;top:125px;left:612px;white-space:nowrap" class="ft211"><i>0</i></p>
<p style="position:absolute;top:109px;left:553px;white-space:nowrap" class="ft211"><i>0</i></p>
<p style="position:absolute;top:121px;left:465px;white-space:nowrap" class="ft212">(</p>
<p style="position:absolute;top:121px;left:569px;white-space:nowrap" class="ft212">)</p>
<p style="position:absolute;top:359px;left:226px;white-space:nowrap" class="ft213">Embryogenesis</p>
<p style="position:absolute;top:423px;left:191px;white-space:nowrap" class="ft213">Regeneration</p>
<p style="position:absolute;top:439px;left:275px;white-space:nowrap" class="ft213">Cancer</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft30{font-size:9px;font-family:Times;color:#000000;}
	.ft31{font-size:9px;font-family:Times;color:#000000;}
	.ft32{font-size:11px;font-family:Times;color:#000000;}
	.ft33{font-size:9px;font-family:Times;color:#000000;}
	.ft34{font-size:11px;font-family:Times;color:#000000;}
	.ft35{font-size:11px;font-family:Times;color:#000000;}
	.ft36{font-size:7px;font-family:Times;color:#000000;}
	.ft37{font-size:7px;font-family:Times;color:#368135;}
	.ft38{font-size:26px;font-family:Times;color:#000000;}
	.ft39{font-size:15px;font-family:Times;color:#000000;}
	.ft310{font-size:9px;line-height:14px;font-family:Times;color:#000000;}
	.ft311{font-size:9px;line-height:15px;font-family:Times;color:#000000;}
	.ft312{font-size:9px;line-height:13px;font-family:Times;color:#000000;}
	.ft313{font-size:11px;line-height:14px;font-family:Times;color:#000000;}
	.ft314{font-size:11px;line-height:15px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page3-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft30"><i><b>Neurotransmitters&#160;and&#160;Electroceuticals&#160;in&#160;Cancer&#160;</b></i></p>
<p style="position:absolute;top:57px;left:560px;white-space:nowrap" class="ft30"><i><b>Current&#160;Pharmaceutical&#160;Design,&#160;</b></i><b>2017<i>, Vol.&#160;23, No. 32&#160; &#160;&#160;</i></b><b>4829<i>&#160;</i></b></p>
<p style="position:absolute;top:88px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:107px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:127px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:146px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:166px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:185px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:205px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:224px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:244px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:263px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:283px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:302px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:322px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:341px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:361px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:380px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:400px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:419px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:438px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:458px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:478px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:497px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:517px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:536px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:555px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:575px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:595px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:614px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:634px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:653px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:672px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:692px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:712px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:731px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:751px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:770px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:789px;left:96px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:810px;left:96px;white-space:nowrap" class="ft312"><b>Fig.&#160;(2).</b>&#160;Normalization of&#160;cancer&#160;by actively patterning environments.&#160;<br/>(<b>A</b>)&#160;Cancer&#160;cells&#160;introduced&#160;into&#160;embryonic&#160;environments&#160;are able&#160;to&#160;par-<br/>ticipate in&#160;normal&#160;development&#160;and contribute to&#160;healthy&#160;organs&#160;[104,&#160;130].&#160;<br/>(<b>B</b>)&#160;Similarly,&#160;tumors&#160;induced&#160;on&#160;limbs&#160;of&#160;regenerative&#160;species&#160;become&#160;<br/>normalized if&#160;the process&#160;of&#160;regeneration is&#160;induced&#160;[131-134].&#160;These&#160;ex-<br/>amples&#160;reveal&#160;that&#160;at&#160;least&#160;in&#160;some&#160;cases,&#160;cancer&#160;is&#160;not&#160;irrevocable&#160;cell-<br/>autonomous&#160;damage&#160;but&#160;a reversible&#160;network disorder&#160;– an error&#160;of&#160;commu-<br/>nication and&#160;geometry&#160;[135].&#160;Images&#160;courtesy&#160;of&#160;Jeremy Guay of&#160;Peregrine&#160;<br/>Creative.&#160;<br/>&#160;</p>
<p style="position:absolute;top:964px;left:96px;white-space:nowrap" class="ft314">activating or&#160;suppressing cancer-relevant&#160;processes&#160;<i>in&#160;vivo</i>. Most&#160;of&#160;<br/>these data&#160;remain&#160;to&#160;be&#160;validated&#160;in&#160;mammalian&#160;models, being&#160;first&#160;<br/>derived in the&#160;frog&#160;<i>Xenopus&#160;laevis</i>&#160;[17].&#160; Artificial&#160;depolarization of&#160;<br/>a&#160;selected&#160;cell&#160;population of&#160;cells&#160;was&#160;sufficient&#160;to&#160;induce&#160;a&#160;mela-<br/>noma-like&#160;phenotype in&#160;normal&#160;animals’&#160;pigment&#160;cell&#160;population&#160;<br/>[60,&#160;61].&#160;This&#160;metastatic&#160;conversion (Fig.&#160;<b>7</b>) takes place in&#160;a wild-<br/>type&#160;background,&#160;not&#160;exposed to&#160;any mutagen or&#160;carcinogen;&#160;it&#160;<br/>features&#160;stochastic&#160;outcomes&#160;within&#160;a&#160;cohort&#160;of&#160;animals&#160;exposed&#160;to&#160;<br/>the&#160;same&#160;manipulation [62],&#160;and may be&#160;a&#160;model&#160;for&#160;the&#160;variability&#160;<br/>of cancer&#160;incidence&#160;in&#160;clinical&#160;settings. &#160;</p>
<p style="position:absolute;top:88px;left:496px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:88px;left:517px;white-space:nowrap" class="ft32">Conversely,&#160;tumorigenesis&#160;induced by expression of&#160;human&#160;</p>
<p style="position:absolute;top:103px;left:496px;white-space:nowrap" class="ft314">oncogenes&#160;in frog larvae&#160;can be&#160;over-ridden by appropriate&#160;modula-<br/>tion of&#160;resting potential&#160;[63].&#160;This&#160;also works&#160;at&#160;considerable&#160;dis-<br/>tance<i>&#160;via</i>&#160;a&#160;gap&#160;junction-dependent&#160;mechanism&#160;[64,&#160;65],&#160;and tumors&#160;<br/>can&#160;be&#160;prevented&#160;or&#160;reverted&#160;to&#160;normal&#160;by pharmacological,&#160;genetic,&#160;<br/>or&#160;even&#160;light-based&#160;stimuli&#160;(Fig.&#160;<b>8</b>)&#160;that&#160;induce&#160;hyperpolarization&#160;<br/>[65,&#160;66].&#160;This&#160;was&#160;another&#160;example&#160;of&#160;the&#160;over-riding of&#160;genetic&#160;<br/>state&#160;by physiological&#160;parameters,&#160;as&#160;the&#160;mutant&#160;oncogene&#160;was&#160;<br/>strongly present&#160;in&#160;the&#160;regions&#160;in&#160;which tumorigenesis was&#160;pre-<br/>vented.&#160;In&#160;normal&#160;cases,&#160;the&#160;appearance&#160;of&#160;tumor&#160;structures&#160;can be&#160;<br/>observed very&#160;early,&#160;by fluorescent&#160;signals&#160;from&#160;a&#160;voltage&#160;reporting&#160;<br/>dye&#160;[60].&#160;</p>
<p style="position:absolute;top:272px;left:496px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:272px;left:517px;white-space:nowrap" class="ft32">A&#160;few&#160;overall&#160;lessons emerged from&#160;this&#160;most&#160;recent&#160;body of&#160;</p>
<p style="position:absolute;top:287px;left:496px;white-space:nowrap" class="ft314">work.&#160;First,&#160;that&#160;it&#160;is&#160;imperative&#160;to&#160;focus&#160;on the&#160;physiological&#160;state&#160;<br/>(Vmem&#160;and cellular&#160;connectivity),&#160;not&#160;individual&#160;channel&#160;genes,&#160;<br/>since&#160;channels&#160;open and&#160;close&#160;post-translationally,&#160;while&#160;Vmem&#160;is&#160;<br/>the sum&#160;of numerous&#160;channels’ activity. Thus, the&#160;same&#160;effect can&#160;<br/>be&#160;obtained<i>&#160;via</i>&#160;the&#160;action of&#160;any number&#160;of&#160;channels&#160;that&#160;contribute&#160;<br/>to&#160;overall&#160;resting potential,&#160;and Vmem&#160;can&#160;change&#160;in&#160;the&#160;absence&#160;of&#160;<br/>detectable&#160;changes&#160;of&#160;channel&#160;mRNA&#160;or&#160;protein levels.&#160;Thus,&#160;track-<br/>ing individual&#160;channels&#160;or&#160;using profiling of fixed&#160;(non-living)&#160;tis-<br/>sue&#160;can give&#160;confusing&#160;results due&#160;to&#160;the lack&#160;of&#160;one-to-one&#160;corre-<br/>spondence&#160;between&#160;genetic&#160;and physiological&#160;states.&#160;Second,&#160;the&#160;<br/>effects&#160;are often&#160;non-local: metastatic or&#160;tumorigenic outcomes can&#160;<br/>be&#160;a&#160;function of&#160;bioelectric&#160;states&#160;at&#160;considerable&#160;distances&#160;– the&#160;<br/>signaling is&#160;definitely not&#160;cell-autonomous,&#160;although the&#160;maximum&#160;<br/>distance&#160;(size&#160;of&#160;the&#160;“microenvironment”)&#160;that&#160;might&#160;be&#160;involved in&#160;<br/>mammals&#160;is&#160;unknown.&#160; Finally,&#160;that&#160;the&#160;physiological&#160;signaling of&#160;<br/>the&#160;environment&#160;is&#160;a&#160;key determinant&#160;of&#160;outcome&#160;which cannot&#160;be&#160;<br/>predicted&#160;from&#160;molecular&#160;profiling&#160;alone.&#160;</p>
<p style="position:absolute;top:547px;left:496px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:547px;left:517px;white-space:nowrap" class="ft32">We&#160;suggest&#160;that&#160;the&#160;multitude&#160;of&#160;ion channel&#160;drugs,&#160;many of&#160;</p>
<p style="position:absolute;top:562px;left:496px;white-space:nowrap" class="ft313">which are&#160;already approved&#160;for&#160;human&#160;use&#160;(as&#160;antiepileptics,&#160;antiar-<br/>rhythmic&#160;agents,&#160;<i>etc</i>.)&#160;and some&#160;of&#160;which are&#160;kept&#160;on pharmaceuti-<br/>cal&#160;company shelves,&#160;form&#160;a&#160;powerful&#160;toolkit.&#160;These&#160;compounds&#160;<br/>are potential&#160;electroceuticals; while&#160;such&#160;approaches&#160;have&#160;so&#160;far&#160;<br/>been focused on neural&#160;targets&#160;[67,&#160;68],&#160;the&#160;existence&#160;of&#160;ion chan-<br/>nel-regulated&#160;bioelectric&#160;signaling in&#160;many cell&#160;types&#160;[69-73]&#160;and&#160;<br/>the&#160;plethora&#160;of&#160;ion channel&#160;drugs&#160;suggest&#160;that&#160;the&#160;next&#160;advances&#160;in&#160;<br/>this field&#160;will&#160;include&#160;expanding&#160;the use of&#160;electroceuticals&#160;to&#160;har-<br/>ness&#160;them&#160;in&#160;modulating cancer&#160;processes.&#160;Work&#160;dissecting the&#160;<br/>mechanisms&#160;by which bioelectric&#160;signals&#160;regulate&#160;melanocyte&#160;con-<br/>version implicated serotonergic&#160;signaling (Fig.&#160;<b>9</b>)&#160;[17,&#160;60-62].&#160;De-<br/>polarized&#160;cells&#160;produce&#160;a&#160;serotonin signal&#160;that&#160;causes&#160;melanocytes&#160;<br/>to undergo a&#160;change&#160;toward highly metastatic&#160;behavior.&#160;The&#160;charac-<br/>terization of this&#160;pathway&#160;suggested that&#160;blocking&#160;serotonin move-<br/>ment&#160;across&#160;cell&#160;membranes could be&#160;a promising&#160;strategy&#160;for&#160;the&#160;<br/>suppression of&#160;metastases.&#160;Luckily,&#160;human-compatible drugs&#160;al-<br/>ready exist&#160;that&#160;do precisely this:&#160;the&#160;class&#160;of&#160;widely-used&#160;serotonin&#160;<br/>reuptake&#160;inhibitors&#160;(SSRIs)&#160;[74].&#160;</p>
<p style="position:absolute;top:844px;left:496px;white-space:nowrap" class="ft35"><b>3.&#160;NEUROTRANSMITTERS&#160;AND CANCER&#160;</b></p>
<p style="position:absolute;top:863px;left:496px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:863px;left:517px;white-space:nowrap" class="ft32">In&#160;the nervous&#160;system,&#160;electrical&#160;activity of&#160;neurons is&#160;coupled&#160;</p>
<p style="position:absolute;top:878px;left:496px;white-space:nowrap" class="ft313">to important&#160;changes&#160;in cell&#160;behavior<i>&#160;via</i>&#160;the&#160;movement&#160;of&#160;neuro-<br/>transmitter&#160;molecules. Voltage&#160;changes&#160;alter the&#160;import/secretion&#160;of&#160;<br/>neurotransmitters&#160;across&#160;membranes.&#160;Neurotransmitters&#160;such&#160;as&#160;<br/>serotonin&#160;are&#160;potent&#160;mitogens&#160;and have many other effects&#160;on tran-<br/>scription,&#160;cytoskeleton,&#160;and cell&#160;metabolism.&#160;In&#160;this&#160;way,&#160;neuro-<br/>transmitter&#160;dynamics&#160;cross&#160;cell&#160;membranes&#160;are&#160;a&#160;crucial&#160;link be-<br/>tween bioelectric&#160;states&#160;and cell&#160;behaviors&#160;they&#160;control.&#160;Recent&#160;<br/>work has&#160;shown this&#160;relationship to be&#160;true&#160;outside&#160;of&#160;the&#160;CNS as&#160;<br/>well&#160;[33,&#160;75,&#160;76].&#160;&#160;</p>
<p style="position:absolute;top:1018px;left:496px;white-space:nowrap" class="ft32">&#160;</p>
<p style="position:absolute;top:1018px;left:517px;white-space:nowrap" class="ft32">Neurotransmitter&#160;signaling in cancer&#160;biology has&#160;attracted at-</p>
<p style="position:absolute;top:1033px;left:496px;white-space:nowrap" class="ft314">tention&#160;to&#160;molecules such&#160;as glutamate, glycine,&#160;acetylcholine,&#160;<br/>GABA,&#160;and dopamine&#160;[77-81].&#160;Some&#160;of the most&#160;interesting data&#160;<br/>implicate&#160;serotonin [82-88],&#160;although the&#160;epidemiological&#160;picture&#160;is&#160;<br/>complicated&#160;by the&#160;fact&#160;that&#160;SSRIs&#160;are most&#160;often used&#160;on de-<br/>pressed patients&#160;who&#160;are&#160;undergoing stresses&#160;that&#160;may&#160;alter&#160;the&#160;</p>
<p style="position:absolute;top:223px;left:148px;white-space:nowrap" class="ft32">mouse cells</p>
<p style="position:absolute;top:262px;left:148px;white-space:nowrap" class="ft32">cancer cells</p>
<p style="position:absolute;top:491px;left:275px;white-space:nowrap" class="ft37"><b>Induce tumor</b></p>
<p style="position:absolute;top:629px;left:219px;white-space:nowrap" class="ft37"><b>Amputate through tumor</b></p>
<p style="position:absolute;top:775px;left:119px;white-space:nowrap" class="ft37"><b>Tumor cells participate in making normal limb!</b></p>
<p style="position:absolute;top:106px;left:120px;white-space:nowrap" class="ft38"><b>A</b></p>
<p style="position:absolute;top:338px;left:120px;white-space:nowrap" class="ft38"><b>B</b></p>
<p style="position:absolute;top:110px;left:185px;white-space:nowrap" class="ft39">+</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft40{font-size:9px;font-family:Times;color:#000000;}
	.ft41{font-size:9px;font-family:Times;color:#000000;}
	.ft42{font-size:11px;font-family:Times;color:#000000;}
	.ft43{font-size:9px;font-family:Times;color:#000000;}
	.ft44{font-size:9px;font-family:Times;color:#000000;}
	.ft45{font-size:12px;font-family:Times;color:#000000;}
	.ft46{font-size:10px;font-family:Times;color:#000000;}
	.ft47{font-size:12px;font-family:Times;color:#000000;}
	.ft48{font-size:5px;font-family:Times;color:#000000;}
	.ft49{font-size:2px;font-family:Times;color:#000000;}
	.ft410{font-size:6px;font-family:Times;color:#000000;}
	.ft411{font-size:14px;font-family:Times;color:#4a4faa;-moz-transform: matrix(         0,          1,         -1,          0, 0, 0);-webkit-transform: matrix(         0,          1,         -1,          0, 0, 0);-o-transform: matrix(         0,          1,         -1,          0, 0, 0);-ms-transform: matrix(         0,          1,         -1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft412{font-size:43px;font-family:Times;color:#000000;}
	.ft413{font-size:14px;font-family:Times;color:#ffffff;}
	.ft414{font-size:8px;font-family:Times;color:#ffffff;}
	.ft415{font-size:9px;line-height:14px;font-family:Times;color:#000000;}
	.ft416{font-size:9px;line-height:15px;font-family:Times;color:#000000;}
	.ft417{font-size:12px;line-height:19px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page4-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft40"><b>4830 &#160; &#160;<i>Current&#160;Pharmaceutical&#160;Design,&#160;</i></b><b>2017<i>, Vol.&#160;23, No. 32&#160;</i></b></p>
<p style="position:absolute;top:57px;left:789px;white-space:nowrap" class="ft41"><i><b>Tuszynski&#160;et&#160;al.&#160;</b></i></p>
<p style="position:absolute;top:88px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:107px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:127px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:146px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:166px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:185px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:205px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:224px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:244px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:263px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:283px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:302px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:322px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:341px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:361px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:380px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:400px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:419px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:438px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:458px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:478px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:497px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:517px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:536px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:555px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:575px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:595px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:614px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:634px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:653px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:672px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:692px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:712px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:731px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:751px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:770px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:789px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:809px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:829px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:848px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:867px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:887px;left:865px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:906px;left:96px;white-space:nowrap" class="ft42">&#160;</p>
<p style="position:absolute;top:927px;left:96px;white-space:nowrap" class="ft416"><b>Fig.&#160;(3).</b>&#160;The basics&#160;of&#160;bioelectricity.&#160;<br/>The&#160;familiar components&#160;of&#160;electrical&#160;signaling in&#160;neurons&#160;include resting potential,&#160;generated by&#160;the activity&#160;of&#160;ion channels&#160;in&#160;the cell&#160;membrane,&#160;and&#160;the&#160;<br/>electrical&#160;synapse which allows&#160;current&#160;to&#160;flow&#160;into&#160;neighboring cells&#160;(<b>A</b>).&#160;These electrical&#160;synapses&#160;occur&#160;in&#160;the CNS alongside the much more&#160;familiar&#160;chemi-<br/>cal&#160;synapses&#160;[136-138],&#160;but&#160;are especially&#160;crucial&#160;outside of&#160;excitable tissues&#160;for&#160;cell&#160;regulation and tumor&#160;suppression&#160;[139-142].&#160;These same components&#160;are&#160;<br/>present&#160;in&#160;most&#160;somatic cells&#160;(<b>B</b>),&#160;which likewise&#160;generate&#160;resting potentials&#160;and share them&#160;with&#160;their&#160;neighbors using the exact&#160;same ion channel&#160;and gap&#160;<br/>junction&#160;proteins.&#160;Even&#160;non-excitable tissues&#160;are composed&#160;of&#160;cell&#160;networks&#160;(<b>C</b>)&#160;in&#160;which cells&#160;coordinate&#160;activity&#160;and execute&#160;group decision-making&#160;during&#160;<br/>pattern&#160;generation and maintenance.&#160;These&#160;networks&#160;signal<i>&#160;via</i>&#160;the voltage-dependent&#160;movement&#160;of&#160;small&#160;molecules&#160;such as&#160;serotonin and other&#160;neurotransmit-<br/>ters. All of&#160;these&#160;components&#160;have&#160;been&#160;implicated&#160;in&#160;various&#160;stages&#160;of&#160;the&#160;cancer&#160;process.&#160;The&#160;result of&#160;this&#160;signaling&#160;is&#160;growth&#160;control, differentiation,&#160;pattern&#160;<br/>regulation –&#160;processes that&#160;go&#160;awry&#160;in&#160;cancer.&#160;Molecular&#160;tools&#160;now&#160;exist&#160;for&#160;manipulating&#160;bioelectric state of&#160;cells&#160;(intrinsic&#160;plasticity),&#160;connectivity&#160;of&#160;the&#160;<br/>bioelectric network (synaptic&#160;plasticity),&#160;or&#160;the movement&#160;of&#160;neurotransmitters&#160;within&#160;the tissue (network&#160;activity).&#160;Images courtesy&#160;of&#160;Jeremy&#160;Guay&#160;of&#160;Pere-<br/>grine Creative and Alexis&#160;Pietak.&#160;<br/>&#160;</p>
<p style="position:absolute;top:179px;left:233px;white-space:nowrap" class="ft43">Presynaptic</p>
<p style="position:absolute;top:192px;left:245px;white-space:nowrap" class="ft43">neuron</p>
<p style="position:absolute;top:291px;left:296px;white-space:nowrap" class="ft43">Nerve</p>
<p style="position:absolute;top:304px;left:291px;white-space:nowrap" class="ft43">impulse</p>
<p style="position:absolute;top:388px;left:220px;white-space:nowrap" class="ft43">neuron</p>
<p style="position:absolute;top:376px;left:206px;white-space:nowrap" class="ft43">Postsynaptic</p>
<p style="position:absolute;top:512px;left:215px;white-space:nowrap" class="ft45"><b>Non-neural</b></p>
<p style="position:absolute;top:529px;left:212px;white-space:nowrap" class="ft45"><b>cell network</b></p>
<p style="position:absolute;top:434px;left:423px;white-space:nowrap" class="ft46">Gap Junction</p>
<p style="position:absolute;top:446px;left:406px;white-space:nowrap" class="ft46">(electrical synapse)</p>
<p style="position:absolute;top:472px;left:527px;white-space:nowrap" class="ft47">Dominant negative Connexin</p>
<p style="position:absolute;top:490px;left:527px;white-space:nowrap" class="ft47">protein</p>
<p style="position:absolute;top:509px;left:527px;white-space:nowrap" class="ft47">GJC drug blocker</p>
<p style="position:absolute;top:528px;left:527px;white-space:nowrap" class="ft47">Cx mutant with altered gating or</p>
<p style="position:absolute;top:545px;left:527px;white-space:nowrap" class="ft47">permeability</p>
<p style="position:absolute;top:628px;left:526px;white-space:nowrap" class="ft47">Dominant ion channel</p>
<p style="position:absolute;top:645px;left:526px;white-space:nowrap" class="ft47">overexpression (depolarizing or</p>
<p style="position:absolute;top:663px;left:525px;white-space:nowrap" class="ft47">hyperpolarizing, light-gated, drug-</p>
<p style="position:absolute;top:681px;left:525px;white-space:nowrap" class="ft47">gated)</p>
<p style="position:absolute;top:700px;left:525px;white-space:nowrap" class="ft417">Drug blocker of native channel<br/>Drug opener of native channel</p>
<p style="position:absolute;top:795px;left:525px;white-space:nowrap" class="ft47">Dominant transporter or receptor</p>
<p style="position:absolute;top:812px;left:525px;white-space:nowrap" class="ft47">overexpression</p>
<p style="position:absolute;top:831px;left:526px;white-space:nowrap" class="ft47">Agonist or&#160;Antagonist of receptor or</p>
<p style="position:absolute;top:848px;left:526px;white-space:nowrap" class="ft47">transporter</p>
<p style="position:absolute;top:867px;left:526px;white-space:nowrap" class="ft47">Photo-uncaging of neurotransmitter</p>
<p style="position:absolute;top:865px;left:284px;white-space:nowrap" class="ft46">Neurotransmitters</p>
<p style="position:absolute;top:879px;left:275px;white-space:nowrap" class="ft46">(control cell behavior)</p>
<p style="position:absolute;top:842px;left:409px;white-space:nowrap" class="ft48">HO</p>
<p style="position:absolute;top:865px;left:460px;white-space:nowrap" class="ft48">N</p>
<p style="position:absolute;top:872px;left:460px;white-space:nowrap" class="ft48">H</p>
<p style="position:absolute;top:817px;left:480px;white-space:nowrap" class="ft48">NH2</p>
<p style="position:absolute;top:624px;left:422px;white-space:nowrap" class="ft46">Ion channels</p>
<p style="position:absolute;top:635px;left:419px;white-space:nowrap" class="ft46">(setting Vmem)</p>
<p style="position:absolute;top:438px;left:602px;white-space:nowrap" class="ft45"><b>Tools</b></p>
<p style="position:absolute;top:435px;left:784px;white-space:nowrap" class="ft411">Synaptic plasticity</p>
<p style="position:absolute;top:602px;left:784px;white-space:nowrap" class="ft411">Intrinsic plasticity</p>
<p style="position:absolute;top:768px;left:784px;white-space:nowrap" class="ft411">Network&#160;</p>
<p style="position:absolute;top:831px;left:784px;white-space:nowrap" class="ft411">Activity</p>
<p style="position:absolute;top:90px;left:172px;white-space:nowrap" class="ft412"><b>A</b></p>
<p style="position:absolute;top:89px;left:464px;white-space:nowrap" class="ft412"><b>B</b></p>
<p style="position:absolute;top:435px;left:159px;white-space:nowrap" class="ft412"><b>C</b></p>
<p style="position:absolute;top:235px;left:673px;white-space:nowrap" class="ft413">Vmem</p>
<p style="position:absolute;top:235px;left:743px;white-space:nowrap" class="ft413">Vmem</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft50{font-size:9px;font-family:Times;color:#000000;}
	.ft51{font-size:9px;font-family:Times;color:#000000;}
	.ft52{font-size:9px;font-family:Times;color:#000000;}
	.ft53{font-size:5px;font-family:Times;color:#000000;}
	.ft54{font-size:9px;font-family:Times;color:#000000;}
	.ft55{font-size:7px;font-family:Times;color:#000000;}
	.ft56{font-size:4px;font-family:Times;color:#000000;}
	.ft57{font-size:7px;font-family:Times;color:#000000;-moz-transform: matrix(         0,          1,         -1,          0, 0, 0);-webkit-transform: matrix(         0,          1,         -1,          0, 0, 0);-o-transform: matrix(         0,          1,         -1,          0, 0, 0);-ms-transform: matrix(         0,          1,         -1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft58{font-size:13px;font-family:Times;color:#000000;}
	.ft59{font-size:11px;font-family:Times;color:#000000;}
	.ft510{font-size:3px;font-family:Times;color:#000000;}
	.ft511{font-size:8px;font-family:Times;color:#000000;}
	.ft512{font-size:9px;font-family:Times;color:#2f5f5c;-moz-transform: matrix(1.2412825183, -0.2412825183, 0.2412825183, 1.2412825183, 0, 0);-webkit-transform: matrix(1.2412825183, -0.2412825183, 0.2412825183, 1.2412825183, 0, 0);-o-transform: matrix(1.2412825183, -0.2412825183, 0.2412825183, 1.2412825183, 0, 0);-ms-transform: matrix(1.2412825183, -0.2412825183, 0.2412825183, 1.2412825183, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft513{font-size:9px;font-family:Times;color:#2f5f5c;-moz-transform: matrix(1.139962972, -0.139962972, 0.1399781474, 1.139962972, 0, 0);-webkit-transform: matrix(1.139962972, -0.139962972, 0.1399781474, 1.139962972, 0, 0);-o-transform: matrix(1.139962972, -0.139962972, 0.1399781474, 1.139962972, 0, 0);-ms-transform: matrix(1.139962972, -0.139962972, 0.1399781474, 1.139962972, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft514{font-size:9px;font-family:Times;color:#2f5f5c;-moz-transform: matrix(1.0177673167, -0.0177673167, 0.0177673167, 1.0177673167, 0, 0);-webkit-transform: matrix(1.0177673167, -0.0177673167, 0.0177673167, 1.0177673167, 0, 0);-o-transform: matrix(1.0177673167, -0.0177673167, 0.0177673167, 1.0177673167, 0, 0);-ms-transform: matrix(1.0177673167, -0.0177673167, 0.0177673167, 1.0177673167, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft515{font-size:9px;font-family:Times;color:#2f5f5c;-moz-transform: matrix(0.9048930031, 0.0951069969, -0.0951069969, 0.9048930031, 0, 0);-webkit-transform: matrix(0.9048930031, 0.0951069969, -0.0951069969, 0.9048930031, 0, 0);-o-transform: matrix(0.9048930031, 0.0951069969, -0.0951069969, 0.9048930031, 0, 0);-ms-transform: matrix(0.9048930031, 0.0951069969, -0.0951069969, 0.9048930031, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft516{font-size:8px;font-family:Times;color:#2f5f5c;-moz-transform: matrix(0.8501059893, 0.1498940107, -0.1498940107, 0.8501059893, 0, 0);-webkit-transform: matrix(0.8501059893, 0.1498940107, -0.1498940107, 0.8501059893, 0, 0);-o-transform: matrix(0.8501059893, 0.1498940107, -0.1498940107, 0.8501059893, 0, 0);-ms-transform: matrix(0.8501059893, 0.1498940107, -0.1498940107, 0.8501059893, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft517{font-size:8px;font-family:Times;color:#2f5f5c;-moz-transform: matrix(0.9662637996, 0.0337362004, -0.0337362004, 0.9662637996, 0, 0);-webkit-transform: matrix(0.9662637996, 0.0337362004, -0.0337362004, 0.9662637996, 0, 0);-o-transform: matrix(0.9662637996, 0.0337362004, -0.0337362004, 0.9662637996, 0, 0);-ms-transform: matrix(0.9662637996, 0.0337362004, -0.0337362004, 0.9662637996, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft518{font-size:8px;font-family:Times;color:#2f5f5c;}
	.ft519{font-size:8px;font-family:Times;color:#2f5f5c;-moz-transform: matrix(1.075186171, -0.075186171, 0.075186171, 1.075186171, 0, 0);-webkit-transform: matrix(1.075186171, -0.075186171, 0.075186171, 1.075186171, 0, 0);-o-transform: matrix(1.075186171, -0.075186171, 0.075186171, 1.075186171, 0, 0);-ms-transform: matrix(1.075186171, -0.075186171, 0.075186171, 1.075186171, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft520{font-size:8px;font-family:Times;color:#2f5f5c;-moz-transform: matrix(1.1881801188, -0.1881801188, 0.1881801188, 1.1881801188, 0, 0);-webkit-transform: matrix(1.1881801188, -0.1881801188, 0.1881801188, 1.1881801188, 0, 0);-o-transform: matrix(1.1881801188, -0.1881801188, 0.1881801188, 1.1881801188, 0, 0);-ms-transform: matrix(1.1881801188, -0.1881801188, 0.1881801188, 1.1881801188, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft521{font-size:12px;font-family:Times;color:#e89b25;-moz-transform: matrix(0.1995594221, 0.8004405779, -0.8004147628, 0.1995594221, 0, 0);-webkit-transform: matrix(0.1995594221, 0.8004405779, -0.8004147628, 0.1995594221, 0, 0);-o-transform: matrix(0.1995594221, 0.8004405779, -0.8004147628, 0.1995594221, 0, 0);-ms-transform: matrix(0.1995594221, 0.8004405779, -0.8004147628, 0.1995594221, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft522{font-size:9px;font-family:Times;color:#2f5f5c;}
	.ft523{font-size:6px;font-family:Times;color:#ffffff;}
	.ft524{font-size:17px;font-family:Times;color:#000000;}
	.ft525{font-size:9px;line-height:15px;font-family:Times;color:#000000;}
	.ft526{font-size:9px;line-height:14px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page5-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft50"><i><b>Neurotransmitters&#160;and&#160;Electroceuticals&#160;in&#160;Cancer&#160;</b></i></p>
<p style="position:absolute;top:57px;left:560px;white-space:nowrap" class="ft50"><i><b>Current&#160;Pharmaceutical&#160;Design,&#160;</b></i><b>2017<i>, Vol.&#160;23, No. 32&#160; &#160;&#160;</i></b><b>4831<i>&#160;</i></b></p>
<p style="position:absolute;top:89px;left:96px;white-space:nowrap" class="ft525">&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/><b>Fig.&#160;(4).&#160;</b>Bioelectric gradients.&#160;<br/>Each&#160;cell in&#160;the&#160;organism&#160;uses&#160;ion&#160;channels&#160;and&#160;pumps&#160;to&#160;maintain&#160;a&#160;resting&#160;potential (Vmem)&#160;across&#160;its&#160;plasma membrane&#160;(in addition to&#160;a number&#160;of&#160;subcellu-<br/>lar&#160;gradients,&#160;such&#160;as&#160;nuclear&#160;envelope&#160;potential, and&#160;tissue-level gradients,&#160;such&#160;as&#160;trans-epithelial electric&#160;fields).&#160;Spatial&#160;patterns&#160;of&#160;resting potential&#160;can be&#160;<br/>detected&#160;<i>in&#160;vivo</i>&#160;using&#160;voltage-sensitive&#160;fluorescent dyes.&#160;Here, a&#160;fluorescent voltage&#160;reporter&#160;(Rhodamine&#160;6G&#160;dye&#160;[143,&#160;144],&#160;courtesy&#160;of&#160;Douglas&#160;J.&#160;Black-<br/>iston)&#160;applied&#160;to&#160;a stage 44&#160;frog embryo&#160;(Xenopus&#160;laevis)&#160;illustrates&#160;an&#160;anterior-posterior&#160;physiological&#160;gradient across&#160;the&#160;middle&#160;flank&#160;of&#160;a&#160;frog&#160;tadpole.&#160;The&#160;<br/>signal&#160;has&#160;been pseudocolored according to&#160;a scale where red is&#160;depolarized and&#160;purple is&#160;hyper-polarized.&#160;Such gradients,&#160;and&#160;their&#160;time-dependent&#160;changes,&#160;<br/>reflect&#160;the&#160;activity&#160;of&#160;the&#160;bioelectric circuits&#160;that&#160;set&#160;up&#160;prepatterns&#160;driving&#160;downstream&#160;gene expression&#160;and morphogenesis.&#160;&#160;Schematic&#160;of&#160;frog embryo was&#160;<br/>used<i>&#160;via</i>&#160;Xenbase,&#160;originally&#160;sourced from&#160;[145].&#160;Dye map image courtesy&#160;of&#160;Douglas&#160;Blackison.&#160;(The color&#160;version of&#160;the figure is&#160;available&#160;in&#160;the electronic&#160;<br/>copy of&#160;the article).&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/><b>Fig.&#160;(5).</b>&#160;Feedback between bioelectrics&#160;and gene regulatory networks&#160;regulates&#160;patterning.&#160;<br/>Cells&#160;are&#160;regulated&#160;by&#160;at least two&#160;layers&#160;of&#160;activity: the&#160;molecular&#160;genetic&#160;and&#160;the&#160;bioelectric&#160;(<b>A</b>).&#160;The&#160;molecular-genetic&#160;layer&#160;of&#160;pattern&#160;control is&#160;imple-<br/>mented&#160;by&#160;gene&#160;regulatory&#160;networks&#160;in&#160;which transcription factors&#160;control&#160;each&#160;other’s&#160;expression.&#160;The&#160;bioelectric layer&#160;of&#160;control&#160;is&#160;formed&#160;by the reciprocal&#160;<br/>interactions&#160;between&#160;ion&#160;channels&#160;and&#160;gap junctions,&#160;and cell&#160;resting potential:&#160;Vmem&#160;is&#160;determined by channels&#160;and electrical&#160;synapses,&#160;and at&#160;the same time,&#160;<br/>Vmem&#160;determines&#160;the&#160;gating&#160;properties&#160;of&#160;voltage&#160;sensitive&#160;channels&#160;and&#160;gap&#160;junctions. Thus, every&#160;cell has&#160;the&#160;opportunity&#160;to&#160;drive&#160;positive&#160;feedback&#160;loops&#160;that&#160;<br/>can amplify small&#160;differences&#160;(useful&#160;for&#160;spontaneous&#160;symmetry&#160;breaking)&#160;or&#160;negative feedback&#160;loops&#160;that&#160;confer&#160;stability&#160;and&#160;robustness&#160;to&#160;environmental&#160;<br/>stimuli. &#160;The&#160;genetic&#160;and&#160;bioelectric&#160;layers&#160;are&#160;functionally&#160;coupled, since&#160;Vmem&#160;changes&#160;can alter&#160;transcription&#160;of&#160;downstream&#160;target&#160;genes&#160;[146,&#160;147],&#160;while&#160;<br/>changes&#160;in&#160;the transcription of&#160;ion channel&#160;genes&#160;alter&#160;electric circuit&#160;dynamics.&#160;Recent&#160;data&#160;have shown that&#160;manipulation of&#160;the complex dynamics&#160;of&#160;the&#160;<br/>bioelectrical&#160;layer&#160;reveal&#160;its&#160;endogenous&#160;patterning functions,&#160;resulting in&#160;the production of&#160;frogs&#160;with&#160;ectopic limbs&#160;(<b>B</b>),&#160;flatworms with&#160;4&#160;heads (<b>C</b>),&#160;or tad-<br/>poles in&#160;which&#160;gut&#160;tissue has been reprogrammed&#160;into&#160;complete&#160;eyes&#160;(<b>D</b>)&#160;[32,&#160;46].&#160;Panel&#160;A was&#160;drawn&#160;by&#160;Alexis&#160;Pietak.&#160;The&#160;ectopic-limb&#160;frog&#160;in&#160;panel&#160;B&#160;was&#160;<br/>obtained from&#160;an&#160;optogenetic&#160;transgenic&#160;EnPAC&#160;[148]&#160;line produced by Gufa&#160;Lin.&#160;Panels&#160;C&#160;and D&#160;come from references&#160;[46]&#160;and [32]&#160;respectively.&#160;</p>
<p style="position:absolute;top:188px;left:178px;white-space:nowrap" class="ft55">Na</p>
<p style="position:absolute;top:242px;left:201px;white-space:nowrap" class="ft55">K</p>
<p style="position:absolute;top:285px;left:200px;white-space:nowrap" class="ft55">Cl-</p>
<p style="position:absolute;top:240px;left:207px;white-space:nowrap" class="ft56">+</p>
<p style="position:absolute;top:185px;left:189px;white-space:nowrap" class="ft56">+</p>
<p style="position:absolute;top:250px;left:185px;white-space:nowrap" class="ft57">Intracellular</p>
<p style="position:absolute;top:250px;left:261px;white-space:nowrap" class="ft57">Extracellular</p>
<p style="position:absolute;top:271px;left:149px;white-space:nowrap" class="ft58"><b>cell</b></p>
<p style="position:absolute;top:271px;left:134px;white-space:nowrap" class="ft58"><b>1</b></p>
<p style="position:absolute;top:122px;left:191px;white-space:nowrap" class="ft59">V</p>
<p style="position:absolute;top:132px;left:198px;white-space:nowrap" class="ft510">MEM</p>
<p style="position:absolute;top:170px;left:793px;white-space:nowrap" class="ft51"><b>-20 mV</b></p>
<p style="position:absolute;top:207px;left:793px;white-space:nowrap" class="ft51"><b>-30 mV</b></p>
<p style="position:absolute;top:244px;left:793px;white-space:nowrap" class="ft51"><b>-40 mV</b></p>
<p style="position:absolute;top:284px;left:793px;white-space:nowrap" class="ft51"><b>-50 mV</b></p>
<p style="position:absolute;top:321px;left:793px;white-space:nowrap" class="ft51"><b>-60 mV</b></p>
<p style="position:absolute;top:362px;left:793px;white-space:nowrap" class="ft51"><b>-70 mV</b></p>
<p style="position:absolute;top:561px;left:247px;white-space:nowrap" class="ft511">Cell signaling pathways;</p>
<p style="position:absolute;top:574px;left:236px;white-space:nowrap" class="ft511">(proliferation, differentiation,</p>
<p style="position:absolute;top:587px;left:240px;white-space:nowrap" class="ft511">cytoskeletal rearrangement,</p>
<p style="position:absolute;top:600px;left:278px;white-space:nowrap" class="ft511">migration)</p>
<p style="position:absolute;top:574px;left:437px;white-space:nowrap" class="ft511">Neurotransmitter</p>
<p style="position:absolute;top:587px;left:451px;white-space:nowrap" class="ft511">movement</p>
<p style="position:absolute;top:648px;left:355px;white-space:nowrap" class="ft512">Voltage&#160;gating</p>
<p style="position:absolute;top:716px;left:344px;white-space:nowrap" class="ft516">Ion&#160;flux&#160;control</p>
<p style="position:absolute;top:717px;left:226px;white-space:nowrap" class="ft52">Ion channel</p>
<p style="position:absolute;top:714px;left:478px;white-space:nowrap" class="ft52">Cell&#160;V</p>
<p style="position:absolute;top:721px;left:507px;white-space:nowrap" class="ft53">mem</p>
<p style="position:absolute;top:675px;left:413px;white-space:nowrap" class="ft53">mV</p>
<p style="position:absolute;top:634px;left:520px;white-space:nowrap" class="ft521">Bioelectrical</p>
<p style="position:absolute;top:758px;left:517px;white-space:nowrap" class="ft521">Molecular-genetic</p>
<p style="position:absolute;top:830px;left:475px;white-space:nowrap" class="ft52">Genes</p>
<p style="position:absolute;top:786px;left:359px;white-space:nowrap" class="ft512">Transcription</p>
<p style="position:absolute;top:853px;left:330px;white-space:nowrap" class="ft516">Transcription&#160;factors</p>
<p style="position:absolute;top:863px;left:227px;white-space:nowrap" class="ft52">Proteins</p>
<p style="position:absolute;top:646px;left:547px;white-space:nowrap" class="ft523"><b>Change Dynamics</b></p>
<p style="position:absolute;top:619px;left:645px;white-space:nowrap" class="ft524"><b>B</b></p>
<p style="position:absolute;top:908px;left:626px;white-space:nowrap" class="ft524"><b>D</b></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft60{font-size:9px;font-family:Times;color:#000000;}
	.ft61{font-size:9px;font-family:Times;color:#000000;}
	.ft62{font-size:9px;font-family:Times;color:#000000;}
	.ft63{font-size:9px;font-family:Times;color:#000000;}
	.ft64{font-size:11px;font-family:Times;color:#000000;}
	.ft65{font-size:11px;font-family:Times;color:#000000;}
	.ft66{font-size:11px;font-family:Times;color:#000000;}
	.ft67{font-size:20px;font-family:Times;color:#ffffff;}
	.ft68{font-size:20px;font-family:Times;color:#000000;}
	.ft69{font-size:11px;font-family:Times;color:#000000;-moz-transform: matrix(         0,          1,         -1,          0, 0, 0);-webkit-transform: matrix(         0,          1,         -1,          0, 0, 0);-o-transform: matrix(         0,          1,         -1,          0, 0, 0);-ms-transform: matrix(         0,          1,         -1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft610{font-size:6px;font-family:Times;color:#000000;-moz-transform: matrix(         0,          1,         -1,          0, 0, 0);-webkit-transform: matrix(         0,          1,         -1,          0, 0, 0);-o-transform: matrix(         0,          1,         -1,          0, 0, 0);-ms-transform: matrix(         0,          1,         -1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft611{font-size:22px;font-family:Times;color:#000000;}
	.ft612{font-size:8px;font-family:Times;color:#000000;}
	.ft613{font-size:7px;font-family:Times;color:#000000;}
	.ft614{font-size:8px;font-family:Times;color:#000000;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft615{font-size:8px;font-family:Times;color:#000000;-moz-transform: matrix(         0,          1,         -1,          0, 0, 0);-webkit-transform: matrix(         0,          1,         -1,          0, 0, 0);-o-transform: matrix(         0,          1,         -1,          0, 0, 0);-ms-transform: matrix(         0,          1,         -1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft616{font-size:16px;font-family:Times;color:#000000;}
	.ft617{font-size:9px;line-height:15px;font-family:Times;color:#000000;}
	.ft618{font-size:9px;line-height:14px;font-family:Times;color:#000000;}
	.ft619{font-size:9px;line-height:13px;font-family:Times;color:#000000;}
	.ft620{font-size:11px;line-height:15px;font-family:Times;color:#000000;}
	.ft621{font-size:11px;line-height:14px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page6-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft60"><b>4832 &#160; &#160;<i>Current&#160;Pharmaceutical&#160;Design,&#160;</i></b><b>2017<i>, Vol.&#160;23, No. 32&#160;</i></b></p>
<p style="position:absolute;top:57px;left:789px;white-space:nowrap" class="ft61"><i><b>Tuszynski&#160;et&#160;al.&#160;</b></i></p>
<p style="position:absolute;top:89px;left:96px;white-space:nowrap" class="ft619">&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/><b>Fig.&#160;(6).</b>&#160;Resting potential&#160;and cancer&#160;signatures&#160;<br/>Human&#160;oncogenes,&#160;when&#160;introduced&#160;into&#160;tadpoles,&#160;cause the formation of&#160;tumor-like structures&#160;(<b>A</b>, closeup&#160;in&#160;A’)&#160;which&#160;exhibit all of&#160;the&#160;key&#160;characteristics&#160;of&#160;<br/>cancer&#160;(over-proliferation,&#160;tissue&#160;disorganization,&#160;invasiveness,&#160;cancer&#160;marker&#160;gene&#160;expression,&#160;etc.).&#160; Because&#160;aberrant&#160;bioelectric signaling is&#160;an&#160;early&#160;compo-<br/>nent&#160;of&#160;the carcinogenic process,&#160;this&#160;transformation is&#160;observed<i>&#160;via</i>&#160;voltage-sensitive&#160;fluorescent&#160;dye&#160;signaling&#160;(<b>B</b>,&#160;closeup in&#160;B)&#160;<i>in&#160;vivo</i>,&#160;revealing the tumor&#160;<br/>sites&#160;and margins&#160;before&#160;they become anatomically&#160;apparent.&#160;Consistent&#160;with&#160;a&#160;reversion&#160;of&#160;cancer&#160;into&#160;a&#160;unicellular phenotype,&#160;a wide range of&#160;data&#160;[149,&#160;150]&#160;<br/>reveal that tumor&#160;cells, like&#160;stem&#160;and&#160;early&#160;embryonic&#160;cells, tend&#160;to&#160;be&#160;depolarized&#160;while&#160;mature,&#160;quiescent somatic&#160;cells&#160;tend&#160;to&#160;be hyperpolarized (<b>C</b>).&#160;Impor-<br/>tantly,&#160;it&#160;is&#160;now&#160;known that&#160;this&#160;relationship is&#160;not&#160;merely&#160;a marker,&#160;but&#160;is&#160;actually&#160;functionally&#160;determinative of&#160;cell&#160;behavior&#160;[51,&#160;52,&#160;63,&#160;151].&#160;Panels&#160;A-B’&#160;<br/>are taken from&#160;[63].&#160;The schematic&#160;of&#160;panel&#160;C&#160;was&#160;drawn by Jeremy&#160;Guay&#160;of&#160;Peregrine&#160;Creative,&#160;while&#160;the voltage diagram&#160;of&#160;panel&#160;C&#160;is&#160;modified after&#160;[149].&#160;<br/>&#160;</p>
<p style="position:absolute;top:827px;left:96px;white-space:nowrap" class="ft620">background of&#160;carcinogenic&#160;induction and progression.&#160;Our&#160;strat-<br/>egy,&#160;based&#160;on the&#160;finding that&#160;blockade&#160;of serotonin transport&#160;effi-<br/>ciently&#160;rescued voltage-induced&#160;melanoma&#160;conversion [61,&#160;62],&#160;was&#160;<br/>to explore&#160;an SSRI&#160;drug that&#160;did not&#160;cross&#160;the&#160;blood-brain barrier&#160;<br/>(an unusual&#160;requirement,&#160;since&#160;all&#160;known SSRIs&#160;were&#160;designed&#160;<br/>specifically&#160;for&#160;access&#160;to&#160;the&#160;brain).&#160;Such&#160;a&#160;compound could be&#160;<br/>expected to exert&#160;its&#160;protective&#160;effects&#160;throughout&#160;the&#160;body&#160;without&#160;<br/>causing&#160;the unwanted&#160;cognitive effects of&#160;SSRIs&#160;[89,&#160;90]. Thus, we&#160;<br/>tested&#160;Prozac&#160;and&#160;an&#160;analog&#160;<i>in&#160;vitro</i>,&#160;to&#160;begin&#160;to&#160;characterize&#160;the&#160;<br/>function of&#160;molecules&#160;suggested&#160;by the&#160;above&#160;strategy.&#160;An&#160;addi-<br/>tional&#160;component&#160;that&#160;must&#160;be&#160;considered is&#160;the&#160;cytoskeleton,&#160;as&#160;it&#160;<br/>is&#160;known to&#160;regulate the distribution of ion&#160;channels&#160;in&#160;a&#160;variety&#160;of&#160;<br/>cell&#160;types&#160;[91,&#160;92].&#160;It&#160;is&#160;also known that&#160;ion channels&#160;regulate&#160;<br/>NMDA&#160;receptors&#160;through microtubules&#160;[93].&#160;Moreover,&#160;voltage-<br/>dependent&#160;anion channels&#160;are&#160;controlled by the&#160;c-termini&#160;of&#160;tubulin&#160;<br/>[94].&#160;This&#160;taken together&#160;with previous&#160;observations&#160;indicates that&#160;<br/>the&#160;microtubule cytoskeleton and&#160;ion channels&#160;are&#160;involved in&#160;sig-<br/>nificant&#160;interactions&#160;such&#160;that&#160;regulation of one&#160;of these&#160;subsystems&#160;</p>
<p style="position:absolute;top:827px;left:496px;white-space:nowrap" class="ft621">affects&#160;the&#160;other.&#160;Hence,&#160;ion channel&#160;regulators may&#160;cause&#160;down-<br/>stream&#160;effects&#160;on microtubules&#160;and consequently the use&#160;of&#160;SSRIs&#160;<br/>could lead&#160;to&#160;hitherto&#160;unknown&#160;effects&#160;on cancer&#160;cells&#160;with&#160;poten-<br/>tial therapeutic applications.&#160;</p>
<p style="position:absolute;top:892px;left:496px;white-space:nowrap" class="ft64">&#160;</p>
<p style="position:absolute;top:892px;left:517px;white-space:nowrap" class="ft64">The&#160;cytoskeleton is&#160;a&#160;target&#160;for&#160;numerous&#160;chemotherapy drugs,&#160;</p>
<p style="position:absolute;top:907px;left:496px;white-space:nowrap" class="ft620">many of&#160;which bind preferentially&#160;to&#160;tubulin&#160;(so-called&#160;tubulin-<br/>binding agents&#160;or&#160;TBAs),&#160;such&#160;as&#160;paclitaxel,&#160;vinca alkaloids,&#160;lauli-<br/>malide,&#160;peloruside&#160;and others&#160;[95].&#160;Some&#160;of&#160;these&#160;compounds&#160;stabi-<br/>lize&#160;microtubules&#160;(<i>e.g</i>.&#160;taxanes)&#160;while others&#160;destabilize&#160;them&#160;(<i>e.g</i>.&#160;<br/>vinca&#160;alkaloids).&#160;Interestingly,&#160;it&#160;has&#160;been&#160;also&#160;discovered that&#160;other&#160;<br/>classes&#160;of&#160;compounds,&#160;<i>e.g</i>.&#160;opioids&#160;such&#160;as&#160;noscapine&#160;[96]&#160;interact&#160;<br/>with&#160;microtubules&#160;as&#160;well&#160;as&#160;anesthetics&#160;[97].&#160;It&#160;is,&#160;therefore,&#160;not&#160;<br/>unexpected&#160;that&#160;compounds&#160;which&#160;alter&#160;mood (psychoactives),&#160;for&#160;<br/>example&#160;the&#160;antidepressants&#160;such&#160;as&#160;Prozac&#160;and its&#160;analogs&#160;should&#160;<br/>also&#160;interact&#160;with&#160;microtubules&#160;and the&#160;cytoskeleton.&#160;It&#160;is&#160;known&#160;<br/>that&#160;they&#160;take several&#160;weeks&#160;for these&#160;compounds&#160;to&#160;achieve&#160;their&#160;<br/>clinical&#160;effects in&#160;human&#160;subjects,&#160;apparently&#160;because of&#160;the&#160;need&#160;</p>
<p style="position:absolute;top:1098px;left:96px;white-space:nowrap" class="ft66"><b>&#160;</b></p>
<p style="position:absolute;top:100px;left:107px;white-space:nowrap" class="ft67"><b>A</b></p>
<p style="position:absolute;top:349px;left:107px;white-space:nowrap" class="ft67"><b>B</b></p>
<p style="position:absolute;top:349px;left:507px;white-space:nowrap" class="ft67"><b>B</b></p>
<p style="position:absolute;top:166px;left:508px;white-space:nowrap" class="ft68"><b>A</b></p>
<p style="position:absolute;top:103px;left:554px;white-space:nowrap" class="ft69">Morphology</p>
<p style="position:absolute;top:228px;left:553px;white-space:nowrap" class="ft69">Physiology</p>
<p style="position:absolute;top:295px;left:554px;white-space:nowrap" class="ft69">(V</p>
<p style="position:absolute;top:313px;left:552px;white-space:nowrap" class="ft610">mem</p>
<p style="position:absolute;top:327px;left:554px;white-space:nowrap" class="ft69">)</p>
<p style="position:absolute;top:392px;left:437px;white-space:nowrap" class="ft611"><b>C</b></p>
<p style="position:absolute;top:156px;left:603px;white-space:nowrap" class="ft612">-90</p>
<p style="position:absolute;top:206px;left:604px;white-space:nowrap" class="ft612">-80</p>
<p style="position:absolute;top:262px;left:606px;white-space:nowrap" class="ft612">-70</p>
<p style="position:absolute;top:317px;left:604px;white-space:nowrap" class="ft612">-60</p>
<p style="position:absolute;top:373px;left:604px;white-space:nowrap" class="ft612">-50</p>
<p style="position:absolute;top:429px;left:605px;white-space:nowrap" class="ft612">-40</p>
<p style="position:absolute;top:484px;left:604px;white-space:nowrap" class="ft612">-30</p>
<p style="position:absolute;top:539px;left:606px;white-space:nowrap" class="ft612">-20</p>
<p style="position:absolute;top:595px;left:606px;white-space:nowrap" class="ft612">-10</p>
<p style="position:absolute;top:459px;left:480px;white-space:nowrap" class="ft613">Undiff. hMSCs</p>
<p style="position:absolute;top:481px;left:472px;white-space:nowrap" class="ft613">Undiff. C-kit&#160;cells</p>
<p style="position:absolute;top:478px;left:520px;white-space:nowrap" class="ft613">+</p>
<p style="position:absolute;top:523px;left:475px;white-space:nowrap" class="ft613">Rat fibrosarcoma</p>
<p style="position:absolute;top:549px;left:481px;white-space:nowrap" class="ft613">Thyroid tumor</p>
<p style="position:absolute;top:573px;left:460px;white-space:nowrap" class="ft613">Cervix Fibrosarcoma</p>
<p style="position:absolute;top:595px;left:471px;white-space:nowrap" class="ft613">Mouse hepatoma</p>
<p style="position:absolute;top:616px;left:459px;white-space:nowrap" class="ft613">Leukemic myeloblast</p>
<p style="position:absolute;top:637px;left:486px;white-space:nowrap" class="ft613">Ovarian tumor</p>
<p style="position:absolute;top:493px;left:432px;white-space:nowrap" class="ft614"><b>Adult S</b></p>
<p style="position:absolute;top:456px;left:432px;white-space:nowrap" class="ft614"><b>tem</b></p>
<p style="position:absolute;top:477px;left:445px;white-space:nowrap" class="ft614"><b>cells</b></p>
<p style="position:absolute;top:587px;left:441px;white-space:nowrap" class="ft614"><b>Cancer cells</b></p>
<p style="position:absolute;top:119px;left:746px;white-space:nowrap" class="ft613">Skeletal muscle</p>
<p style="position:absolute;top:144px;left:771px;white-space:nowrap" class="ft613">Glia</p>
<p style="position:absolute;top:162px;left:763px;white-space:nowrap" class="ft613">Neuron</p>
<p style="position:absolute;top:179px;left:749px;white-space:nowrap" class="ft613">Kidney&#160;Tubule</p>
<p style="position:absolute;top:197px;left:758px;white-space:nowrap" class="ft613">Fibroblast</p>
<p style="position:absolute;top:215px;left:748px;white-space:nowrap" class="ft613">Adrenal Cortex</p>
<p style="position:absolute;top:233px;left:748px;white-space:nowrap" class="ft613">CHO, 3T3 cells</p>
<p style="position:absolute;top:251px;left:741px;white-space:nowrap" class="ft613">Corneal epithelium</p>
<p style="position:absolute;top:269px;left:747px;white-space:nowrap" class="ft613">Smooth muscle</p>
<p style="position:absolute;top:286px;left:764px;white-space:nowrap" class="ft613">Thyroid</p>
<p style="position:absolute;top:303px;left:774px;white-space:nowrap" class="ft613">Fat</p>
<p style="position:absolute;top:389px;left:767px;white-space:nowrap" class="ft613">Liver</p>
<p style="position:absolute;top:457px;left:721px;white-space:nowrap" class="ft613">16 cell embryo</p>
<p style="position:absolute;top:475px;left:726px;white-space:nowrap" class="ft613">4-cell embryo</p>
<p style="position:absolute;top:493px;left:720px;white-space:nowrap" class="ft613">Proliferative fibroblast</p>
<p style="position:absolute;top:513px;left:725px;white-space:nowrap" class="ft613">Proliferative kidney</p>
<p style="position:absolute;top:533px;left:724px;white-space:nowrap" class="ft613">Proliferating 3T3 cell</p>
<p style="position:absolute;top:552px;left:721px;white-space:nowrap" class="ft613">Proliferating CHO cell</p>
<p style="position:absolute;top:573px;left:726px;white-space:nowrap" class="ft613">Fertilized egg</p>
<p style="position:absolute;top:624px;left:734px;white-space:nowrap" class="ft613">Undiff. mESCs</p>
<p style="position:absolute;top:464px;left:835px;white-space:nowrap" class="ft615"><b>Proliferative cells</b></p>
<p style="position:absolute;top:588px;left:839px;white-space:nowrap" class="ft615"><b>Embryonic</b></p>
<p style="position:absolute;top:590px;left:826px;white-space:nowrap" class="ft615"><b>S</b></p>
<p style="position:absolute;top:597px;left:826px;white-space:nowrap" class="ft615"><b>tem cells</b></p>
<p style="position:absolute;top:159px;left:848px;white-space:nowrap" class="ft615"><b>Quiescent cells</b></p>
<p style="position:absolute;top:99px;left:632px;white-space:nowrap" class="ft616"><b>mV</b></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft70{font-size:9px;font-family:Times;color:#000000;}
	.ft71{font-size:9px;font-family:Times;color:#000000;}
	.ft72{font-size:11px;font-family:Times;color:#000000;}
	.ft73{font-size:9px;font-family:Times;color:#000000;}
	.ft74{font-size:16px;font-family:Times;color:#000000;}
	.ft75{font-size:11px;font-family:Times;color:#000000;}
	.ft76{font-size:16px;font-family:Times;color:#000000;}
	.ft77{font-size:17px;font-family:Times;color:#000000;}
	.ft78{font-size:17px;font-family:Times;color:#ffffff;}
	.ft79{font-size:7px;font-family:Times;color:#000000;}
	.ft710{font-size:5px;font-family:Times;color:#000000;}
	.ft711{font-size:9px;line-height:14px;font-family:Times;color:#000000;}
	.ft712{font-size:9px;line-height:15px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page7-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft70"><i><b>Neurotransmitters&#160;and&#160;Electroceuticals&#160;in&#160;Cancer&#160;</b></i></p>
<p style="position:absolute;top:57px;left:560px;white-space:nowrap" class="ft70"><i><b>Current&#160;Pharmaceutical&#160;Design,&#160;</b></i><b>2017<i>, Vol.&#160;23, No. 32&#160; &#160;&#160;</i></b><b>4833<i>&#160;</i></b></p>
<p style="position:absolute;top:89px;left:96px;white-space:nowrap" class="ft72"><b>Table&#160;1.&#160;</b></p>
<p style="position:absolute;top:89px;left:159px;white-space:nowrap" class="ft72"><b>list&#160;of&#160;ion&#160;channel&#160;oncogenes.&#160;</b></p>
<p style="position:absolute;top:129px;left:184px;white-space:nowrap" class="ft71"><b>Ion&#160;Translocator Protein&#160;</b></p>
<p style="position:absolute;top:129px;left:438px;white-space:nowrap" class="ft71"><b>Species&#160;</b></p>
<p style="position:absolute;top:129px;left:567px;white-space:nowrap" class="ft71"><b>References&#160;</b></p>
<p style="position:absolute;top:129px;left:717px;white-space:nowrap" class="ft71"><b>Cancer-relevant&#160;role&#160;</b></p>
<p style="position:absolute;top:158px;left:189px;white-space:nowrap" class="ft73">NaV1.5&#160;sodium channel&#160;</p>
<p style="position:absolute;top:158px;left:439px;white-space:nowrap" class="ft73">Human&#160;</p>
<p style="position:absolute;top:158px;left:570px;white-space:nowrap" class="ft73">[109,&#160;110]&#160;</p>
<p style="position:absolute;top:158px;left:746px;white-space:nowrap" class="ft73">Oncogene&#160;</p>
<p style="position:absolute;top:184px;left:187px;white-space:nowrap" class="ft73">ERG&#160;potassium channels&#160;</p>
<p style="position:absolute;top:184px;left:439px;white-space:nowrap" class="ft73">Human&#160;</p>
<p style="position:absolute;top:184px;left:571px;white-space:nowrap" class="ft73">[111-113]&#160;</p>
<p style="position:absolute;top:184px;left:746px;white-space:nowrap" class="ft73">Oncogene&#160;</p>
<p style="position:absolute;top:210px;left:182px;white-space:nowrap" class="ft73">KCNK9&#160;potassium channel&#160;</p>
<p style="position:absolute;top:210px;left:440px;white-space:nowrap" class="ft73">Mouse&#160;</p>
<p style="position:absolute;top:210px;left:582px;white-space:nowrap" class="ft73">[114]&#160;</p>
<p style="position:absolute;top:210px;left:746px;white-space:nowrap" class="ft73">Oncogene&#160;</p>
<p style="position:absolute;top:235px;left:155px;white-space:nowrap" class="ft73">Ductin&#160;(proton V-ATPase&#160;component)&#160;</p>
<p style="position:absolute;top:235px;left:440px;white-space:nowrap" class="ft73">Mouse&#160;</p>
<p style="position:absolute;top:235px;left:582px;white-space:nowrap" class="ft73">[115]&#160;</p>
<p style="position:absolute;top:235px;left:746px;white-space:nowrap" class="ft73">Oncogene&#160;</p>
<p style="position:absolute;top:261px;left:158px;white-space:nowrap" class="ft73">SLC5A8&#160;sodium/butyrate transporter&#160;</p>
<p style="position:absolute;top:261px;left:439px;white-space:nowrap" class="ft73">Human&#160;</p>
<p style="position:absolute;top:261px;left:582px;white-space:nowrap" class="ft73">[116]&#160;</p>
<p style="position:absolute;top:261px;left:746px;white-space:nowrap" class="ft73">Oncogene&#160;</p>
<p style="position:absolute;top:287px;left:182px;white-space:nowrap" class="ft73">KCNE2 potassium channel&#160;</p>
<p style="position:absolute;top:287px;left:440px;white-space:nowrap" class="ft73">Mouse&#160;</p>
<p style="position:absolute;top:287px;left:582px;white-space:nowrap" class="ft73">[117]&#160;</p>
<p style="position:absolute;top:287px;left:746px;white-space:nowrap" class="ft73">Oncogene&#160;</p>
<p style="position:absolute;top:313px;left:182px;white-space:nowrap" class="ft73">KCNQ1&#160;potassium channel&#160;</p>
<p style="position:absolute;top:313px;left:420px;white-space:nowrap" class="ft73">Human,&#160;mouse&#160;</p>
<p style="position:absolute;top:313px;left:571px;white-space:nowrap" class="ft73">[118-120]&#160;</p>
<p style="position:absolute;top:313px;left:746px;white-space:nowrap" class="ft73">Oncogene&#160;</p>
<p style="position:absolute;top:339px;left:155px;white-space:nowrap" class="ft73">SCN5A&#160;voltage-gated&#160;sodium&#160;channel&#160;</p>
<p style="position:absolute;top:339px;left:439px;white-space:nowrap" class="ft73">Human&#160;</p>
<p style="position:absolute;top:339px;left:582px;white-space:nowrap" class="ft73">[121]&#160;</p>
<p style="position:absolute;top:339px;left:746px;white-space:nowrap" class="ft73">Oncogene&#160;</p>
<p style="position:absolute;top:365px;left:169px;white-space:nowrap" class="ft73">Metabotropic glutamate receptor&#160;</p>
<p style="position:absolute;top:365px;left:420px;white-space:nowrap" class="ft73">Mouse,&#160;Human&#160;</p>
<p style="position:absolute;top:365px;left:571px;white-space:nowrap" class="ft73">[122-124]&#160;</p>
<p style="position:absolute;top:365px;left:746px;white-space:nowrap" class="ft73">Oncogene&#160;</p>
<p style="position:absolute;top:391px;left:191px;white-space:nowrap" class="ft73">CFTR&#160;chloride channel&#160;</p>
<p style="position:absolute;top:391px;left:439px;white-space:nowrap" class="ft73">Human&#160;</p>
<p style="position:absolute;top:391px;left:570px;white-space:nowrap" class="ft73">[125,&#160;126]&#160;</p>
<p style="position:absolute;top:391px;left:727px;white-space:nowrap" class="ft73">Tumor&#160;suppressor&#160;</p>
<p style="position:absolute;top:417px;left:218px;white-space:nowrap" class="ft73">Connexin43 Human&#160;</p>
<p style="position:absolute;top:417px;left:582px;white-space:nowrap" class="ft73">[127]&#160;</p>
<p style="position:absolute;top:417px;left:727px;white-space:nowrap" class="ft73">Tumor&#160;</p>
<p style="position:absolute;top:417px;left:763px;white-space:nowrap" class="ft73">suppressor&#160;</p>
<p style="position:absolute;top:442px;left:233px;white-space:nowrap" class="ft73">BKCa&#160;Human&#160;</p>
<p style="position:absolute;top:442px;left:582px;white-space:nowrap" class="ft73">[128]&#160;</p>
<p style="position:absolute;top:442px;left:746px;white-space:nowrap" class="ft73">Oncogene&#160;</p>
<p style="position:absolute;top:468px;left:164px;white-space:nowrap" class="ft73">Muscarinic&#160;Acetylcholine receptor&#160;</p>
<p style="position:absolute;top:468px;left:420px;white-space:nowrap" class="ft73">Human,&#160;mouse&#160;</p>
<p style="position:absolute;top:468px;left:582px;white-space:nowrap" class="ft73">[129]&#160;</p>
<p style="position:absolute;top:468px;left:727px;white-space:nowrap" class="ft73">Tumor&#160;suppressor&#160;</p>
<p style="position:absolute;top:490px;left:96px;white-space:nowrap" class="ft74">&#160;</p>
<p style="position:absolute;top:520px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:540px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:559px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:579px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:598px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:617px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:637px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:657px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:676px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:696px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:715px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:734px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:754px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:774px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:793px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:813px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:832px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:851px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:871px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:891px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:910px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:930px;left:96px;white-space:nowrap" class="ft75">&#160;</p>
<p style="position:absolute;top:950px;left:96px;white-space:nowrap" class="ft712"><b>Fig.&#160;(7).</b>&#160;Metastasis&#160;induced by depolarization.&#160;<br/>The black cells&#160;in&#160;these histological&#160;sections&#160;of&#160;a&#160;frog tadpole are melanocytes,&#160;pigment&#160;cells&#160;that&#160;normally&#160;have&#160;a round morphology.&#160;Here&#160;are shown&#160;sections&#160;<br/>of&#160;frog&#160;larvae&#160;in&#160;which&#160;a specific cell&#160;subpopulation&#160;has&#160;been&#160;artificially&#160;depolarized,&#160;but&#160;no&#160;other&#160;carcinogenic or&#160;mutagenic&#160;treatment was&#160;applied.&#160;In&#160;the&#160;<br/>context&#160;of&#160;a&#160;wild-type genome,&#160;the normally&#160;small&#160;number&#160;of&#160;round melanocytes&#160;seen in&#160;sections&#160;through the anterior&#160;torso (<b>A</b>)&#160;and&#160;the&#160;tail (<b>B</b>)&#160;become&#160;highly&#160;<br/>arborized&#160;and over-proliferative (<b>C</b>,&#160;<b>D</b>).&#160;These&#160;cells&#160;become&#160;highly migratory,&#160;invading&#160;the brain and&#160;neural&#160;tube&#160;(<b>E</b>,&#160;red&#160;arrows) and&#160;extend&#160;long&#160;processes as&#160;<br/>they&#160;reach&#160;throughout lateral tissues&#160;(<b>F</b>,&#160;red arrow).&#160;They&#160;also&#160;invade&#160;blood&#160;vessels,&#160;which are&#160;normally&#160;free of&#160;melanocytes&#160;(<b>G</b>)&#160;but&#160;become choked with&#160;these&#160;<br/>cells&#160;after&#160;depolarization&#160;by&#160;pharmacological&#160;agents&#160;[61]&#160;or&#160;injection&#160;of&#160;dominant&#160;negative potassium&#160;channel&#160;subunits&#160;(<b>H</b>).&#160;These animals’&#160;normal&#160;vasculature&#160;<br/>(<b>I</b>)&#160;also&#160;begins&#160;to&#160;overgrow&#160;(<b>J</b>).&#160;Together,&#160;these&#160;data&#160;reveal&#160;that&#160;depolarization can trigger&#160;the key&#160;aspects&#160;of&#160;metastatic&#160;melanoma:&#160;rapid over-growth,&#160;cell&#160;<br/>shape change,&#160;and invasiveness.&#160;Panels&#160;A-F&#160;are taken from&#160;[61],&#160;panels&#160;G,H&#160;are taken from [152],&#160;and panels&#160;I,J&#160;are taken from&#160;[60].&#160;(The color&#160;version of&#160;the&#160;<br/>figure&#160;is&#160;available&#160;in&#160;the&#160;electronic copy of&#160;the article).&#160;</p>
<p style="position:absolute;top:509px;left:271px;white-space:nowrap" class="ft76"><b>A</b></p>
<p style="position:absolute;top:508px;left:412px;white-space:nowrap" class="ft76"><b>B</b></p>
<p style="position:absolute;top:508px;left:492px;white-space:nowrap" class="ft76"><b>C</b></p>
<p style="position:absolute;top:508px;left:635px;white-space:nowrap" class="ft76"><b>D</b></p>
<p style="position:absolute;top:646px;left:269px;white-space:nowrap" class="ft76"><b>E</b></p>
<p style="position:absolute;top:646px;left:492px;white-space:nowrap" class="ft76"><b>F</b></p>
<p style="position:absolute;top:804px;left:469px;white-space:nowrap" class="ft76"><b>I</b></p>
<p style="position:absolute;top:804px;left:597px;white-space:nowrap" class="ft76"><b>J</b></p>
<p style="position:absolute;top:904px;left:267px;white-space:nowrap" class="ft76"><b>G</b></p>
<p style="position:absolute;top:906px;left:436px;white-space:nowrap" class="ft76"><b>H</b></p>
<p style="position:absolute;top:571px;left:326px;white-space:nowrap" class="ft75">NT</p>
<p style="position:absolute;top:552px;left:565px;white-space:nowrap" class="ft75">NT</p>
<p style="position:absolute;top:621px;left:592px;white-space:nowrap" class="ft77">IVM</p>
<p style="position:absolute;top:693px;left:591px;white-space:nowrap" class="ft75">NT</p>
<p style="position:absolute;top:621px;left:337px;white-space:nowrap" class="ft78">Control</p>
<p style="position:absolute;top:774px;left:450px;white-space:nowrap" class="ft77">Ivm</p>
<p style="position:absolute;top:776px;left:670px;white-space:nowrap" class="ft77">Ivm</p>
<p style="position:absolute;top:915px;left:300px;white-space:nowrap" class="ft79"><b>Controls</b></p>
<p style="position:absolute;top:918px;left:364px;white-space:nowrap" class="ft710"><b>KCNE1-injected</b></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft80{font-size:9px;font-family:Times;color:#000000;}
	.ft81{font-size:9px;font-family:Times;color:#000000;}
	.ft82{font-size:11px;font-family:Times;color:#000000;}
	.ft83{font-size:11px;font-family:Times;color:#000000;}
	.ft84{font-size:11px;font-family:Times;color:#000000;}
	.ft85{font-size:7px;font-family:Times;color:#000000;}
	.ft86{font-size:9px;font-family:Times;color:#000000;}
	.ft87{font-size:9px;font-family:Times;color:#000000;}
	.ft88{font-size:10px;font-family:Times;color:#000000;}
	.ft89{font-size:10px;font-family:Times;color:#374aa6;}
	.ft810{font-size:6px;font-family:Times;color:#000000;}
	.ft811{font-size:6px;font-family:Times;color:#000000;}
	.ft812{font-size:6px;font-family:Times;color:#000000;}
	.ft813{font-size:3px;font-family:Times;color:#000000;}
	.ft814{font-size:5px;font-family:Times;color:#000000;}
	.ft815{font-size:5px;font-family:Times;color:#000000;}
	.ft816{font-size:5px;font-family:Times;color:#000000;}
	.ft817{font-size:5px;font-family:Times;color:#d1294b;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft818{font-size:5px;font-family:Times;color:#279840;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft819{font-size:11px;line-height:15px;font-family:Times;color:#000000;}
	.ft820{font-size:11px;line-height:14px;font-family:Times;color:#000000;}
	.ft821{font-size:11px;line-height:15px;font-family:Times;color:#000000;}
	.ft822{font-size:9px;line-height:14px;font-family:Times;color:#000000;}
	.ft823{font-size:9px;line-height:15px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page8-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft80"><b>4834 &#160; &#160;<i>Current&#160;Pharmaceutical&#160;Design,&#160;</i></b><b>2017<i>, Vol.&#160;23, No. 32&#160;</i></b></p>
<p style="position:absolute;top:57px;left:789px;white-space:nowrap" class="ft81"><i><b>Tuszynski&#160;et&#160;al.&#160;</b></i></p>
<p style="position:absolute;top:794px;left:96px;white-space:nowrap" class="ft819">for&#160;cytoskeletal&#160;reconfiguration. Anesthetics also&#160;appear&#160;to&#160;act in&#160;<br/>microtubules&#160;to&#160;prevent&#160;consciousness,&#160;not exclusively on mem-<br/>brane&#160;proteins&#160;as&#160;has&#160;been&#160;previously&#160;assumed [97].&#160;However&#160;the&#160;<br/>effects&#160;of anesthesia&#160;cannot&#160;be readily&#160;explained<i>&#160;via</i>&#160;a&#160;simple&#160;<br/>mechanistic mode&#160;of&#160;action yet.&#160;Conversely,&#160;it&#160;is&#160;highly&#160;probable&#160;<br/>that&#160;psychoactive&#160;compounds&#160;should exert&#160;cytotoxic&#160;effects&#160;on&#160;<br/>cancer&#160;cells&#160;since&#160;microtubules&#160;are&#160;not&#160;only fundamentally&#160;impor-<br/>tant&#160;to&#160;neuronal&#160;cells&#160;but&#160;are&#160;the&#160;essential&#160;part&#160;of&#160;the&#160;mitotic&#160;appara-<br/>tus&#160;(spindles)&#160;in&#160;dividing cells.&#160;Recently,&#160;a&#160;study was&#160;published that&#160;<br/>reports&#160;computational&#160;docking of&#160;three&#160;specific&#160;psychotropic&#160;com-<br/>pounds&#160;Lysergic&#160;Acid Diethylamide&#160;(LSD-25),&#160;heroin (morphine&#160;<br/>diacetate)&#160;and cocaine&#160;(benzoylmethylecgonine)&#160;to&#160;tubulin&#160;[89].&#160;It&#160;<br/>demonstrated&#160;significant&#160;binding affinity&#160;of&#160;these&#160;compounds&#160;to&#160;<br/>tubulin with unique&#160;binding modes&#160;and locations&#160;compared to the&#160;<br/>standard&#160;control,&#160;chemotherapy drug paclitaxel,&#160;which has&#160;no&#160;<br/>known involvement&#160;in&#160;the&#160;cognitive&#160;process.&#160;It&#160;was&#160;also&#160;predicted&#160;<br/>that&#160;the&#160;binding affinity of&#160;these&#160;psychotropic&#160;drugs&#160;strongly de-<br/>pends&#160;on the&#160;conformational&#160;state&#160;of&#160;the&#160;tubulin dimer.&#160;Most&#160;impor-<br/>tantly,&#160;this&#160;points&#160;to&#160;the&#160;possibility&#160;of&#160;off-target&#160;interactions&#160;of&#160;psy-<br/>choactive&#160;drugs,&#160;not&#160;only binding to&#160;their standard&#160;receptor&#160;sites in&#160;<br/>neurons&#160;but&#160;also&#160;affecting the&#160;cytoskeleton and hence affecting&#160;</p>
<p style="position:absolute;top:794px;left:496px;white-space:nowrap" class="ft819">other&#160;cellular&#160;functions&#160;including cell&#160;division of&#160;dividing&#160;cells&#160;<br/>including&#160;cancer cells.&#160;</p>
<p style="position:absolute;top:836px;left:496px;white-space:nowrap" class="ft821"><b>4.&#160;EFFECTS OF PSYCHOACTIVE COMPOUNDS ON CAN-<br/>CER AND NORMAL BREAST&#160;CELLS&#160;</b></p>
<p style="position:absolute;top:870px;left:496px;white-space:nowrap" class="ft82">&#160;</p>
<p style="position:absolute;top:870px;left:517px;white-space:nowrap" class="ft82">A&#160;biophysical&#160;perspective suggests&#160;serotonergic&#160;signaling to&#160;be&#160;</p>
<p style="position:absolute;top:885px;left:496px;white-space:nowrap" class="ft820">an&#160;important&#160;control point&#160;in&#160;the cancer problem, both&#160;because&#160;of&#160;<br/>its role&#160;as&#160;a transducer&#160;of bioelectric state&#160;and because&#160;of&#160;its&#160;interac-<br/>tion&#160;with&#160;the&#160;cytoskeleton.&#160;To&#160;examine&#160;some&#160;of&#160;these predictions&#160;in&#160;<br/>a&#160;proof-of-concept&#160;investigation,&#160;we&#160;have&#160;exposed normal&#160;and can-<br/>cer&#160;breast&#160;cells&#160;to&#160;Prozac&#160;(Fluoxetine)&#160;and&#160;its&#160;close&#160;analog.&#160;Fluoxet-<br/>ine,&#160;also&#160;known by trade names&#160;Prozac&#160;is&#160;an&#160;antidepressant&#160;of&#160;the&#160;<br/>selective&#160;serotonin&#160;reuptake&#160;inhibitor (SSRI)&#160;class.&#160;Its chemical&#160;<br/>formula is C17H18F3NO&#160;and its&#160;molecular&#160;weight&#160;is&#160;309.33.</p>
<p style="position:absolute;top:987px;left:837px;white-space:nowrap" class="ft85">&#160;&#160;It is&#160;</p>
<p style="position:absolute;top:1005px;left:496px;white-space:nowrap" class="ft820">used&#160;for the treatment&#160;of&#160;major&#160;depressive&#160;disorder,&#160;OCD,&#160;bulimia&#160;<br/>nervosa,&#160;panic&#160;disorder,&#160;and premenstrual&#160;dysphoric&#160;disorder.&#160;The&#160;<br/>analog chosen was:&#160;ZINC&#160;ID&#160;=&#160;ZINC06811610&#160;</p>
<p style="position:absolute;top:1035px;left:868px;white-space:nowrap" class="ft82">&#160;</p>
<p style="position:absolute;top:1050px;left:496px;white-space:nowrap" class="ft819">(http://zinc.docking.org/)&#160;with a&#160;chemical&#160;formula&#160;C15H23NO4&#160;<br/>and a&#160;popular&#160;name&#160;=&#160;2-[3-hydroxy-3-(4-propoxyphenyl)-propyl]&#160;<br/>aminopropanoic.&#160;It&#160;has&#160;a polar&#160;surface area&#160;=&#160;86 in&#160;the&#160;units&#160;of&#160;<br/>Angstrom&#160;squared.&#160;Its&#160;molecular&#160;weight&#160;is&#160;281.352.&#160;This&#160;is&#160;one&#160;of&#160;</p>
<p style="position:absolute;top:671px;left:98px;white-space:nowrap" class="ft823"><b>Fig.&#160;(8).&#160;</b>Non-cell-autonomous&#160;signaling<i>&#160;via</i>&#160;serotonin underlies&#160;voltage-mediated conversion to&#160;metastasis.&#160;<br/>Remarkably,&#160;the conversion of&#160;normal&#160;melanocytes&#160;to&#160;melanoma&#160;is&#160;not&#160;cell-autonomous&#160;(<b>A</b>):&#160;the depolarized ventral&#160;cells&#160;in&#160;this&#160;section through the tadpole&#160;<br/>trunk are marked&#160;with&#160;blue<i>&#160;via</i>&#160;b-galactosidase staining,&#160;which is&#160;at&#160;a distance&#160;from the cells&#160;that&#160;respond and convert&#160;(the dorsal&#160;melanocytes,&#160;red&#160;arrow).&#160;<br/>Mechanistic&#160;dissection of&#160;this&#160;process&#160;[60]&#160;revealed that&#160;the long-range communication is&#160;mediated by the voltage-dependent&#160;release of&#160;serotonin from instruc-<br/>tor&#160;cells&#160;(a&#160;widely-distributed population that,&#160;when&#160;depolarized,&#160;releases&#160;serotonin that&#160;activates&#160;genes&#160;such as&#160;<i>SLUG</i>&#160;and other&#160;aspects&#160;of&#160;epithelial-to-<br/>mesenchymal transition&#160;in&#160;normal&#160;melanocytes). The&#160;whole&#160;process&#160;is&#160;shown&#160;in&#160;panel&#160;<b>C</b>, which&#160;reveals&#160;how&#160;a&#160;bioelectric&#160;signal is&#160;transduced&#160;and&#160;results&#160;in&#160;<br/>altered system-wide cell&#160;behavior.&#160;Panels&#160;<b>A</b>-<b>B</b>&#160;are taken from [152].&#160;(The color&#160;version of&#160;the figure is&#160;available in&#160;the electronic copy of&#160;the article).&#160;</p>
<p style="position:absolute;top:131px;left:261px;white-space:nowrap" class="ft88"><b>converted</b></p>
<p style="position:absolute;top:146px;left:254px;white-space:nowrap" class="ft88"><b>melanocytes</b></p>
<p style="position:absolute;top:222px;left:315px;white-space:nowrap" class="ft89"><b>depolarized</b></p>
<p style="position:absolute;top:237px;left:329px;white-space:nowrap" class="ft89"><b>region</b></p>
<p style="position:absolute;top:298px;left:323px;white-space:nowrap" class="ft810"><i><b>Target</b></i></p>
<p style="position:absolute;top:308px;left:312px;white-space:nowrap" class="ft810"><i><b>Melanocyte</b></i></p>
<p style="position:absolute;top:410px;left:288px;white-space:nowrap" class="ft810"><i><b>Instructor</b></i></p>
<p style="position:absolute;top:420px;left:301px;white-space:nowrap" class="ft810"><i><b>cell</b></i></p>
<p style="position:absolute;top:490px;left:169px;white-space:nowrap" class="ft811"><b>depolarization</b></p>
<p style="position:absolute;top:373px;left:126px;white-space:nowrap" class="ft812"><i>Ion channel</i></p>
<p style="position:absolute;top:358px;left:192px;white-space:nowrap" class="ft813">Cl-</p>
<p style="position:absolute;top:607px;left:131px;white-space:nowrap" class="ft814"><i>SERT</i></p>
<p style="position:absolute;top:615px;left:112px;white-space:nowrap" class="ft814"><i>(5HT transporter)</i></p>
<p style="position:absolute;top:508px;left:501px;white-space:nowrap" class="ft815"><b>Cell</b></p>
<p style="position:absolute;top:517px;left:492px;white-space:nowrap" class="ft815"><b>behavior</b></p>
<p style="position:absolute;top:612px;left:481px;white-space:nowrap" class="ft815"><b>Morphogenetic</b></p>
<p style="position:absolute;top:620px;left:493px;white-space:nowrap" class="ft815"><b>process</b></p>
<p style="position:absolute;top:612px;left:559px;white-space:nowrap" class="ft816">local blastema</p>
<p style="position:absolute;top:620px;left:558px;white-space:nowrap" class="ft816">morphogenesis</p>
<p style="position:absolute;top:502px;left:575px;white-space:nowrap" class="ft816">Proliferation</p>
<p style="position:absolute;top:505px;left:679px;white-space:nowrap" class="ft816">Migration</p>
<p style="position:absolute;top:491px;left:783px;white-space:nowrap" class="ft816">Cell shape</p>
<p style="position:absolute;top:499px;left:789px;white-space:nowrap" class="ft816">change</p>
<p style="position:absolute;top:384px;left:488px;white-space:nowrap" class="ft815"><b>Secondary</b></p>
<p style="position:absolute;top:393px;left:490px;white-space:nowrap" class="ft815"><b>response</b></p>
<p style="position:absolute;top:245px;left:492px;white-space:nowrap" class="ft815"><b>Proximal</b></p>
<p style="position:absolute;top:254px;left:487px;white-space:nowrap" class="ft815"><b>biophysical</b></p>
<p style="position:absolute;top:262px;left:485px;white-space:nowrap" class="ft815"><b>transduction</b></p>
<p style="position:absolute;top:271px;left:487px;white-space:nowrap" class="ft815"><b>mechanism</b></p>
<p style="position:absolute;top:166px;left:484px;white-space:nowrap" class="ft815"><b>Physiological</b></p>
<p style="position:absolute;top:175px;left:493px;white-space:nowrap" class="ft815"><b>process</b></p>
<p style="position:absolute;top:183px;left:493px;white-space:nowrap" class="ft815"><b>affected</b></p>
<p style="position:absolute;top:102px;left:491px;white-space:nowrap" class="ft815"><b>Source of</b></p>
<p style="position:absolute;top:110px;left:486px;white-space:nowrap" class="ft815"><b>bioelectrical</b></p>
<p style="position:absolute;top:119px;left:497px;white-space:nowrap" class="ft815"><b>signal</b></p>
<p style="position:absolute;top:408px;left:630px;white-space:nowrap" class="ft816">Slug/</p>
<p style="position:absolute;top:417px;left:628px;white-space:nowrap" class="ft816">Sox10</p>
<p style="position:absolute;top:353px;left:646px;white-space:nowrap" class="ft816">5HT-R2.&#160;-R1</p>
<p style="position:absolute;top:301px;left:680px;white-space:nowrap" class="ft816">5HT</p>
<p style="position:absolute;top:288px;left:654px;white-space:nowrap" class="ft816">SERT</p>
<p style="position:absolute;top:174px;left:587px;white-space:nowrap" class="ft816">membrane</p>
<p style="position:absolute;top:183px;left:592px;white-space:nowrap" class="ft816">voltage</p>
<p style="position:absolute;top:111px;left:681px;white-space:nowrap" class="ft816">GlyR</p>
<p style="position:absolute;top:540px;left:578px;white-space:nowrap" class="ft816">Apoptosis</p>
<p style="position:absolute;top:534px;left:675px;white-space:nowrap" class="ft816">Orientation</p>
<p style="position:absolute;top:542px;left:674px;white-space:nowrap" class="ft816">of cleavege</p>
<p style="position:absolute;top:551px;left:684px;white-space:nowrap" class="ft816">plane</p>
<p style="position:absolute;top:519px;left:780px;white-space:nowrap" class="ft816">Differentiatio</p>
<p style="position:absolute;top:528px;left:783px;white-space:nowrap" class="ft816">n trajectory</p>
<p style="position:absolute;top:546px;left:794px;white-space:nowrap" class="ft816">De-</p>
<p style="position:absolute;top:556px;left:778px;white-space:nowrap" class="ft816">differentiation</p>
<p style="position:absolute;top:412px;left:808px;white-space:nowrap" class="ft816">Mad3</p>
<p style="position:absolute;top:413px;left:768px;white-space:nowrap" class="ft816">NF-kB</p>
<p style="position:absolute;top:412px;left:740px;white-space:nowrap" class="ft816">?</p>
<p style="position:absolute;top:412px;left:707px;white-space:nowrap" class="ft816">SIK</p>
<p style="position:absolute;top:412px;left:670px;white-space:nowrap" class="ft816">Notch</p>
<p style="position:absolute;top:399px;left:579px;white-space:nowrap" class="ft816">integrin,</p>
<p style="position:absolute;top:408px;left:582px;white-space:nowrap" class="ft816">PTEN,</p>
<p style="position:absolute;top:417px;left:581px;white-space:nowrap" class="ft816">GPCR,</p>
<p style="position:absolute;top:425px;left:577px;white-space:nowrap" class="ft816">KID1/pim</p>
<p style="position:absolute;top:240px;left:596px;white-space:nowrap" class="ft816">voltage</p>
<p style="position:absolute;top:249px;left:595px;white-space:nowrap" class="ft816">sensing</p>
<p style="position:absolute;top:257px;left:595px;white-space:nowrap" class="ft816">domain</p>
<p style="position:absolute;top:285px;left:590px;white-space:nowrap" class="ft816">VGCC</p>
<p style="position:absolute;top:301px;left:617px;white-space:nowrap" class="ft816">Ca++</p>
<p style="position:absolute;top:260px;left:650px;white-space:nowrap" class="ft816">increase</p>
<p style="position:absolute;top:248px;left:652px;white-space:nowrap" class="ft816">[Na+]in</p>
<p style="position:absolute;top:249px;left:704px;white-space:nowrap" class="ft816">[K+]in</p>
<p style="position:absolute;top:261px;left:707px;white-space:nowrap" class="ft816">loss</p>
<p style="position:absolute;top:248px;left:748px;white-space:nowrap" class="ft816">Electro-</p>
<p style="position:absolute;top:256px;left:747px;white-space:nowrap" class="ft816">osmosis</p>
<p style="position:absolute;top:248px;left:799px;white-space:nowrap" class="ft816">Ca</p>
<p style="position:absolute;top:257px;left:799px;white-space:nowrap" class="ft816">influx</p>
<p style="position:absolute;top:246px;left:808px;white-space:nowrap" class="ft816">++</p>
<p style="position:absolute;top:288px;left:722px;white-space:nowrap" class="ft816">SLC5A8</p>
<p style="position:absolute;top:303px;left:753px;white-space:nowrap" class="ft816">Bu</p>
<p style="position:absolute;top:287px;left:789px;white-space:nowrap" class="ft816">GJC</p>
<p style="position:absolute;top:303px;left:789px;white-space:nowrap" class="ft816">5HT</p>
<p style="position:absolute;top:172px;left:674px;white-space:nowrap" class="ft816">pH</p>
<p style="position:absolute;top:181px;left:666px;white-space:nowrap" class="ft816">gradient</p>
<p style="position:absolute;top:177px;left:737px;white-space:nowrap" class="ft816">ion flux</p>
<p style="position:absolute;top:172px;left:802px;white-space:nowrap" class="ft816">electric</p>
<p style="position:absolute;top:181px;left:807px;white-space:nowrap" class="ft816">field</p>
<p style="position:absolute;top:107px;left:755px;white-space:nowrap" class="ft816">break in epithelium,</p>
<p style="position:absolute;top:115px;left:748px;white-space:nowrap" class="ft816">trans-epithelial potential</p>
<p style="position:absolute;top:106px;left:588px;white-space:nowrap" class="ft816">gap junctional</p>
<p style="position:absolute;top:115px;left:593px;white-space:nowrap" class="ft816">connection</p>
<p style="position:absolute;top:540px;left:560px;white-space:nowrap" class="ft817"><i>Cell Number</i></p>
<p style="position:absolute;top:465px;left:540px;white-space:nowrap" class="ft818"><i>Genetic</i></p>
<p style="position:absolute;top:364px;left:545px;white-space:nowrap" class="ft818"><i>2nd</i></p>
<p style="position:absolute;top:376px;left:553px;white-space:nowrap" class="ft818"><i>messenger</i></p>
<p style="position:absolute;top:257px;left:549px;white-space:nowrap" class="ft818"><i>Biophysical</i></p>
<p style="position:absolute;top:150px;left:545px;white-space:nowrap" class="ft818"><i>Feedback</i></p>
<p style="position:absolute;top:143px;left:554px;white-space:nowrap" class="ft818"><i>loop</i></p>
<p style="position:absolute;top:129px;left:554px;white-space:nowrap" class="ft818"><i>s</i></p>
<p style="position:absolute;top:539px;left:659px;white-space:nowrap" class="ft817"><i>Cell Position</i></p>
<p style="position:absolute;top:534px;left:761px;white-space:nowrap" class="ft817"><i>Cell T</i></p>
<p style="position:absolute;top:515px;left:761px;white-space:nowrap" class="ft817"><i>ype</i></p>
<p style="position:absolute;top:350px;left:381px;white-space:nowrap" class="ft811"><b>SLUG</b></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft90{font-size:9px;font-family:Times;color:#000000;}
	.ft91{font-size:9px;font-family:Times;color:#000000;}
	.ft92{font-size:11px;font-family:Times;color:#000000;}
	.ft93{font-size:7px;font-family:Times;color:#000000;}
	.ft94{font-size:11px;font-family:Times;color:#000000;}
	.ft95{font-size:11px;font-family:Times;color:#000000;}
	.ft96{font-size:9px;font-family:Times;color:#000000;}
	.ft97{font-size:9px;font-family:Times;color:#000000;}
	.ft98{font-size:10px;font-family:Times;color:#ffffff;}
	.ft99{font-size:7px;font-family:Times;color:#ffffff;}
	.ft910{font-size:5px;font-family:Times;color:#000000;}
	.ft911{font-size:3px;font-family:Times;color:#000000;}
	.ft912{font-size:8px;font-family:Times;color:#ffffff;}
	.ft913{font-size:5px;font-family:Times;color:#000000;}
	.ft914{font-size:7px;font-family:Times;color:#000000;}
	.ft915{font-size:4px;font-family:Times;color:#000000;}
	.ft916{font-size:7px;font-family:Times;color:#000000;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft917{font-size:4px;font-family:Times;color:#000000;-moz-transform: matrix(-0.0020845808, -0.9979154192, 0.9979819484, -0.0020845808, 0, 0);-webkit-transform: matrix(-0.0020845808, -0.9979154192, 0.9979819484, -0.0020845808, 0, 0);-o-transform: matrix(-0.0020845808, -0.9979154192, 0.9979819484, -0.0020845808, 0, 0);-ms-transform: matrix(-0.0020845808, -0.9979154192, 0.9979819484, -0.0020845808, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft918{font-size:23px;font-family:Times;color:#000000;}
	.ft919{font-size:11px;line-height:15px;font-family:Times;color:#000000;}
	.ft920{font-size:11px;line-height:14px;font-family:Times;color:#000000;}
	.ft921{font-size:9px;line-height:14px;font-family:Times;color:#000000;}
	.ft922{font-size:9px;line-height:15px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page9-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft90"><i><b>Neurotransmitters&#160;and&#160;Electroceuticals&#160;in&#160;Cancer&#160;</b></i></p>
<p style="position:absolute;top:57px;left:560px;white-space:nowrap" class="ft90"><i><b>Current&#160;Pharmaceutical&#160;Design,&#160;</b></i><b>2017<i>, Vol.&#160;23, No. 32&#160; &#160;&#160;</i></b><b>4835<i>&#160;</i></b></p>
<p style="position:absolute;top:731px;left:96px;white-space:nowrap" class="ft920">several&#160;compounds&#160;similar&#160;to Prozac&#160;that&#160;can be&#160;found in the&#160;ZINC&#160;<br/>database,&#160;which may have&#160;high DMSO&#160;solubility because&#160;of&#160;smal-<br/>ler&#160;radii&#160;of&#160;gyration and lower&#160;lipophilicity&#160;and hence&#160;are&#160;also&#160;less&#160;<br/>likely to&#160;cross the&#160;blood brain barrier.&#160;</p>
<p style="position:absolute;top:796px;left:96px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:796px;left:117px;white-space:nowrap" class="ft92">The&#160;binding affinities&#160;of&#160;Fluoxetine&#160;for&#160;its&#160;receptor&#160;targets&#160;is&#160;in&#160;</p>
<p style="position:absolute;top:811px;left:96px;white-space:nowrap" class="ft920">the&#160;range&#160;of 1 nM&#160;(for&#160;SERT)&#160;to 72.6 nM&#160;(5-HT2C,&#160;200nM&#160;for&#160;5-<br/>HT2A&#160;and 4 uM&#160;for&#160;5-HT2B&#160;[98,&#160;99].&#160;A number&#160;of&#160;other&#160;receptors&#160;<br/>are&#160;characterized by Fluoxetine’s&#160;affinity&#160;in&#160;the low&#160;micromolar&#160;<br/>range&#160;(<i>e.g</i>. M1, M2, M3, M4, M5&#160;and H1).&#160;To the&#160;best&#160;of&#160;our knowl-<br/>edge,&#160;it’s&#160;affinity&#160;for&#160;tubulin&#160;has&#160;not&#160;been&#160;reported so&#160;far.&#160;Based on&#160;<br/>previous&#160;studies&#160;of&#160;binding of&#160;psychoactive&#160;compounds&#160;to tubulin&#160;<br/>mentioned above&#160;we&#160;expect&#160;Fluoxetine&#160;to&#160;have&#160;an&#160;off-target&#160;inter-<br/>action with&#160;tubulin&#160;and microtubules&#160;and hence&#160;cytotoxic&#160;properties&#160;<br/>we&#160;examined&#160;and report&#160;here for the first&#160;time.&#160;</p>
<p style="position:absolute;top:951px;left:96px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:951px;left:117px;white-space:nowrap" class="ft92">The survival of&#160;two&#160;cell&#160;lines: breast&#160;cancer&#160;cell&#160;line&#160;and&#160;a&#160;cor-</p>
<p style="position:absolute;top:965px;left:96px;white-space:nowrap" class="ft919">responding normal&#160;breast&#160;cell&#160;line&#160;(MCF7 and MCF10A)&#160;after&#160;ex-<br/>posure&#160;to the&#160;ligands&#160;was&#160;evaluated by an MTT and a&#160;proliferation&#160;<br/>assay.&#160;Here,&#160;MCF-10A&#160;was&#160;used&#160;as&#160;a&#160;reference&#160;since&#160;its&#160;immortal&#160;<br/>transformation&#160;allows&#160;its&#160;<i>in&#160;vitro</i>&#160;culture&#160;and it&#160;is&#160;not&#160;malignant.&#160;We&#160;<br/>performed&#160;an&#160;MTT&#160;assay&#160;to&#160;determine the survival&#160;of&#160;these&#160;cell&#160;<br/>lines&#160;and a&#160;Crystal&#160;violet&#160;staining&#160;assay for&#160;proliferation&#160;analysis&#160;<br/>for&#160;both compounds.&#160;In Figs.&#160;(<b>10)</b>&#160;and (<b>11)</b>&#160;we&#160;show&#160;the&#160;data&#160;for&#160;the&#160;<br/>MTT&#160;and&#160;proliferation&#160;assays&#160;for Prozac while in&#160;Figs.&#160;(<b>12)</b>&#160;and&#160;</p>
<p style="position:absolute;top:731px;left:496px;white-space:nowrap" class="ft919">(<b>13)</b>&#160;similar&#160;data&#160;are&#160;shown for&#160;the&#160;Prozac&#160;analog.&#160;We&#160;found an&#160;<br/>IC50&#160;value&#160;for&#160;the&#160;concentration&#160;of&#160;these&#160;compounds&#160;(25&#160;</p>
<p style="position:absolute;top:743px;left:824px;white-space:nowrap" class="ft92">μM for&#160;</p>
<p style="position:absolute;top:761px;left:496px;white-space:nowrap" class="ft92">Prozac&#160;and&#160;100&#160;</p>
<p style="position:absolute;top:758px;left:590px;white-space:nowrap" class="ft92">μM&#160;for the&#160;Prozac&#160;analog)&#160;at&#160;which&#160;these com-</p>
<p style="position:absolute;top:776px;left:496px;white-space:nowrap" class="ft919">pounds&#160;inhibited tumor&#160;cell&#160;survival&#160;and proliferation.&#160;Additionally,&#160;<br/>at&#160;these&#160;concentrations&#160;we&#160;did not&#160;observe alterations&#160;in&#160;a&#160;non-<br/>tumoral cell&#160;(see&#160;the panels&#160;in&#160;Figs. (<b>10</b>-<b>13)</b>&#160;corresponding to&#160;MCF-<br/>10A).&#160;While&#160;these&#160;IC50 concentrations&#160;are&#160;higher&#160;than&#160;the&#160;concen-<br/>tration&#160;values&#160;for the kinetically&#160;determined&#160;affinities&#160;for&#160;the&#160;pri-<br/>mary&#160;receptor&#160;targets&#160;of&#160;Prozac&#160;mentioned above,&#160;they&#160;are&#160;not&#160;neg-<br/>ligible&#160;especially&#160;in&#160;view&#160;of pharmacokinetic&#160;considerations&#160;that&#160;<br/>may be&#160;brought&#160;to bear&#160;on the&#160;delivery of&#160;these&#160;compounds&#160;to the&#160;<br/>tumor&#160;site.&#160;Importantly,&#160;the&#160;bioavailability of&#160;fluoxetine&#160;is&#160;very&#160;<br/>high (72%),&#160;and peak&#160;plasma&#160;concentrations&#160;are reached&#160;in&#160;6–<br/>8&#160;hours.&#160;It&#160;is&#160;highly bound to&#160;plasma&#160;proteins,&#160;mostly&#160;albumin&#160;and&#160;<br/>α1-glycoprotein&#160;[z].&#160;The&#160;extremely slow&#160;elimination of&#160;fluoxetine&#160;<br/>and its&#160;active&#160;metabolite&#160;norfluoxetine&#160;from&#160;the&#160;body distinguishes&#160;<br/>it&#160;from&#160;other&#160;antidepressants.&#160;Fluoxetine&#160;elimination half-life&#160;<br/>changes&#160;from&#160;1 to&#160;3&#160;days,&#160;after&#160;a&#160;single&#160;dose,&#160;to&#160;4 to&#160;6&#160;days,&#160;after&#160;<br/>long-term&#160;use&#160;[100].&#160;Its&#160;therapeutic&#160;dose&#160;for&#160;depression depends&#160;<br/>ranges&#160;between 10 and 80 mg a&#160;day and&#160;a&#160;maximum&#160;dose&#160;is&#160;90 mg.&#160;<br/>The&#160;latter&#160;translates&#160;into&#160;an&#160;approximate&#160;concentration in&#160;the&#160;blood&#160;<br/>at&#160;300 mM,&#160;which is&#160;much higher&#160;than the&#160;IC50 value&#160;determined&#160;<br/>in this&#160;study.&#160;</p>
<p style="position:absolute;top:1086px;left:96px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:104px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:135px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:167px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:198px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:230px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:261px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:293px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:324px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:356px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:387px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:419px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:450px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:482px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:513px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:545px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:576px;left:98px;white-space:nowrap" class="ft92">&#160;</p>
<p style="position:absolute;top:608px;left:98px;white-space:nowrap" class="ft922"><b>Fig.&#160;(9).</b>&#160;Optogenetic&#160;approaches&#160;to&#160;cancer:&#160;light&#160;gating of&#160;electrical&#160;cues.&#160;<br/>Optogenetics&#160;[153-155]&#160;is&#160;the use of&#160;light-gated&#160;ion channels&#160;to&#160;gain&#160;spatio-temporal&#160;control&#160;of&#160;bioelectrical&#160;state&#160;of&#160;cells&#160;<i>in&#160;vivo</i>&#160;(<b>A</b>).&#160;Recent&#160;data&#160;have&#160;shown&#160;<br/>that&#160;when&#160;light-gated&#160;channels&#160;such&#160;as channelrhodopsin&#160;are&#160;co-injected&#160;with&#160;oncogenes&#160;(<b>B</b>),&#160;the incidence of&#160;resulting tumors&#160;can&#160;be reduced&#160;by&#160;light&#160;expo-<br/>sure&#160;which forces&#160;hyperpolarization and thus&#160;antagonizes&#160;the steps&#160;by which oncoproteins&#160;transform&#160;cells.&#160;This&#160;occurs&#160;by prevention&#160;of&#160;tumor&#160;formation and&#160;<br/>tumor&#160;normalization.&#160;Such therapies,&#160;especially&#160;when&#160;combined with&#160;novel&#160;chemical&#160;strategies&#160;to&#160;render&#160;ion&#160;cannels&#160;light-gated&#160;without&#160;the&#160;use&#160;of&#160;gene&#160;ther-<br/>apy [156,&#160;157],&#160;are&#160;a&#160;promising&#160;novel&#160;path&#160;forward&#160;for&#160;cancer&#160;treatments&#160;that&#160;focus&#160;on tumor&#160;reprogramming instead&#160;of&#160;targeted&#160;toxicity.&#160;Panel&#160;A&#160;was&#160;drawn&#160;<br/>by Jeremy Guay&#160;of&#160;Peregrine Creative,&#160;while&#160;panels&#160;B,&#160;C&#160;are taken from&#160;[66].&#160;</p>
<p style="position:absolute;top:364px;left:220px;white-space:nowrap" class="ft98">H&#160;, Na, K, Ca</p>
<p style="position:absolute;top:363px;left:229px;white-space:nowrap" class="ft99">+</p>
<p style="position:absolute;top:363px;left:253px;white-space:nowrap" class="ft99">+&#160;+</p>
<p style="position:absolute;top:363px;left:294px;white-space:nowrap" class="ft99">2+</p>
<p style="position:absolute;top:467px;left:326px;white-space:nowrap" class="ft98">H+</p>
<p style="position:absolute;top:107px;left:525px;white-space:nowrap" class="ft910"><b>KRASG12D&#160;+</b></p>
<p style="position:absolute;top:116px;left:510px;white-space:nowrap" class="ft910"><b>Optogenetic Channel</b></p>
<p style="position:absolute;top:97px;left:636px;white-space:nowrap" class="ft912"><b>Light</b></p>
<p style="position:absolute;top:109px;left:631px;white-space:nowrap" class="ft912"><b>Source</b></p>
<p style="position:absolute;top:214px;left:503px;white-space:nowrap" class="ft913">Inject Channel + Oncogene</p>
<p style="position:absolute;top:214px;left:610px;white-space:nowrap" class="ft913">Apply light to activate channel</p>
<p style="position:absolute;top:214px;left:761px;white-space:nowrap" class="ft913">Score for tumors</p>
<p style="position:absolute;top:338px;left:511px;white-space:nowrap" class="ft910"><b>40</b></p>
<p style="position:absolute;top:367px;left:511px;white-space:nowrap" class="ft910"><b>35</b></p>
<p style="position:absolute;top:397px;left:511px;white-space:nowrap" class="ft910"><b>30</b></p>
<p style="position:absolute;top:426px;left:511px;white-space:nowrap" class="ft910"><b>25</b></p>
<p style="position:absolute;top:456px;left:511px;white-space:nowrap" class="ft910"><b>20</b></p>
<p style="position:absolute;top:485px;left:511px;white-space:nowrap" class="ft910"><b>15</b></p>
<p style="position:absolute;top:515px;left:511px;white-space:nowrap" class="ft910"><b>10</b></p>
<p style="position:absolute;top:544px;left:516px;white-space:nowrap" class="ft910"><b>5</b></p>
<p style="position:absolute;top:574px;left:516px;white-space:nowrap" class="ft910"><b>0</b></p>
<p style="position:absolute;top:580px;left:558px;white-space:nowrap" class="ft914"><b>KRASG12D&#160;+&#160;Arch</b></p>
<p style="position:absolute;top:580px;left:706px;white-space:nowrap" class="ft914"><b>KRASG12D&#160;+ ChR2(D156A)</b></p>
<p style="position:absolute;top:518px;left:585px;white-space:nowrap" class="ft916"><b>Light ON</b></p>
<p style="position:absolute;top:483px;left:621px;white-space:nowrap" class="ft916"><b>Light OFF</b></p>
<p style="position:absolute;top:525px;left:749px;white-space:nowrap" class="ft916"><b>Light ON</b></p>
<p style="position:absolute;top:486px;left:785px;white-space:nowrap" class="ft916"><b>Light OFF</b></p>
<p style="position:absolute;top:420px;left:566px;white-space:nowrap" class="ft914"><b>n = 219</b></p>
<p style="position:absolute;top:351px;left:602px;white-space:nowrap" class="ft914"><b>n = 209</b></p>
<p style="position:absolute;top:421px;left:729px;white-space:nowrap" class="ft914"><b>n = 239</b></p>
<p style="position:absolute;top:355px;left:765px;white-space:nowrap" class="ft914"><b>n = 231</b></p>
<p style="position:absolute;top:336px;left:760px;white-space:nowrap" class="ft95"><b>*</b></p>
<p style="position:absolute;top:526px;left:507px;white-space:nowrap" class="ft916"><b>% Embryos with KRAS</b></p>
<p style="position:absolute;top:404px;left:507px;white-space:nowrap" class="ft916"><b>tumor</b></p>
<p style="position:absolute;top:426px;left:505px;white-space:nowrap" class="ft917"><b>G12D</b></p>
<p style="position:absolute;top:231px;left:490px;white-space:nowrap" class="ft918"><b>C</b></p>
<p style="position:absolute;top:201px;left:146px;white-space:nowrap" class="ft918"><b>A</b></p>
<p style="position:absolute;top:85px;left:490px;white-space:nowrap" class="ft918"><b>B</b></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft100{font-size:9px;font-family:Times;color:#000000;}
	.ft101{font-size:9px;font-family:Times;color:#000000;}
	.ft102{font-size:11px;font-family:Times;color:#000000;}
	.ft103{font-size:9px;font-family:Times;color:#000000;}
	.ft104{font-size:5px;font-family:Times;color:#000000;}
	.ft105{font-size:7px;font-family:Times;color:#000000;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft106{font-size:6px;font-family:Times;color:#000000;-moz-transform: matrix(    4.1208,    -4.1208,     4.1208,     4.1208, 0, 0);-webkit-transform: matrix(    4.1208,    -4.1208,     4.1208,     4.1208, 0, 0);-o-transform: matrix(    4.1208,    -4.1208,     4.1208,     4.1208, 0, 0);-ms-transform: matrix(    4.1208,    -4.1208,     4.1208,     4.1208, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft107{font-size:6px;font-family:Times;color:#000000;-moz-transform: matrix(    4.1208,    -4.1208,     4.1208,     4.1208, 0, 0);-webkit-transform: matrix(    4.1208,    -4.1208,     4.1208,     4.1208, 0, 0);-o-transform: matrix(    4.1208,    -4.1208,     4.1208,     4.1208, 0, 0);-ms-transform: matrix(    4.1208,    -4.1208,     4.1208,     4.1208, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft108{font-size:17px;font-family:Times;color:#ce1f24;}
	.ft109{font-size:7px;font-family:Times;color:#000000;-moz-transform: matrix(    4.3841,    -4.3841,     4.3841,     4.3841, 0, 0);-webkit-transform: matrix(    4.3841,    -4.3841,     4.3841,     4.3841, 0, 0);-o-transform: matrix(    4.3841,    -4.3841,     4.3841,     4.3841, 0, 0);-ms-transform: matrix(    4.3841,    -4.3841,     4.3841,     4.3841, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft1010{font-size:7px;font-family:Times;color:#000000;-moz-transform: matrix(    4.3841,    -4.3841,     4.3841,     4.3841, 0, 0);-webkit-transform: matrix(    4.3841,    -4.3841,     4.3841,     4.3841, 0, 0);-o-transform: matrix(    4.3841,    -4.3841,     4.3841,     4.3841, 0, 0);-ms-transform: matrix(    4.3841,    -4.3841,     4.3841,     4.3841, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft1011{font-size:6px;font-family:Times;color:#000000;}
	.ft1012{font-size:8px;font-family:Times;color:#000000;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft1013{font-size:7px;font-family:Times;color:#000000;}
	.ft1014{font-size:10px;font-family:Times;color:#000000;}
	.ft1015{font-size:20px;font-family:Times;color:#ce1f24;}
	.ft1016{font-size:9px;line-height:14px;font-family:Times;color:#000000;}
	.ft1017{font-size:9px;line-height:15px;font-family:Times;color:#000000;}
	.ft1018{font-size:9px;line-height:13px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page10-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft100"><b>4836 &#160; &#160;<i>Current&#160;Pharmaceutical&#160;Design,&#160;</i></b><b>2017<i>, Vol.&#160;23, No. 32&#160;</i></b></p>
<p style="position:absolute;top:57px;left:789px;white-space:nowrap" class="ft101"><i><b>Tuszynski&#160;et&#160;al.&#160;</b></i></p>
<p style="position:absolute;top:88px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:107px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:127px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:146px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:166px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:185px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:205px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:224px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:244px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:263px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:283px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:302px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:322px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:341px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:361px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:380px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:400px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:419px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:438px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:458px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:478px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:497px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:517px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:536px;left:96px;white-space:nowrap" class="ft102">&#160;</p>
<p style="position:absolute;top:557px;left:96px;white-space:nowrap" class="ft1017"><b>Fig. (10).</b>&#160;MMT&#160;survival&#160;assay&#160;results&#160;for&#160;Prozac-exposed&#160;MCF7&#160;breast&#160;cancer&#160;cells&#160;(top&#160;panel)&#160;and MCF10A&#160;non-malignant&#160;breast&#160;cells&#160;(bottom&#160;panel)&#160;at&#160;24h,&#160;<br/>48h and 72 h,&#160;respectively,&#160;from left&#160;to&#160;right.&#160;<br/>&#160;</p>
<p style="position:absolute;top:1052px;left:96px;white-space:nowrap" class="ft1018">&#160;<br/><b>Fig. (11).</b>&#160;Crystal&#160;violet&#160;staining proliferation assay results&#160;for&#160;Prozac-exposed MCF7&#160;breast&#160;cancer&#160;cells&#160;(top panel)&#160;and MCF10A&#160;non-malignant&#160;breast&#160;cells&#160;<br/>(bottom panel)&#160;at&#160;24h,&#160;48h and 72 h,&#160;respectively,&#160;from left&#160;to&#160;right.&#160;<br/>&#160;</p>
<p style="position:absolute;top:109px;left:169px;white-space:nowrap" class="ft104"><b>0.5</b></p>
<p style="position:absolute;top:132px;left:169px;white-space:nowrap" class="ft104"><b>0.4</b></p>
<p style="position:absolute;top:155px;left:169px;white-space:nowrap" class="ft104"><b>0.3</b></p>
<p style="position:absolute;top:178px;left:169px;white-space:nowrap" class="ft104"><b>0.2</b></p>
<p style="position:absolute;top:201px;left:169px;white-space:nowrap" class="ft104"><b>0.1</b></p>
<p style="position:absolute;top:224px;left:169px;white-space:nowrap" class="ft104"><b>0.0</b></p>
<p style="position:absolute;top:189px;left:162px;white-space:nowrap" class="ft105"><b>OD (570nm)</b></p>
<p style="position:absolute;top:271px;left:158px;white-space:nowrap" class="ft106"><b>No treatment</b></p>
<p style="position:absolute;top:252px;left:197px;white-space:nowrap" class="ft106"><b>DMSO100</b></p>
<p style="position:absolute;top:242px;left:226px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:249px;left:238px;white-space:nowrap" class="ft106"><b>50</b></p>
<p style="position:absolute;top:242px;left:245px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:249px;left:257px;white-space:nowrap" class="ft106"><b>40</b></p>
<p style="position:absolute;top:242px;left:264px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:249px;left:277px;white-space:nowrap" class="ft106"><b>30</b></p>
<p style="position:absolute;top:242px;left:283px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:249px;left:295px;white-space:nowrap" class="ft106"><b>25</b></p>
<p style="position:absolute;top:242px;left:302px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:248px;left:315px;white-space:nowrap" class="ft106"><b>10</b></p>
<p style="position:absolute;top:242px;left:322px;white-space:nowrap" class="ft107">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:108px;left:398px;white-space:nowrap" class="ft104"><b>0.5</b></p>
<p style="position:absolute;top:132px;left:398px;white-space:nowrap" class="ft104"><b>0.4</b></p>
<p style="position:absolute;top:155px;left:398px;white-space:nowrap" class="ft104"><b>0.3</b></p>
<p style="position:absolute;top:178px;left:398px;white-space:nowrap" class="ft104"><b>0.2</b></p>
<p style="position:absolute;top:201px;left:398px;white-space:nowrap" class="ft104"><b>0.1</b></p>
<p style="position:absolute;top:224px;left:398px;white-space:nowrap" class="ft104"><b>0.0</b></p>
<p style="position:absolute;top:189px;left:392px;white-space:nowrap" class="ft105"><b>OD (570nm)</b></p>
<p style="position:absolute;top:271px;left:387px;white-space:nowrap" class="ft106"><b>No treatment</b></p>
<p style="position:absolute;top:251px;left:426px;white-space:nowrap" class="ft106"><b>DMSO100</b></p>
<p style="position:absolute;top:242px;left:455px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:249px;left:467px;white-space:nowrap" class="ft106"><b>50</b></p>
<p style="position:absolute;top:242px;left:474px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:249px;left:486px;white-space:nowrap" class="ft106"><b>40</b></p>
<p style="position:absolute;top:242px;left:493px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:249px;left:506px;white-space:nowrap" class="ft106"><b>30</b></p>
<p style="position:absolute;top:242px;left:513px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:248px;left:525px;white-space:nowrap" class="ft106"><b>25</b></p>
<p style="position:absolute;top:241px;left:532px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:248px;left:544px;white-space:nowrap" class="ft106"><b>10</b></p>
<p style="position:absolute;top:241px;left:551px;white-space:nowrap" class="ft107">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:90px;left:186px;white-space:nowrap" class="ft100"><b>MCF7_Prozac_24hs_MTT</b></p>
<p style="position:absolute;top:89px;left:415px;white-space:nowrap" class="ft100"><b>MCF7_Prozac_48hs_MTT</b></p>
<p style="position:absolute;top:110px;left:628px;white-space:nowrap" class="ft104"><b>0.5</b></p>
<p style="position:absolute;top:133px;left:628px;white-space:nowrap" class="ft104"><b>0.4</b></p>
<p style="position:absolute;top:156px;left:628px;white-space:nowrap" class="ft104"><b>0.3</b></p>
<p style="position:absolute;top:179px;left:628px;white-space:nowrap" class="ft104"><b>0.2</b></p>
<p style="position:absolute;top:202px;left:628px;white-space:nowrap" class="ft104"><b>0.1</b></p>
<p style="position:absolute;top:225px;left:628px;white-space:nowrap" class="ft104"><b>0.0</b></p>
<p style="position:absolute;top:190px;left:621px;white-space:nowrap" class="ft105"><b>OD (570nm)</b></p>
<p style="position:absolute;top:272px;left:617px;white-space:nowrap" class="ft106"><b>No treatment</b></p>
<p style="position:absolute;top:253px;left:656px;white-space:nowrap" class="ft106"><b>DMSO100</b></p>
<p style="position:absolute;top:243px;left:685px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:250px;left:697px;white-space:nowrap" class="ft106"><b>50</b></p>
<p style="position:absolute;top:243px;left:704px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:250px;left:716px;white-space:nowrap" class="ft106"><b>40</b></p>
<p style="position:absolute;top:243px;left:723px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:250px;left:736px;white-space:nowrap" class="ft106"><b>30</b></p>
<p style="position:absolute;top:243px;left:742px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:250px;left:754px;white-space:nowrap" class="ft106"><b>25</b></p>
<p style="position:absolute;top:243px;left:761px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:249px;left:774px;white-space:nowrap" class="ft106"><b>10</b></p>
<p style="position:absolute;top:243px;left:781px;white-space:nowrap" class="ft107">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:91px;left:645px;white-space:nowrap" class="ft100"><b>MCF7_Prozac_72hs_MTT</b></p>
<p style="position:absolute;top:362px;left:172px;white-space:nowrap" class="ft104"><b>0.5</b></p>
<p style="position:absolute;top:386px;left:172px;white-space:nowrap" class="ft104"><b>0.4</b></p>
<p style="position:absolute;top:409px;left:172px;white-space:nowrap" class="ft104"><b>0.3</b></p>
<p style="position:absolute;top:432px;left:172px;white-space:nowrap" class="ft104"><b>0.2</b></p>
<p style="position:absolute;top:455px;left:172px;white-space:nowrap" class="ft104"><b>0.1</b></p>
<p style="position:absolute;top:478px;left:172px;white-space:nowrap" class="ft104"><b>0.0</b></p>
<p style="position:absolute;top:443px;left:165px;white-space:nowrap" class="ft105"><b>OD (570nm)</b></p>
<p style="position:absolute;top:525px;left:161px;white-space:nowrap" class="ft106"><b>No treatment</b></p>
<p style="position:absolute;top:505px;left:200px;white-space:nowrap" class="ft106"><b>DMSO100</b></p>
<p style="position:absolute;top:496px;left:229px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:503px;left:241px;white-space:nowrap" class="ft106"><b>50</b></p>
<p style="position:absolute;top:496px;left:248px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:503px;left:260px;white-space:nowrap" class="ft106"><b>40</b></p>
<p style="position:absolute;top:496px;left:267px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:502px;left:280px;white-space:nowrap" class="ft106"><b>30</b></p>
<p style="position:absolute;top:495px;left:286px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:502px;left:298px;white-space:nowrap" class="ft106"><b>25</b></p>
<p style="position:absolute;top:495px;left:305px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:502px;left:318px;white-space:nowrap" class="ft106"><b>10</b></p>
<p style="position:absolute;top:495px;left:325px;white-space:nowrap" class="ft107">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:343px;left:181px;white-space:nowrap" class="ft100"><b>MCF10A_Prozac_24hs_MTT</b></p>
<p style="position:absolute;top:362px;left:398px;white-space:nowrap" class="ft104"><b>0.5</b></p>
<p style="position:absolute;top:386px;left:398px;white-space:nowrap" class="ft104"><b>0.4</b></p>
<p style="position:absolute;top:409px;left:398px;white-space:nowrap" class="ft104"><b>0.3</b></p>
<p style="position:absolute;top:432px;left:398px;white-space:nowrap" class="ft104"><b>0.2</b></p>
<p style="position:absolute;top:455px;left:398px;white-space:nowrap" class="ft104"><b>0.1</b></p>
<p style="position:absolute;top:478px;left:398px;white-space:nowrap" class="ft104"><b>0.0</b></p>
<p style="position:absolute;top:443px;left:392px;white-space:nowrap" class="ft105"><b>OD (570nm)</b></p>
<p style="position:absolute;top:525px;left:387px;white-space:nowrap" class="ft106"><b>No treatment</b></p>
<p style="position:absolute;top:505px;left:426px;white-space:nowrap" class="ft106"><b>DMSO100</b></p>
<p style="position:absolute;top:496px;left:455px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:503px;left:467px;white-space:nowrap" class="ft106"><b>50</b></p>
<p style="position:absolute;top:496px;left:474px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:503px;left:486px;white-space:nowrap" class="ft106"><b>40</b></p>
<p style="position:absolute;top:496px;left:493px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:502px;left:506px;white-space:nowrap" class="ft106"><b>30</b></p>
<p style="position:absolute;top:496px;left:513px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:502px;left:525px;white-space:nowrap" class="ft106"><b>25</b></p>
<p style="position:absolute;top:495px;left:532px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:502px;left:544px;white-space:nowrap" class="ft106"><b>10</b></p>
<p style="position:absolute;top:495px;left:551px;white-space:nowrap" class="ft107">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:343px;left:408px;white-space:nowrap" class="ft100"><b>MCF10A_Prozac_48hs_MTT</b></p>
<p style="position:absolute;top:367px;left:628px;white-space:nowrap" class="ft104"><b>0.5</b></p>
<p style="position:absolute;top:391px;left:628px;white-space:nowrap" class="ft104"><b>0.4</b></p>
<p style="position:absolute;top:414px;left:628px;white-space:nowrap" class="ft104"><b>0.3</b></p>
<p style="position:absolute;top:437px;left:628px;white-space:nowrap" class="ft104"><b>0.2</b></p>
<p style="position:absolute;top:460px;left:628px;white-space:nowrap" class="ft104"><b>0.1</b></p>
<p style="position:absolute;top:483px;left:628px;white-space:nowrap" class="ft104"><b>0.0</b></p>
<p style="position:absolute;top:448px;left:621px;white-space:nowrap" class="ft105"><b>OD (570nm)</b></p>
<p style="position:absolute;top:530px;left:617px;white-space:nowrap" class="ft106"><b>No treatment</b></p>
<p style="position:absolute;top:510px;left:656px;white-space:nowrap" class="ft106"><b>DMSO100</b></p>
<p style="position:absolute;top:501px;left:685px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:508px;left:697px;white-space:nowrap" class="ft106"><b>50</b></p>
<p style="position:absolute;top:501px;left:704px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:508px;left:716px;white-space:nowrap" class="ft106"><b>40</b></p>
<p style="position:absolute;top:501px;left:723px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:507px;left:736px;white-space:nowrap" class="ft106"><b>30</b></p>
<p style="position:absolute;top:501px;left:743px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:507px;left:755px;white-space:nowrap" class="ft106"><b>25</b></p>
<p style="position:absolute;top:500px;left:761px;white-space:nowrap" class="ft107">m<b>M</b></p>
<p style="position:absolute;top:507px;left:774px;white-space:nowrap" class="ft106"><b>10</b></p>
<p style="position:absolute;top:500px;left:781px;white-space:nowrap" class="ft107">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:348px;left:637px;white-space:nowrap" class="ft100"><b>MCF10A_Prozac_72hs_MTT</b></p>
<p style="position:absolute;top:105px;left:306px;white-space:nowrap" class="ft108"><b>.</b></p>
<p style="position:absolute;top:111px;left:531px;white-space:nowrap" class="ft108"><b>.</b></p>
<p style="position:absolute;top:110px;left:760px;white-space:nowrap" class="ft108"><b>.</b></p>
<p style="position:absolute;top:353px;left:311px;white-space:nowrap" class="ft108"><b>.</b></p>
<p style="position:absolute;top:358px;left:536px;white-space:nowrap" class="ft108"><b>.</b></p>
<p style="position:absolute;top:357px;left:765px;white-space:nowrap" class="ft108"><b>.</b></p>
<p style="position:absolute;top:796px;left:115px;white-space:nowrap" class="ft109"><b>No treatment</b></p>
<p style="position:absolute;top:775px;left:156px;white-space:nowrap" class="ft109"><b>DMSO100</b></p>
<p style="position:absolute;top:765px;left:187px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:772px;left:200px;white-space:nowrap" class="ft109"><b>50</b></p>
<p style="position:absolute;top:764px;left:207px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:772px;left:221px;white-space:nowrap" class="ft109"><b>40</b></p>
<p style="position:absolute;top:765px;left:228px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:772px;left:242px;white-space:nowrap" class="ft109"><b>30</b></p>
<p style="position:absolute;top:765px;left:249px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:772px;left:263px;white-space:nowrap" class="ft109"><b>25</b></p>
<p style="position:absolute;top:765px;left:270px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:772px;left:283px;white-space:nowrap" class="ft109"><b>10</b></p>
<p style="position:absolute;top:765px;left:291px;white-space:nowrap" class="ft1010">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:622px;left:122px;white-space:nowrap" class="ft1011"><b>0.10</b></p>
<p style="position:absolute;top:647px;left:122px;white-space:nowrap" class="ft1011"><b>0.08</b></p>
<p style="position:absolute;top:671px;left:122px;white-space:nowrap" class="ft1011"><b>0.06</b></p>
<p style="position:absolute;top:696px;left:122px;white-space:nowrap" class="ft1011"><b>0.04</b></p>
<p style="position:absolute;top:721px;left:122px;white-space:nowrap" class="ft1011"><b>0.02</b></p>
<p style="position:absolute;top:746px;left:122px;white-space:nowrap" class="ft1011"><b>0.00</b></p>
<p style="position:absolute;top:708px;left:115px;white-space:nowrap" class="ft1012"><b>OD (570nm)</b></p>
<p style="position:absolute;top:795px;left:378px;white-space:nowrap" class="ft109"><b>No treatment</b></p>
<p style="position:absolute;top:774px;left:419px;white-space:nowrap" class="ft109"><b>DMSO100</b></p>
<p style="position:absolute;top:764px;left:450px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:771px;left:463px;white-space:nowrap" class="ft109"><b>50</b></p>
<p style="position:absolute;top:764px;left:471px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:771px;left:484px;white-space:nowrap" class="ft109"><b>40</b></p>
<p style="position:absolute;top:764px;left:492px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:772px;left:505px;white-space:nowrap" class="ft109"><b>30</b></p>
<p style="position:absolute;top:764px;left:512px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:772px;left:525px;white-space:nowrap" class="ft109"><b>25</b></p>
<p style="position:absolute;top:764px;left:533px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:771px;left:547px;white-space:nowrap" class="ft109"><b>10</b></p>
<p style="position:absolute;top:764px;left:554px;white-space:nowrap" class="ft1010">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:795px;left:636px;white-space:nowrap" class="ft109"><b>No treatment</b></p>
<p style="position:absolute;top:773px;left:679px;white-space:nowrap" class="ft109"><b>DMSO100</b></p>
<p style="position:absolute;top:763px;left:710px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:770px;left:724px;white-space:nowrap" class="ft109"><b>50</b></p>
<p style="position:absolute;top:763px;left:731px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:771px;left:745px;white-space:nowrap" class="ft109"><b>40</b></p>
<p style="position:absolute;top:763px;left:752px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:770px;left:766px;white-space:nowrap" class="ft109"><b>30</b></p>
<p style="position:absolute;top:763px;left:774px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:770px;left:788px;white-space:nowrap" class="ft109"><b>25</b></p>
<p style="position:absolute;top:763px;left:795px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:770px;left:809px;white-space:nowrap" class="ft109"><b>10</b></p>
<p style="position:absolute;top:763px;left:817px;white-space:nowrap" class="ft1010">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:1036px;left:115px;white-space:nowrap" class="ft109"><b>No treatment</b></p>
<p style="position:absolute;top:1015px;left:155px;white-space:nowrap" class="ft109"><b>DMSO100</b></p>
<p style="position:absolute;top:1005px;left:185px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1013px;left:198px;white-space:nowrap" class="ft109"><b>50</b></p>
<p style="position:absolute;top:1006px;left:206px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1012px;left:219px;white-space:nowrap" class="ft109"><b>40</b></p>
<p style="position:absolute;top:1005px;left:226px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1013px;left:239px;white-space:nowrap" class="ft109"><b>30</b></p>
<p style="position:absolute;top:1005px;left:246px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1013px;left:259px;white-space:nowrap" class="ft109"><b>25</b></p>
<p style="position:absolute;top:1006px;left:266px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1012px;left:279px;white-space:nowrap" class="ft109"><b>10</b></p>
<p style="position:absolute;top:1005px;left:287px;white-space:nowrap" class="ft1010">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:1042px;left:377px;white-space:nowrap" class="ft109"><b>No treatment</b></p>
<p style="position:absolute;top:1022px;left:419px;white-space:nowrap" class="ft109"><b>DMSO100</b></p>
<p style="position:absolute;top:1011px;left:449px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1018px;left:463px;white-space:nowrap" class="ft109"><b>50</b></p>
<p style="position:absolute;top:1011px;left:471px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1018px;left:484px;white-space:nowrap" class="ft109"><b>40</b></p>
<p style="position:absolute;top:1011px;left:491px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1019px;left:505px;white-space:nowrap" class="ft109"><b>30</b></p>
<p style="position:absolute;top:1011px;left:513px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1018px;left:526px;white-space:nowrap" class="ft109"><b>25</b></p>
<p style="position:absolute;top:1011px;left:533px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1019px;left:547px;white-space:nowrap" class="ft109"><b>10</b></p>
<p style="position:absolute;top:1011px;left:554px;white-space:nowrap" class="ft1010">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:1043px;left:636px;white-space:nowrap" class="ft109"><b>No treatment</b></p>
<p style="position:absolute;top:1022px;left:678px;white-space:nowrap" class="ft109"><b>DMSO100</b></p>
<p style="position:absolute;top:1012px;left:710px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1019px;left:724px;white-space:nowrap" class="ft109"><b>50</b></p>
<p style="position:absolute;top:1012px;left:731px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1019px;left:745px;white-space:nowrap" class="ft109"><b>40</b></p>
<p style="position:absolute;top:1012px;left:752px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1019px;left:766px;white-space:nowrap" class="ft109"><b>30</b></p>
<p style="position:absolute;top:1012px;left:774px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1019px;left:788px;white-space:nowrap" class="ft109"><b>25</b></p>
<p style="position:absolute;top:1012px;left:795px;white-space:nowrap" class="ft1010">m<b>M</b></p>
<p style="position:absolute;top:1019px;left:809px;white-space:nowrap" class="ft109"><b>10</b></p>
<p style="position:absolute;top:1012px;left:816px;white-space:nowrap" class="ft1010">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:620px;left:384px;white-space:nowrap" class="ft1011"><b>0.25</b></p>
<p style="position:absolute;top:645px;left:384px;white-space:nowrap" class="ft1011"><b>0.20</b></p>
<p style="position:absolute;top:670px;left:384px;white-space:nowrap" class="ft1011"><b>0.15</b></p>
<p style="position:absolute;top:695px;left:384px;white-space:nowrap" class="ft1011"><b>0.10</b></p>
<p style="position:absolute;top:720px;left:384px;white-space:nowrap" class="ft1011"><b>0.05</b></p>
<p style="position:absolute;top:745px;left:384px;white-space:nowrap" class="ft1011"><b>0.00</b></p>
<p style="position:absolute;top:706px;left:377px;white-space:nowrap" class="ft1012"><b>OD (570nm)</b></p>
<p style="position:absolute;top:615px;left:647px;white-space:nowrap" class="ft1011"><b>1.0</b></p>
<p style="position:absolute;top:641px;left:647px;white-space:nowrap" class="ft1011"><b>0.8</b></p>
<p style="position:absolute;top:667px;left:647px;white-space:nowrap" class="ft1011"><b>0.6</b></p>
<p style="position:absolute;top:692px;left:647px;white-space:nowrap" class="ft1011"><b>0.4</b></p>
<p style="position:absolute;top:718px;left:648px;white-space:nowrap" class="ft1011"><b>0.2</b></p>
<p style="position:absolute;top:743px;left:648px;white-space:nowrap" class="ft1011"><b>0.0</b></p>
<p style="position:absolute;top:704px;left:640px;white-space:nowrap" class="ft1012"><b>OD (570nm)</b></p>
<p style="position:absolute;top:865px;left:121px;white-space:nowrap" class="ft1011"><b>0.08</b></p>
<p style="position:absolute;top:895px;left:121px;white-space:nowrap" class="ft1011"><b>0.06</b></p>
<p style="position:absolute;top:926px;left:121px;white-space:nowrap" class="ft1011"><b>0.04</b></p>
<p style="position:absolute;top:957px;left:121px;white-space:nowrap" class="ft1011"><b>0.02</b></p>
<p style="position:absolute;top:987px;left:120px;white-space:nowrap" class="ft1011"><b>0.00</b></p>
<p style="position:absolute;top:949px;left:114px;white-space:nowrap" class="ft1012"><b>OD (570nm)</b></p>
<p style="position:absolute;top:867px;left:384px;white-space:nowrap" class="ft1013"><b>0.20</b></p>
<p style="position:absolute;top:898px;left:384px;white-space:nowrap" class="ft1013"><b>0.15</b></p>
<p style="position:absolute;top:929px;left:384px;white-space:nowrap" class="ft1013"><b>0.10</b></p>
<p style="position:absolute;top:960px;left:384px;white-space:nowrap" class="ft1013"><b>0.05</b></p>
<p style="position:absolute;top:992px;left:384px;white-space:nowrap" class="ft1013"><b>0.00</b></p>
<p style="position:absolute;top:953px;left:378px;white-space:nowrap" class="ft1012"><b>OD (570nm)</b></p>
<p style="position:absolute;top:864px;left:647px;white-space:nowrap" class="ft1013"><b>0.5</b></p>
<p style="position:absolute;top:889px;left:647px;white-space:nowrap" class="ft1013"><b>0.4</b></p>
<p style="position:absolute;top:915px;left:647px;white-space:nowrap" class="ft1013"><b>0.3</b></p>
<p style="position:absolute;top:940px;left:647px;white-space:nowrap" class="ft1013"><b>0.2</b></p>
<p style="position:absolute;top:966px;left:647px;white-space:nowrap" class="ft1013"><b>0.1</b></p>
<p style="position:absolute;top:991px;left:647px;white-space:nowrap" class="ft1013"><b>0.0</b></p>
<p style="position:absolute;top:953px;left:640px;white-space:nowrap" class="ft1012"><b>OD (570nm)</b></p>
<p style="position:absolute;top:594px;left:659px;white-space:nowrap" class="ft1014"><b>MCF7_Prozac_72hs_Crystal</b></p>
<p style="position:absolute;top:599px;left:399px;white-space:nowrap" class="ft1014"><b>MCF7_Prozac_48hs_Crystal</b></p>
<p style="position:absolute;top:601px;left:137px;white-space:nowrap" class="ft1014"><b>MCF7_Prozac_24hs_Crystal</b></p>
<p style="position:absolute;top:845px;left:129px;white-space:nowrap" class="ft100"><b>MCF10A_Prozac_24hs_Crystal</b></p>
<p style="position:absolute;top:846px;left:392px;white-space:nowrap" class="ft1014"><b>MCF10A_Prozac_48hs_Crystal</b></p>
<p style="position:absolute;top:842px;left:651px;white-space:nowrap" class="ft1014"><b>MCF10A_Prozac_72hs_Crystal</b></p>
<p style="position:absolute;top:611px;left:273px;white-space:nowrap" class="ft1015"><b>.</b></p>
<p style="position:absolute;top:611px;left:537px;white-space:nowrap" class="ft1015"><b>.</b></p>
<p style="position:absolute;top:600px;left:799px;white-space:nowrap" class="ft1015"><b>.</b></p>
<p style="position:absolute;top:860px;left:273px;white-space:nowrap" class="ft1015"><b>.</b></p>
<p style="position:absolute;top:860px;left:536px;white-space:nowrap" class="ft1015"><b>.</b></p>
<p style="position:absolute;top:841px;left:799px;white-space:nowrap" class="ft1015"><b>.</b></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft110{font-size:9px;font-family:Times;color:#000000;}
	.ft111{font-size:9px;font-family:Times;color:#000000;}
	.ft112{font-size:11px;font-family:Times;color:#000000;}
	.ft113{font-size:9px;font-family:Times;color:#000000;}
	.ft114{font-size:6px;font-family:Times;color:#000000;}
	.ft115{font-size:7px;font-family:Times;color:#000000;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft116{font-size:6px;font-family:Times;color:#000000;-moz-transform: matrix(     4.241,     -4.241,     4.2411,      4.241, 0, 0);-webkit-transform: matrix(     4.241,     -4.241,     4.2411,      4.241, 0, 0);-o-transform: matrix(     4.241,     -4.241,     4.2411,      4.241, 0, 0);-ms-transform: matrix(     4.241,     -4.241,     4.2411,      4.241, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft117{font-size:6px;font-family:Times;color:#000000;-moz-transform: matrix(     4.241,     -4.241,     4.2411,      4.241, 0, 0);-webkit-transform: matrix(     4.241,     -4.241,     4.2411,      4.241, 0, 0);-o-transform: matrix(     4.241,     -4.241,     4.2411,      4.241, 0, 0);-ms-transform: matrix(     4.241,     -4.241,     4.2411,      4.241, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft118{font-size:18px;font-family:Times;color:#ce1f24;}
	.ft119{font-size:7px;font-family:Times;color:#000000;-moz-transform: matrix(    4.3884,    -4.3884,     4.3885,     4.3884, 0, 0);-webkit-transform: matrix(    4.3884,    -4.3884,     4.3885,     4.3884, 0, 0);-o-transform: matrix(    4.3884,    -4.3884,     4.3885,     4.3884, 0, 0);-ms-transform: matrix(    4.3884,    -4.3884,     4.3885,     4.3884, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft1110{font-size:7px;font-family:Times;color:#000000;-moz-transform: matrix(    4.3884,    -4.3884,     4.3885,     4.3884, 0, 0);-webkit-transform: matrix(    4.3884,    -4.3884,     4.3885,     4.3884, 0, 0);-o-transform: matrix(    4.3884,    -4.3884,     4.3885,     4.3884, 0, 0);-ms-transform: matrix(    4.3884,    -4.3884,     4.3885,     4.3884, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft1111{font-size:8px;font-family:Times;color:#000000;-moz-transform: matrix(         0,         -1,          1,          0, 0, 0);-webkit-transform: matrix(         0,         -1,          1,          0, 0, 0);-o-transform: matrix(         0,         -1,          1,          0, 0, 0);-ms-transform: matrix(         0,         -1,          1,          0, 0, 0);-moz-transform-origin: left 75%;-webkit-transform-origin: left 75%;-o-transform-origin: left 75%;-ms-transform-origin: left 75%;}
	.ft1112{font-size:10px;font-family:Times;color:#000000;}
	.ft1113{font-size:19px;font-family:Times;color:#ce1f24;}
	.ft1114{font-size:9px;line-height:14px;font-family:Times;color:#000000;}
	.ft1115{font-size:9px;line-height:15px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page11-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft110"><i><b>Neurotransmitters&#160;and&#160;Electroceuticals&#160;in&#160;Cancer&#160;</b></i></p>
<p style="position:absolute;top:57px;left:560px;white-space:nowrap" class="ft110"><i><b>Current&#160;Pharmaceutical&#160;Design,&#160;</b></i><b>2017<i>, Vol.&#160;23, No. 32&#160; &#160;&#160;</i></b><b>4837<i>&#160;</i></b></p>
<p style="position:absolute;top:536px;left:96px;white-space:nowrap" class="ft112">&#160;</p>
<p style="position:absolute;top:557px;left:96px;white-space:nowrap" class="ft1114"><b>Fig. (12).</b>&#160;MMT&#160;survival&#160;assay results&#160;for&#160;the Prozac analog-exposed MCF7&#160;breast&#160;cancer&#160;cells&#160;(top&#160;panel)&#160;and MCF10A&#160;non-malignant&#160;breast&#160;cells&#160;(bottom&#160;<br/>panel)&#160;at&#160;24h,&#160;48h and 72 h,&#160;respectively,&#160;from left&#160;to&#160;right.&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/>&#160;<br/><b>Fig. (13).</b>&#160;Crystal&#160;violet&#160;staining&#160;proliferation&#160;assay&#160;results&#160;for&#160;the Prozac&#160;analog-exposed MCF7&#160;breast&#160;cancer&#160;cells&#160;(top&#160;panel)&#160;and MCF10A&#160;non-malignant&#160;<br/>breast&#160;cells&#160;(bottom panel)&#160;at&#160;24h,&#160;48h and 72 h,&#160;respectively,&#160;from left&#160;to&#160;right.</p>
<p style="position:absolute;top:1096px;left:478px;white-space:nowrap" class="ft112">&#160;</p>
<p style="position:absolute;top:113px;left:147px;white-space:nowrap" class="ft114"><b>0.5</b></p>
<p style="position:absolute;top:137px;left:147px;white-space:nowrap" class="ft114"><b>0.4</b></p>
<p style="position:absolute;top:161px;left:147px;white-space:nowrap" class="ft114"><b>0.3</b></p>
<p style="position:absolute;top:185px;left:147px;white-space:nowrap" class="ft114"><b>0.2</b></p>
<p style="position:absolute;top:209px;left:147px;white-space:nowrap" class="ft114"><b>0.1</b></p>
<p style="position:absolute;top:233px;left:147px;white-space:nowrap" class="ft114"><b>0.0</b></p>
<p style="position:absolute;top:196px;left:141px;white-space:nowrap" class="ft115"><b>OD (570nm)</b></p>
<p style="position:absolute;top:281px;left:136px;white-space:nowrap" class="ft116"><b>No treatment</b></p>
<p style="position:absolute;top:261px;left:176px;white-space:nowrap" class="ft116"><b>DMSO100</b></p>
<p style="position:absolute;top:251px;left:206px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:94px;left:145px;white-space:nowrap" class="ft111"><b>MCF7_ProzacAnalog_24hs_MTT</b></p>
<p style="position:absolute;top:117px;left:212px;white-space:nowrap" class="ft118"><b>.</b></p>
<p style="position:absolute;top:258px;left:219px;white-space:nowrap" class="ft116"><b>50</b></p>
<p style="position:absolute;top:251px;left:226px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:258px;left:239px;white-space:nowrap" class="ft116"><b>40</b></p>
<p style="position:absolute;top:251px;left:246px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:258px;left:259px;white-space:nowrap" class="ft116"><b>30</b></p>
<p style="position:absolute;top:251px;left:266px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:258px;left:278px;white-space:nowrap" class="ft116"><b>25</b></p>
<p style="position:absolute;top:251px;left:285px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:258px;left:298px;white-space:nowrap" class="ft116"><b>10</b></p>
<p style="position:absolute;top:251px;left:305px;white-space:nowrap" class="ft117">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:112px;left:390px;white-space:nowrap" class="ft114"><b>0.5</b></p>
<p style="position:absolute;top:136px;left:390px;white-space:nowrap" class="ft114"><b>0.4</b></p>
<p style="position:absolute;top:160px;left:390px;white-space:nowrap" class="ft114"><b>0.3</b></p>
<p style="position:absolute;top:184px;left:390px;white-space:nowrap" class="ft114"><b>0.2</b></p>
<p style="position:absolute;top:208px;left:390px;white-space:nowrap" class="ft114"><b>0.1</b></p>
<p style="position:absolute;top:232px;left:390px;white-space:nowrap" class="ft114"><b>0.0</b></p>
<p style="position:absolute;top:195px;left:384px;white-space:nowrap" class="ft115"><b>OD (570nm)</b></p>
<p style="position:absolute;top:280px;left:379px;white-space:nowrap" class="ft116"><b>No treatment</b></p>
<p style="position:absolute;top:260px;left:419px;white-space:nowrap" class="ft116"><b>DMSO100mM</b></p>
<p style="position:absolute;top:93px;left:388px;white-space:nowrap" class="ft111"><b>MCF7_ProzacAnalog_48hs_MTT</b></p>
<p style="position:absolute;top:118px;left:453px;white-space:nowrap" class="ft118"><b>.</b></p>
<p style="position:absolute;top:259px;left:461px;white-space:nowrap" class="ft116"><b>50mM&#160;40mM&#160;30mM&#160;25mM&#160;10mM&#160;5mM</b></p>
<p style="position:absolute;top:112px;left:633px;white-space:nowrap" class="ft114"><b>0.5</b></p>
<p style="position:absolute;top:136px;left:633px;white-space:nowrap" class="ft114"><b>0.4</b></p>
<p style="position:absolute;top:160px;left:633px;white-space:nowrap" class="ft114"><b>0.3</b></p>
<p style="position:absolute;top:184px;left:633px;white-space:nowrap" class="ft114"><b>0.2</b></p>
<p style="position:absolute;top:208px;left:633px;white-space:nowrap" class="ft114"><b>0.1</b></p>
<p style="position:absolute;top:232px;left:633px;white-space:nowrap" class="ft114"><b>0.0</b></p>
<p style="position:absolute;top:196px;left:627px;white-space:nowrap" class="ft115"><b>OD (570nm)</b></p>
<p style="position:absolute;top:280px;left:622px;white-space:nowrap" class="ft116"><b>No treatment</b></p>
<p style="position:absolute;top:260px;left:662px;white-space:nowrap" class="ft116"><b>DMSO100</b></p>
<p style="position:absolute;top:250px;left:692px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:92px;left:631px;white-space:nowrap" class="ft111"><b>MCF7_ProzacAnalog_72hs_MTT</b></p>
<p style="position:absolute;top:258px;left:705px;white-space:nowrap" class="ft116"><b>50</b></p>
<p style="position:absolute;top:250px;left:712px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:257px;left:725px;white-space:nowrap" class="ft116"><b>40</b></p>
<p style="position:absolute;top:250px;left:732px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:258px;left:745px;white-space:nowrap" class="ft116"><b>30</b></p>
<p style="position:absolute;top:250px;left:752px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:257px;left:764px;white-space:nowrap" class="ft116"><b>25</b></p>
<p style="position:absolute;top:250px;left:771px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:258px;left:784px;white-space:nowrap" class="ft116"><b>10</b></p>
<p style="position:absolute;top:251px;left:791px;white-space:nowrap" class="ft117">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:359px;left:147px;white-space:nowrap" class="ft114"><b>0.5</b></p>
<p style="position:absolute;top:383px;left:147px;white-space:nowrap" class="ft114"><b>0.4</b></p>
<p style="position:absolute;top:407px;left:147px;white-space:nowrap" class="ft114"><b>0.3</b></p>
<p style="position:absolute;top:431px;left:147px;white-space:nowrap" class="ft114"><b>0.2</b></p>
<p style="position:absolute;top:455px;left:147px;white-space:nowrap" class="ft114"><b>0.1</b></p>
<p style="position:absolute;top:479px;left:147px;white-space:nowrap" class="ft114"><b>0.0</b></p>
<p style="position:absolute;top:442px;left:140px;white-space:nowrap" class="ft115"><b>OD (570nm)</b></p>
<p style="position:absolute;top:527px;left:136px;white-space:nowrap" class="ft116"><b>No treatment</b></p>
<p style="position:absolute;top:507px;left:176px;white-space:nowrap" class="ft116"><b>DMSO100</b></p>
<p style="position:absolute;top:497px;left:206px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:341px;left:138px;white-space:nowrap" class="ft111"><b>MCF10A_ProzacAnalog_24hs_MTT</b></p>
<p style="position:absolute;top:348px;left:211px;white-space:nowrap" class="ft118"><b>.</b></p>
<p style="position:absolute;top:504px;left:219px;white-space:nowrap" class="ft116"><b>50</b></p>
<p style="position:absolute;top:497px;left:226px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:504px;left:238px;white-space:nowrap" class="ft116"><b>40</b></p>
<p style="position:absolute;top:497px;left:245px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:505px;left:258px;white-space:nowrap" class="ft116"><b>30</b></p>
<p style="position:absolute;top:497px;left:265px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:504px;left:278px;white-space:nowrap" class="ft116"><b>25</b></p>
<p style="position:absolute;top:497px;left:285px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:505px;left:298px;white-space:nowrap" class="ft116"><b>10</b></p>
<p style="position:absolute;top:498px;left:305px;white-space:nowrap" class="ft117">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:359px;left:391px;white-space:nowrap" class="ft114"><b>0.5</b></p>
<p style="position:absolute;top:383px;left:391px;white-space:nowrap" class="ft114"><b>0.4</b></p>
<p style="position:absolute;top:407px;left:391px;white-space:nowrap" class="ft114"><b>0.3</b></p>
<p style="position:absolute;top:431px;left:391px;white-space:nowrap" class="ft114"><b>0.2</b></p>
<p style="position:absolute;top:455px;left:391px;white-space:nowrap" class="ft114"><b>0.1</b></p>
<p style="position:absolute;top:478px;left:391px;white-space:nowrap" class="ft114"><b>0.0</b></p>
<p style="position:absolute;top:442px;left:384px;white-space:nowrap" class="ft115"><b>OD (570nm)</b></p>
<p style="position:absolute;top:527px;left:380px;white-space:nowrap" class="ft116"><b>No treatment</b></p>
<p style="position:absolute;top:507px;left:420px;white-space:nowrap" class="ft116"><b>DMSO100</b></p>
<p style="position:absolute;top:497px;left:449px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:339px;left:381px;white-space:nowrap" class="ft111"><b>MCF10A_ProzacAnalog_48hs_MTT</b></p>
<p style="position:absolute;top:349px;left:453px;white-space:nowrap" class="ft118"><b>.</b></p>
<p style="position:absolute;top:504px;left:462px;white-space:nowrap" class="ft116"><b>50</b></p>
<p style="position:absolute;top:497px;left:469px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:504px;left:482px;white-space:nowrap" class="ft116"><b>40</b></p>
<p style="position:absolute;top:497px;left:489px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:504px;left:502px;white-space:nowrap" class="ft116"><b>30</b></p>
<p style="position:absolute;top:497px;left:509px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:504px;left:522px;white-space:nowrap" class="ft116"><b>25</b></p>
<p style="position:absolute;top:497px;left:529px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:504px;left:542px;white-space:nowrap" class="ft116"><b>10</b></p>
<p style="position:absolute;top:497px;left:549px;white-space:nowrap" class="ft117">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:359px;left:634px;white-space:nowrap" class="ft114"><b>0.5</b></p>
<p style="position:absolute;top:383px;left:633px;white-space:nowrap" class="ft114"><b>0.4</b></p>
<p style="position:absolute;top:407px;left:633px;white-space:nowrap" class="ft114"><b>0.3</b></p>
<p style="position:absolute;top:431px;left:633px;white-space:nowrap" class="ft114"><b>0.2</b></p>
<p style="position:absolute;top:455px;left:633px;white-space:nowrap" class="ft114"><b>0.1</b></p>
<p style="position:absolute;top:478px;left:633px;white-space:nowrap" class="ft114"><b>0.0</b></p>
<p style="position:absolute;top:442px;left:627px;white-space:nowrap" class="ft115"><b>OD (570nm)</b></p>
<p style="position:absolute;top:527px;left:622px;white-space:nowrap" class="ft116"><b>No treatment</b></p>
<p style="position:absolute;top:507px;left:663px;white-space:nowrap" class="ft116"><b>DMSO100</b></p>
<p style="position:absolute;top:497px;left:692px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:338px;left:624px;white-space:nowrap" class="ft111"><b>MCF10A_ProzacAnalog_72hs_MTT</b></p>
<p style="position:absolute;top:504px;left:705px;white-space:nowrap" class="ft116"><b>50</b></p>
<p style="position:absolute;top:497px;left:712px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:504px;left:725px;white-space:nowrap" class="ft116"><b>40</b></p>
<p style="position:absolute;top:497px;left:732px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:504px;left:745px;white-space:nowrap" class="ft116"><b>30</b></p>
<p style="position:absolute;top:497px;left:752px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:504px;left:764px;white-space:nowrap" class="ft116"><b>25</b></p>
<p style="position:absolute;top:497px;left:772px;white-space:nowrap" class="ft117">m<b>M</b></p>
<p style="position:absolute;top:504px;left:784px;white-space:nowrap" class="ft116"><b>10</b></p>
<p style="position:absolute;top:497px;left:792px;white-space:nowrap" class="ft117">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:799px;left:126px;white-space:nowrap" class="ft119"><b>No treatment</b></p>
<p style="position:absolute;top:778px;left:167px;white-space:nowrap" class="ft119"><b>DMSO100</b></p>
<p style="position:absolute;top:768px;left:198px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:211px;white-space:nowrap" class="ft119"><b>50</b></p>
<p style="position:absolute;top:768px;left:218px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:231px;white-space:nowrap" class="ft119"><b>40</b></p>
<p style="position:absolute;top:768px;left:239px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:252px;white-space:nowrap" class="ft119"><b>30</b></p>
<p style="position:absolute;top:768px;left:260px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:273px;white-space:nowrap" class="ft119"><b>25</b></p>
<p style="position:absolute;top:768px;left:280px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:293px;white-space:nowrap" class="ft119"><b>10</b></p>
<p style="position:absolute;top:768px;left:301px;white-space:nowrap" class="ft1110">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:798px;left:375px;white-space:nowrap" class="ft119"><b>No treatment</b></p>
<p style="position:absolute;top:778px;left:416px;white-space:nowrap" class="ft119"><b>DMSO100</b></p>
<p style="position:absolute;top:767px;left:447px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:460px;white-space:nowrap" class="ft119"><b>50</b></p>
<p style="position:absolute;top:768px;left:467px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:482px;white-space:nowrap" class="ft119"><b>40</b></p>
<p style="position:absolute;top:767px;left:489px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:502px;white-space:nowrap" class="ft119"><b>30</b></p>
<p style="position:absolute;top:768px;left:510px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:523px;white-space:nowrap" class="ft119"><b>25</b></p>
<p style="position:absolute;top:767px;left:530px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:544px;white-space:nowrap" class="ft119"><b>10</b></p>
<p style="position:absolute;top:767px;left:551px;white-space:nowrap" class="ft1110">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:799px;left:627px;white-space:nowrap" class="ft119"><b>No treatment</b></p>
<p style="position:absolute;top:778px;left:669px;white-space:nowrap" class="ft119"><b>DMSO100</b></p>
<p style="position:absolute;top:768px;left:700px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:713px;white-space:nowrap" class="ft119"><b>50</b></p>
<p style="position:absolute;top:768px;left:721px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:734px;white-space:nowrap" class="ft119"><b>40</b></p>
<p style="position:absolute;top:767px;left:741px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:755px;white-space:nowrap" class="ft119"><b>30</b></p>
<p style="position:absolute;top:768px;left:762px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:776px;white-space:nowrap" class="ft119"><b>25</b></p>
<p style="position:absolute;top:768px;left:783px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:775px;left:796px;white-space:nowrap" class="ft119"><b>10</b></p>
<p style="position:absolute;top:767px;left:804px;white-space:nowrap" class="ft1110">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:1055px;left:126px;white-space:nowrap" class="ft119"><b>No treatment</b></p>
<p style="position:absolute;top:1034px;left:168px;white-space:nowrap" class="ft119"><b>DMSO100</b></p>
<p style="position:absolute;top:1024px;left:198px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1032px;left:211px;white-space:nowrap" class="ft119"><b>50</b></p>
<p style="position:absolute;top:1024px;left:218px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1031px;left:232px;white-space:nowrap" class="ft119"><b>40</b></p>
<p style="position:absolute;top:1024px;left:239px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1031px;left:252px;white-space:nowrap" class="ft119"><b>30</b></p>
<p style="position:absolute;top:1024px;left:259px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1031px;left:272px;white-space:nowrap" class="ft119"><b>25</b></p>
<p style="position:absolute;top:1024px;left:280px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1031px;left:293px;white-space:nowrap" class="ft119"><b>10</b></p>
<p style="position:absolute;top:1024px;left:301px;white-space:nowrap" class="ft1110">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:1055px;left:379px;white-space:nowrap" class="ft119"><b>No treatment</b></p>
<p style="position:absolute;top:1034px;left:419px;white-space:nowrap" class="ft119"><b>DMSO100</b></p>
<p style="position:absolute;top:1024px;left:450px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1032px;left:463px;white-space:nowrap" class="ft119"><b>50</b></p>
<p style="position:absolute;top:1025px;left:470px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1032px;left:483px;white-space:nowrap" class="ft119"><b>40</b></p>
<p style="position:absolute;top:1024px;left:490px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1032px;left:503px;white-space:nowrap" class="ft119"><b>30</b></p>
<p style="position:absolute;top:1024px;left:511px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1032px;left:524px;white-space:nowrap" class="ft119"><b>25</b></p>
<p style="position:absolute;top:1025px;left:531px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1032px;left:544px;white-space:nowrap" class="ft119"><b>10</b></p>
<p style="position:absolute;top:1025px;left:551px;white-space:nowrap" class="ft1110">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:1055px;left:627px;white-space:nowrap" class="ft119"><b>No treatment</b></p>
<p style="position:absolute;top:1034px;left:669px;white-space:nowrap" class="ft119"><b>DMSO100</b></p>
<p style="position:absolute;top:1024px;left:699px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1031px;left:713px;white-space:nowrap" class="ft119"><b>50</b></p>
<p style="position:absolute;top:1024px;left:720px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1031px;left:733px;white-space:nowrap" class="ft119"><b>40</b></p>
<p style="position:absolute;top:1024px;left:740px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1031px;left:754px;white-space:nowrap" class="ft119"><b>30</b></p>
<p style="position:absolute;top:1024px;left:761px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1031px;left:775px;white-space:nowrap" class="ft119"><b>25</b></p>
<p style="position:absolute;top:1024px;left:782px;white-space:nowrap" class="ft1110">m<b>M</b></p>
<p style="position:absolute;top:1031px;left:795px;white-space:nowrap" class="ft119"><b>10</b></p>
<p style="position:absolute;top:1024px;left:803px;white-space:nowrap" class="ft1110">m<b>M&#160;5</b>m<b>M</b></p>
<p style="position:absolute;top:625px;left:132px;white-space:nowrap" class="ft114"><b>0.20</b></p>
<p style="position:absolute;top:711px;left:126px;white-space:nowrap" class="ft1111"><b>OD (570nm)</b></p>
<p style="position:absolute;top:605px;left:128px;white-space:nowrap" class="ft111"><b>MCF7_ProzacAnalog_24hs_Crystal</b></p>
<p style="position:absolute;top:656px;left:132px;white-space:nowrap" class="ft114"><b>0.15</b></p>
<p style="position:absolute;top:687px;left:132px;white-space:nowrap" class="ft114"><b>0.10</b></p>
<p style="position:absolute;top:717px;left:132px;white-space:nowrap" class="ft114"><b>0.05</b></p>
<p style="position:absolute;top:749px;left:132px;white-space:nowrap" class="ft114"><b>0.00</b></p>
<p style="position:absolute;top:603px;left:377px;white-space:nowrap" class="ft1112"><b>MCF7_ProzacAnalog_48hs_Crystal</b></p>
<p style="position:absolute;top:624px;left:386px;white-space:nowrap" class="ft114"><b>0.4</b></p>
<p style="position:absolute;top:654px;left:386px;white-space:nowrap" class="ft114"><b>0.3</b></p>
<p style="position:absolute;top:686px;left:386px;white-space:nowrap" class="ft114"><b>0.2</b></p>
<p style="position:absolute;top:717px;left:386px;white-space:nowrap" class="ft114"><b>0.1</b></p>
<p style="position:absolute;top:748px;left:386px;white-space:nowrap" class="ft114"><b>0.0</b></p>
<p style="position:absolute;top:710px;left:379px;white-space:nowrap" class="ft1111"><b>OD (570nm)</b></p>
<p style="position:absolute;top:623px;left:638px;white-space:nowrap" class="ft114"><b>1.5</b></p>
<p style="position:absolute;top:665px;left:638px;white-space:nowrap" class="ft114"><b>1.0</b></p>
<p style="position:absolute;top:706px;left:638px;white-space:nowrap" class="ft114"><b>0.5</b></p>
<p style="position:absolute;top:748px;left:638px;white-space:nowrap" class="ft114"><b>0.0</b></p>
<p style="position:absolute;top:710px;left:631px;white-space:nowrap" class="ft1111"><b>OD (570nm)</b></p>
<p style="position:absolute;top:603px;left:630px;white-space:nowrap" class="ft1112"><b>MCF7_ProzacAnalog_72hs_Crystal</b></p>
<p style="position:absolute;top:882px;left:132px;white-space:nowrap" class="ft114"><b>0.20</b></p>
<p style="position:absolute;top:968px;left:126px;white-space:nowrap" class="ft1111"><b>OD (570nm)</b></p>
<p style="position:absolute;top:913px;left:132px;white-space:nowrap" class="ft114"><b>0.15</b></p>
<p style="position:absolute;top:943px;left:132px;white-space:nowrap" class="ft114"><b>0.10</b></p>
<p style="position:absolute;top:974px;left:132px;white-space:nowrap" class="ft114"><b>0.05</b></p>
<p style="position:absolute;top:1005px;left:132px;white-space:nowrap" class="ft114"><b>0.00</b></p>
<p style="position:absolute;top:884px;left:385px;white-space:nowrap" class="ft114"><b>0.20</b></p>
<p style="position:absolute;top:969px;left:379px;white-space:nowrap" class="ft1111"><b>OD (570nm)</b></p>
<p style="position:absolute;top:914px;left:385px;white-space:nowrap" class="ft114"><b>0.15</b></p>
<p style="position:absolute;top:945px;left:385px;white-space:nowrap" class="ft114"><b>0.10</b></p>
<p style="position:absolute;top:975px;left:385px;white-space:nowrap" class="ft114"><b>0.05</b></p>
<p style="position:absolute;top:1005px;left:385px;white-space:nowrap" class="ft114"><b>0.00</b></p>
<p style="position:absolute;top:880px;left:638px;white-space:nowrap" class="ft114"><b>1.0</b></p>
<p style="position:absolute;top:905px;left:638px;white-space:nowrap" class="ft114"><b>0.8</b></p>
<p style="position:absolute;top:930px;left:638px;white-space:nowrap" class="ft114"><b>0.6</b></p>
<p style="position:absolute;top:955px;left:638px;white-space:nowrap" class="ft114"><b>0.4</b></p>
<p style="position:absolute;top:980px;left:638px;white-space:nowrap" class="ft114"><b>0.2</b></p>
<p style="position:absolute;top:1004px;left:638px;white-space:nowrap" class="ft114"><b>0.0</b></p>
<p style="position:absolute;top:967px;left:631px;white-space:nowrap" class="ft1111"><b>OD (570nm)</b></p>
<p style="position:absolute;top:862px;left:121px;white-space:nowrap" class="ft111"><b>MCF10A_ProzacAnalog_24hs_Crystal</b></p>
<p style="position:absolute;top:863px;left:374px;white-space:nowrap" class="ft111"><b>MCF10A_ProzacAnalog_48hs_Crystal</b></p>
<p style="position:absolute;top:860px;left:622px;white-space:nowrap" class="ft111"><b>MCF10A_ProzacAnalog_72hs_Crystal</b></p>
<p style="position:absolute;top:618px;left:200px;white-space:nowrap" class="ft1113"><b>.</b></p>
<p style="position:absolute;top:611px;left:452px;white-space:nowrap" class="ft1113"><b>.</b></p>
<p style="position:absolute;top:859px;left:200px;white-space:nowrap" class="ft1113"><b>.</b></p>
<p style="position:absolute;top:863px;left:451px;white-space:nowrap" class="ft1113"><b>.</b></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft120{font-size:9px;font-family:Times;color:#000000;}
	.ft121{font-size:9px;font-family:Times;color:#000000;}
	.ft122{font-size:11px;font-family:Times;color:#000000;}
	.ft123{font-size:11px;font-family:Times;color:#000000;}
	.ft124{font-size:7px;font-family:Times;color:#000000;}
	.ft125{font-size:11px;font-family:Times;color:#000000;}
	.ft126{font-size:11px;font-family:Times;color:#191919;}
	.ft127{font-size:9px;font-family:Times;color:#000000;}
	.ft128{font-size:9px;font-family:Times;color:#000000;}
	.ft129{font-size:11px;line-height:19px;font-family:Times;color:#000000;}
	.ft1210{font-size:11px;line-height:15px;font-family:Times;color:#000000;}
	.ft1211{font-size:11px;line-height:14px;font-family:Times;color:#000000;}
	.ft1212{font-size:11px;line-height:14px;font-family:Times;color:#000000;}
	.ft1213{font-size:11px;line-height:19px;font-family:Times;color:#000000;}
	.ft1214{font-size:11px;line-height:15px;font-family:Times;color:#000000;}
	.ft1215{font-size:9px;line-height:13px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page12-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:55px;left:96px;white-space:nowrap" class="ft120"><b>4838&#160; &#160;&#160;<i>Current&#160;Pharmaceutical&#160;Design,&#160;</i></b><b>2017<i>, Vol.&#160;23, No.&#160;32&#160;</i></b></p>
<p style="position:absolute;top:55px;left:788px;white-space:nowrap" class="ft121"><i><b>Tuszynski&#160;et&#160;al.&#160;</b></i></p>
<p style="position:absolute;top:93px;left:96px;white-space:nowrap" class="ft122"><b>5.&#160;MATERIALS&#160;AND&#160;METHODS&#160;</b></p>
<p style="position:absolute;top:120px;left:96px;white-space:nowrap" class="ft129"><b>5.1.&#160;Reagents,&#160;Cell&#160;Lines&#160;and&#160;Culture&#160;Conditions&#160;<br/></b>&#160;</p>
<p style="position:absolute;top:139px;left:117px;white-space:nowrap" class="ft123">Unless&#160;stated&#160;otherwise,&#160;all&#160;chemical&#160;and&#160;tissue&#160;culture&#160;reagents&#160;</p>
<p style="position:absolute;top:154px;left:96px;white-space:nowrap" class="ft1210">were&#160;purchased&#160;from&#160;Sigma-Aldrich&#160;(Oakville,&#160;Canada)&#160;and&#160;tissue&#160;<br/>culture&#160;reagents&#160;from&#160;Invitrogen&#160;(Burlington,&#160;Canada),&#160;respectively.<b>&#160;<br/></b>MCF-7&#160;(Luminal&#160;A)&#160;and&#160;the&#160;non-tumoral&#160;breast&#160;epithelial&#160;cell&#160;line&#160;<br/>MCF-10A&#160;&#160;were&#160;&#160;maintained&#160;&#160;in&#160;&#160;MEM&#160;&#160;media&#160;&#160;supplemented&#160;&#160;with&#160;<br/>10%&#160;FBS&#160;and&#160;1%&#160;PSK.<b>&#160;</b></p>
<p style="position:absolute;top:241px;left:96px;white-space:nowrap" class="ft129"><b>5.2.&#160;Cell&#160;Proliferation&#160;and&#160;Survival&#160;Assays&#160;<br/></b>&#160;</p>
<p style="position:absolute;top:261px;left:117px;white-space:nowrap" class="ft123">For&#160;&#160;cell&#160;&#160;growth,&#160;&#160;replicate&#160;&#160;cultures&#160;&#160;were&#160;&#160;established&#160;&#160;48&#160;&#160;h&#160;&#160;after&#160;</p>
<p style="position:absolute;top:275px;left:96px;white-space:nowrap" class="ft129">transfection&#160;&#160;in&#160;&#160;24-well&#160;&#160;plates&#160;&#160;(Sarstedt,&#160;&#160;Canada)&#160;&#160;at&#160;&#160;5&#160;&#160;x&#160;&#160;104&#160;<br/>cells/well.&#160;&#160;At&#160;&#160;24,&#160;&#160;48,&#160;&#160;72&#160;&#160;and&#160;&#160;96&#160;&#160;h&#160;&#160;after&#160;&#160;plating,&#160;&#160;cultures&#160;&#160;were&#160;<br/>trypsinized,&#160;&#160;stained&#160;&#160;with&#160;&#160;trypan&#160;&#160;blue&#160;&#160;and&#160;&#160;counted&#160;&#160;using&#160;&#160;hemocy-<br/>tometer.&#160;The&#160;total&#160;number&#160;of&#160;cells/well&#160;for&#160;each&#160;cell&#160;line&#160;was&#160;calcu-<br/>lated&#160;&#160;and&#160;&#160;plotted&#160;&#160;for&#160;&#160;each&#160;&#160;time&#160;&#160;point.&#160;&#160;For&#160;&#160;further&#160;&#160;verification,&#160;&#160;we&#160;<br/>also&#160;assessed&#160;cell&#160;proliferation&#160;by&#160;crystal&#160;violet&#160;staining.&#160;Cells&#160;were&#160;<br/>plated&#160;in&#160;96-well&#160;microtiter&#160;plates&#160;at&#160;5&#160;x&#160;103&#160;cells/well.&#160;At&#160;specific&#160;<br/>time&#160;points,&#160;cells&#160;were&#160;washed&#160;with&#160;PBS,&#160;fixed&#160;with&#160;glutaraldehyde&#160;<br/>for&#160;&#160;10&#160;&#160;min,&#160;&#160;and&#160;&#160;stained&#160;&#160;with&#160;&#160;0.1%&#160;&#160;(W/V)&#160;&#160;crystal&#160;&#160;violet&#160;&#160;in&#160;&#160;0.2%&#160;<br/>(V/V)&#160;&#160;Triton&#160;&#160;X-100.&#160;&#160;Microtiter&#160;&#160;plates&#160;&#160;were&#160;&#160;read&#160;&#160;on&#160;&#160;a&#160;&#160;spectropho-<br/>tometer&#160;at&#160;570&#160;nm.&#160;<b>&#160;<br/></b>&#160;</p>
<p style="position:absolute;top:445px;left:117px;white-space:nowrap" class="ft123">For&#160;&#160;cell&#160;&#160;survival,&#160;&#160;cells&#160;&#160;were&#160;&#160;plated&#160;&#160;in&#160;&#160;96-well&#160;&#160;plate&#160;&#160;at&#160;&#160;5&#160;&#160;x&#160;&#160;103&#160;</p>
<p style="position:absolute;top:460px;left:96px;white-space:nowrap" class="ft1210">cells/well.&#160;At&#160;24,&#160;48,&#160;72&#160;and&#160;96&#160;h,&#160;20&#160;µl&#160;of&#160;3-(4,5-dimethylthiazol-<br/>2-yl)-2,5-&#160;&#160;diphenyltetrazolium&#160;&#160;bromide&#160;&#160;(MTT)&#160;&#160;was&#160;&#160;added&#160;&#160;to&#160;&#160;each&#160;<br/>well,&#160;and&#160;the&#160;plates&#160;were&#160;incubated&#160;at&#160;37°C&#160;for&#160;another&#160;4&#160;h&#160;at&#160;which&#160;<br/>time&#160;&#160;the&#160;&#160;resulting&#160;&#160;formazan&#160;&#160;crystals&#160;&#160;were&#160;&#160;solubilized&#160;&#160;by&#160;&#160;the&#160;&#160;addi-<br/>tion&#160;&#160;of&#160;&#160;200&#160;&#160;µl&#160;&#160;of&#160;&#160;MTT&#160;&#160;solubilization&#160;&#160;solution.&#160;&#160;The&#160;&#160;absorbance&#160;&#160;at&#160;<br/>570&#160;&#160;nm&#160;&#160;was&#160;&#160;recorded&#160;&#160;using&#160;&#160;a&#160;&#160;microplate&#160;&#160;reader&#160;&#160;(Bio&#160;&#160;Tek&#160;&#160;Instru-<br/>ments,&#160;&#160;Winooski,&#160;&#160;VT,&#160;&#160;USA).&#160;&#160;Each&#160;&#160;experiment&#160;&#160;for&#160;&#160;each&#160;&#160;cell&#160;&#160;lines&#160;<br/>was&#160;repeated&#160;3-5&#160;times.&#160;&#160;</p>
<p style="position:absolute;top:592px;left:96px;white-space:nowrap" class="ft129"><b>CONCLUSION&#160;<br/></b>&#160;</p>
<p style="position:absolute;top:612px;left:117px;white-space:nowrap" class="ft123">Cancer&#160;is&#160;the&#160;uncontrolled&#160;cell&#160;growth&#160;in&#160;which&#160;the&#160;cells&#160;show&#160;</p>
<p style="position:absolute;top:626px;left:96px;white-space:nowrap" class="ft1213">invasive&#160;intrusion&#160;or&#160;destruction&#160;of&#160;adjacent&#160;tissues&#160;and&#160;metastasize&#160;<br/>to&#160;other&#160;locations&#160;in&#160;the&#160;body<i>&#160;via</i>&#160;lymph&#160;and&#160;/or&#160;blood.&#160;Cancer&#160;cells&#160;<br/>escape&#160;&#160;the&#160;&#160;normal&#160;&#160;control&#160;&#160;of&#160;&#160;cell&#160;&#160;division&#160;&#160;and&#160;&#160;programmed&#160;&#160;cell&#160;<br/>death.&#160;&#160;The&#160;&#160;conventional&#160;&#160;methods&#160;&#160;to&#160;&#160;treat&#160;&#160;metastatic&#160;&#160;cancer&#160;&#160;are&#160;<br/>chemotherapy&#160;and&#160;radiation&#160;therapy.&#160;But&#160;these&#160;have&#160;a&#160;major&#160;draw-<br/>back&#160;&#160;of&#160;&#160;producing&#160;&#160;severe&#160;&#160;side&#160;&#160;effects&#160;&#160;as&#160;&#160;they&#160;&#160;cannot&#160;&#160;differentiate&#160;<br/>between&#160;&#160;the&#160;&#160;cancerous&#160;&#160;cells&#160;&#160;and&#160;&#160;the&#160;&#160;normal&#160;&#160;cells.&#160;&#160;The&#160;&#160;&#34;normal&#34;&#160;<br/>cells&#160;most&#160;commonly&#160;affected&#160;by&#160;chemotherapy&#160;are&#160;the&#160;blood&#160;cells,&#160;<br/>the&#160;&#160;cells&#160;&#160;in&#160;&#160;the&#160;&#160;mouth,&#160;&#160;stomach&#160;&#160;and&#160;&#160;bowel,&#160;&#160;and&#160;&#160;the&#160;&#160;hair&#160;&#160;follicles;&#160;<br/>resulting&#160;in&#160;low&#160;blood&#160;counts,&#160;mouth&#160;sores,&#160;nausea,&#160;diarrhea,&#160;and/or&#160;<br/>hair&#160;loss.&#160;Therefore,&#160;recently&#160;the&#160;focus&#160;has&#160;shifted&#160;to&#160;comparatively&#160;<br/>newer&#160;&#160;methods&#160;&#160;of&#160;&#160;cancer&#160;&#160;treatment,&#160;&#160;<i>i.e</i>.&#160;&#160;targeted&#160;&#160;cancer&#160;&#160;therapy,&#160;<br/>which&#160;uses&#160;drugs&#160;or&#160;other&#160;&#160;substances&#160;&#160;to&#160;identify&#160;and&#160;attack&#160;&#160;cancer&#160;<br/>cells&#160;thereby&#160;avoiding&#160;any&#160;damage&#160;to&#160;normal&#160;cells.&#160;In&#160;this&#160;paper,&#160;we&#160;<br/>have&#160;advanced&#160;a&#160;new&#160;hypothesis&#160;that&#160;reprogramming&#160;of&#160;tumor&#160;cells&#160;<br/>can&#160;&#160;be&#160;&#160;achieved&#160;&#160;by&#160;&#160;avoiding&#160;&#160;toxic&#160;&#160;chemotherapy&#160;&#160;and&#160;&#160;instead&#160;&#160;by&#160;<br/>using&#160;a&#160;completely&#160;different&#160;set&#160;of&#160;pharmacological&#160;agents,&#160;in&#160;par-<br/>ticular&#160;psychoactive&#160;compounds.&#160;Their&#160;repurposing&#160;can&#160;be&#160;achieved&#160;<br/>by&#160;&#160;rational&#160;&#160;drug&#160;&#160;design&#160;&#160;[101]&#160;&#160;involving&#160;&#160;derivatization&#160;&#160;that&#160;&#160;should&#160;<br/>take&#160;&#160;into&#160;&#160;account&#160;&#160;the&#160;&#160;molecular&#160;&#160;structure&#160;&#160;of&#160;&#160;the&#160;&#160;target&#160;&#160;and&#160;&#160;such&#160;<br/>aspects&#160;as&#160;blood-brain-barrier&#160;permeation.&#160;<br/>&#160;</p>
<p style="position:absolute;top:946px;left:117px;white-space:nowrap" class="ft123">A&#160;&#160;view&#160;&#160;of&#160;&#160;cancer&#160;&#160;as&#160;&#160;a&#160;&#160;disease&#160;&#160;of&#160;&#160;pattern&#160;&#160;coordination&#160;&#160;is&#160;&#160;com-</p>
<p style="position:absolute;top:961px;left:96px;white-space:nowrap" class="ft1210">plementary&#160;and&#160;distinct&#160;from&#160;the&#160;prevailing&#160;paradigm&#160;that&#160;sees&#160;can-<br/>cer&#160;as&#160;arising&#160;from&#160;genetically&#160;damaged&#160;cells,&#160;which&#160;are&#160;irrevocably&#160;<br/>broken&#160;[102,&#160;103].&#160;It&#160;has&#160;long&#160;been&#160;known&#160;that&#160;appropriate&#160;pattern-<br/>ing&#160;&#160;environments,&#160;&#160;such&#160;&#160;as&#160;&#160;embryos&#160;&#160;and&#160;&#160;regenerating&#160;&#160;limbs&#160;&#160;[15,&#160;<br/>104],&#160;can&#160;normalize&#160;aggressive&#160;transformed&#160;cells.&#160;Likewise,&#160;cancer&#160;<br/>can&#160;be&#160;induced&#160;by&#160;factors&#160;such&#160;as&#160;denervation,&#160;barriers&#160;made&#160;from&#160;<br/>non-carcinogenic&#160;&#160;substances,&#160;&#160;and&#160;&#160;even&#160;&#160;apposition&#160;&#160;of&#160;&#160;healthy&#160;&#160;but&#160;<br/>ectopic&#160;tissues&#160;[17].&#160;It&#160;is&#160;clear&#160;that&#160;at&#160;least&#160;in&#160;some&#160;cases,&#160;the&#160;proc-<br/>ess&#160;is&#160;fundamentally&#160;physiological,&#160;not&#160;genetic,&#160;and&#160;thus&#160;could&#160;po-<br/>tentially&#160;&#160;be&#160;&#160;reversed&#160;&#160;[105,&#160;&#160;106].&#160;&#160;Strategies&#160;&#160;which&#160;&#160;seek&#160;&#160;to&#160;&#160;manipu-</p>
<p style="position:absolute;top:85px;left:495px;white-space:nowrap" class="ft1212">late&#160;the&#160;environment&#160;to&#160;normalize&#160;or&#160;reprogram&#160;tumors&#160;[107,&#160;108],&#160;<br/>and&#160;&#160;thus&#160;&#160;avoid&#160;&#160;toxic&#160;&#160;chemotherapy&#160;&#160;and&#160;&#160;the&#160;&#160;compensatory&#160;&#160;growth&#160;<br/>and&#160;tumor&#160;evolution&#160;that&#160;plagues&#160;conventional&#160;approaches,&#160;could&#160;be&#160;<br/>an&#160;important&#160;frontier&#160;in&#160;this&#160;field.&#160;</p>
<p style="position:absolute;top:149px;left:496px;white-space:nowrap" class="ft123">&#160;</p>
<p style="position:absolute;top:149px;left:517px;white-space:nowrap" class="ft123">Future&#160;&#160;work&#160;&#160;in&#160;&#160;this&#160;&#160;emerging&#160;&#160;field&#160;&#160;will&#160;&#160;focus&#160;&#160;on&#160;&#160;the&#160;&#160;role&#160;&#160;of&#160;</p>
<p style="position:absolute;top:165px;left:496px;white-space:nowrap" class="ft1210">neurotransmitters&#160;&#160;in&#160;&#160;mediating&#160;&#160;long-range&#160;&#160;growth&#160;&#160;control&#160;&#160;signals,&#160;<br/>resulting&#160;in&#160;a&#160;better&#160;understanding&#160;of&#160;the&#160;limits&#160;of&#160;the&#160;“microenvi-<br/>ronment”&#160;&#160;and&#160;&#160;strategies&#160;&#160;for&#160;&#160;manipulating&#160;&#160;endogenous&#160;&#160;morphoge-<br/>netic&#160;&#160;cues&#160;for&#160;&#160;cancer&#160;prevention&#160;and&#160;normalization.&#160;The&#160;numerous&#160;<br/>drugs&#160;emerging&#160;from&#160;psychopharmacology&#160;form&#160;an&#160;exciting&#160;toolkit&#160;<br/>with&#160;&#160;which&#160;&#160;to&#160;&#160;address&#160;&#160;the&#160;&#160;subcellular&#160;&#160;and&#160;&#160;network-level&#160;&#160;mecha-<br/>nisms&#160;that&#160;go&#160;awry&#160;in&#160;cancer.&#160;In&#160;parallel&#160;with&#160;the&#160;modeling&#160;and&#160;<i>in&#160;<br/>vivo</i>&#160;studies&#160;of&#160;neurotransmitter&#160;pathways&#160;in&#160;computational&#160;psychia-<br/>try,&#160;a&#160;combined&#160;understanding&#160;of&#160;cytoskeletal,&#160;bioelectric,&#160;and&#160;neu-<br/>rotransmitter&#160;&#160;signaling&#160;&#160;in&#160;&#160;cellular&#160;&#160;networks&#160;&#160;is&#160;&#160;likely&#160;&#160;to&#160;&#160;have&#160;&#160;pro-<br/>found&#160;implications&#160;for&#160;novel&#160;approaches&#160;to&#160;the&#160;cancer&#160;problem.&#160;</p>
<p style="position:absolute;top:342px;left:496px;white-space:nowrap" class="ft129"><b>LIST&#160;OF&#160;ABBREVIATIONS&#160;<br/></b>5-HT&#160;</p>
<p style="position:absolute;top:361px;left:550px;white-space:nowrap" class="ft123">=&#160;</p>
<p style="position:absolute;top:361px;left:604px;white-space:nowrap" class="ft123">Serotonin&#160;</p>
<p style="position:absolute;top:381px;left:496px;white-space:nowrap" class="ft123">SSRI&#160;</p>
<p style="position:absolute;top:381px;left:550px;white-space:nowrap" class="ft123">=&#160;</p>
<p style="position:absolute;top:381px;left:604px;white-space:nowrap" class="ft123">Selective&#160;Serotonin&#160;Reuptake&#160;Inhibitors&#160;</p>
<p style="position:absolute;top:400px;left:496px;white-space:nowrap" class="ft123">Vmem&#160;&#160;=&#160;</p>
<p style="position:absolute;top:400px;left:604px;white-space:nowrap" class="ft123">Resting&#160;Potential&#160;Across&#160;Plasma&#160;Membrane&#160;</p>
<p style="position:absolute;top:427px;left:496px;white-space:nowrap" class="ft129"><b>CONSENT&#160;FOR&#160;PUBLICATION&#160;<br/></b>&#160;</p>
<p style="position:absolute;top:446px;left:517px;white-space:nowrap" class="ft126">Not&#160;applicable.&#160;</p>
<p style="position:absolute;top:474px;left:496px;white-space:nowrap" class="ft129"><b>CONFLICT&#160;OF&#160;INTEREST&#160;<br/></b>&#160;</p>
<p style="position:absolute;top:493px;left:517px;white-space:nowrap" class="ft123">The&#160;&#160;authors&#160;&#160;declare&#160;&#160;no&#160;&#160;conflict&#160;&#160;of&#160;&#160;interest,&#160;&#160;financial&#160;&#160;or&#160;&#160;other-</p>
<p style="position:absolute;top:508px;left:496px;white-space:nowrap" class="ft123">wise.&#160;&#160;</p>
<p style="position:absolute;top:535px;left:496px;white-space:nowrap" class="ft129"><b>ACKNOWLEDGEMENTS&#160;<br/></b>&#160;</p>
<p style="position:absolute;top:554px;left:517px;white-space:nowrap" class="ft123">JT&#160;&#160;acknowledges&#160;&#160;support&#160;&#160;from&#160;&#160;the&#160;&#160;Canadian&#160;&#160;Breast&#160;&#160;Cancer&#160;</p>
<p style="position:absolute;top:570px;left:496px;white-space:nowrap" class="ft1210">Foundation,&#160;&#160;the&#160;Allard&#160;Foundation&#160;and&#160;the&#160;Alberta&#160;Cancer&#160;Founda-<br/>tion.&#160;M.L.&#160;gratefully&#160;acknowledges&#160;&#160;support&#160;by&#160;an&#160;Allen&#160;Discovery&#160;<br/>Center&#160;award&#160;from&#160;the&#160;Paul&#160;G.&#160;Allen&#160;Frontiers&#160;Group&#160;(No.&#160;12171)&#160;<br/>and&#160;by&#160;the&#160;G.&#160;Harold&#160;and&#160;Leila&#160;Y.&#160;Mathers&#160;Foundation.&#160;</p>
<p style="position:absolute;top:642px;left:496px;white-space:nowrap" class="ft129"><b>REFERENCES&#160;<br/></b>[1]&#160;</p>
<p style="position:absolute;top:661px;left:539px;white-space:nowrap" class="ft1215">Knapp&#160;&#160;D,&#160;&#160;Tanaka&#160;&#160;EM.&#160;&#160;Regeneration&#160;&#160;and&#160;&#160;reprogramming.&#160;&#160;Curr&#160;<br/>Opin&#160;Genet&#160;Develop&#160;2012;&#160;22:&#160;485-93.&#160;</p>
<p style="position:absolute;top:688px;left:496px;white-space:nowrap" class="ft127">[2]&#160;</p>
<p style="position:absolute;top:688px;left:539px;white-space:nowrap" class="ft1215">Stocum&#160;&#160;DL,&#160;&#160;Cameron&#160;&#160;JA.&#160;&#160;Looking&#160;&#160;proximally&#160;&#160;and&#160;&#160;distally:&#160;&#160;100&#160;<br/>years&#160;&#160;of&#160;&#160;limb&#160;&#160;regeneration&#160;&#160;and&#160;&#160;beyond.&#160;&#160;Dev&#160;&#160;Dyn&#160;&#160;2011;&#160;240:&#160;943-<br/>68.&#160;</p>
<p style="position:absolute;top:729px;left:496px;white-space:nowrap" class="ft127">[3]&#160;</p>
<p style="position:absolute;top:729px;left:539px;white-space:nowrap" class="ft1215">Birnbaum&#160;&#160;KD,&#160;&#160;Alvarado&#160;&#160;AS.&#160;&#160;Slicing&#160;&#160;across&#160;&#160;kingdoms:&#160;&#160;Regenera-<br/>tion&#160;in&#160;plants&#160;and&#160;animals.&#160;Cell&#160;2008;&#160;132:&#160;697-10.&#160;</p>
<p style="position:absolute;top:756px;left:496px;white-space:nowrap" class="ft127">[4]&#160;</p>
<p style="position:absolute;top:756px;left:539px;white-space:nowrap" class="ft1215">Levin&#160;&#160;M.&#160;&#160;Morphogenetic&#160;&#160;fields&#160;&#160;in&#160;&#160;embryogenesis,&#160;&#160;regeneration,&#160;<br/>and&#160;cancer:&#160;Non-local&#160;control&#160;of&#160;complex&#160;patterning.&#160;Bio&#160;Systems&#160;<br/>2012;&#160;109:&#160;243-61.&#160;</p>
<p style="position:absolute;top:796px;left:496px;white-space:nowrap" class="ft127">[5]&#160;</p>
<p style="position:absolute;top:796px;left:539px;white-space:nowrap" class="ft1215">Burr&#160;HS.&#160;Biologic&#160;organization&#160;and&#160;the&#160;cancer&#160;problem.&#160;Yale&#160;J&#160;Biol&#160;<br/>Med&#160;1940;&#160;12:&#160;277-82.&#160;</p>
<p style="position:absolute;top:823px;left:496px;white-space:nowrap" class="ft127">[6]&#160;</p>
<p style="position:absolute;top:823px;left:539px;white-space:nowrap" class="ft127">Needham&#160;J.&#160;Order&#160;and&#160;life.&#160;M.I.T.&#160;Press:&#160;Cambridge&#160;1968.&#160;</p>
<p style="position:absolute;top:837px;left:496px;white-space:nowrap" class="ft127">[7]&#160;</p>
<p style="position:absolute;top:837px;left:539px;white-space:nowrap" class="ft1215">Rubin&#160;H.&#160;Cancer&#160;as&#160;a&#160;dynamic&#160;developmental&#160;disorder.&#160;Cancer&#160;Res&#160;<br/>1985;&#160;45:&#160;2935-42.&#160;</p>
<p style="position:absolute;top:864px;left:496px;white-space:nowrap" class="ft127">[8]&#160;</p>
<p style="position:absolute;top:864px;left:539px;white-space:nowrap" class="ft1215">Johnston&#160;&#160;RN,&#160;&#160;Pai&#160;&#160;SB,&#160;&#160;Pai&#160;&#160;RB.&#160;&#160;The&#160;&#160;origin&#160;&#160;of&#160;&#160;the&#160;&#160;cancer&#160;&#160;cell:&#160;&#160;On-<br/>cogeny&#160;reverses&#160;phylogeny.&#160;Biochem&#160;Cell&#160;Biol&#160;1992;&#160;70:&#160;831-4.&#160;</p>
<p style="position:absolute;top:891px;left:496px;white-space:nowrap" class="ft127">[9]&#160;</p>
<p style="position:absolute;top:891px;left:539px;white-space:nowrap" class="ft1215">Davies&#160;&#160;PC,&#160;&#160;Demetrius&#160;&#160;L,&#160;&#160;Tuszynski&#160;&#160;JA.&#160;&#160;Cancer&#160;&#160;as&#160;&#160;a&#160;&#160;dynamical&#160;<br/>phase&#160;transition.&#160;Theor&#160;Biol&#160;Med&#160;Model&#160;2011;&#160;8:&#160;30.&#160;</p>
<p style="position:absolute;top:918px;left:496px;white-space:nowrap" class="ft127">[10]&#160;</p>
<p style="position:absolute;top:918px;left:539px;white-space:nowrap" class="ft1215">Tsonis&#160;PA.&#160;Embryogenesis&#160;and&#160;carcinogenesis:&#160;Order&#160;and&#160;disorder.&#160;<br/>Anticancer&#160;Res&#160;1987;&#160;7:&#160;617-23.&#160;</p>
<p style="position:absolute;top:945px;left:496px;white-space:nowrap" class="ft127">[11]&#160;</p>
<p style="position:absolute;top:945px;left:539px;white-space:nowrap" class="ft1215">Dean&#160;M.&#160;Cancer&#160;as&#160;a&#160;complex&#160;developmental&#160;disorder--nineteenth&#160;<br/>Cornelius&#160;&#160;P.&#160;&#160;Rhoads&#160;&#160;Memorial&#160;&#160;Award&#160;&#160;Lecture.&#160;&#160;Cancer&#160;&#160;Res&#160;&#160;1998;&#160;<br/>58:&#160;5633-6.&#160;</p>
<p style="position:absolute;top:985px;left:496px;white-space:nowrap" class="ft127">[12]&#160;</p>
<p style="position:absolute;top:985px;left:539px;white-space:nowrap" class="ft1215">Aranda-Anzaldo&#160;A.&#160;Towards&#160;a&#160;morphogenetic&#160;perspective&#160;on&#160;can-<br/>cer.&#160;Riv&#160;Biol&#160;2002;&#160;95:&#160;35-61.&#160;</p>
<p style="position:absolute;top:1012px;left:496px;white-space:nowrap" class="ft127">[13]&#160;</p>
<p style="position:absolute;top:1012px;left:539px;white-space:nowrap" class="ft1215">Needham&#160;&#160;J.&#160;&#160;New&#160;&#160;advances&#160;&#160;in&#160;&#160;the&#160;&#160;chemistry&#160;&#160;and&#160;&#160;biology&#160;&#160;of&#160;&#160;orga-<br/>nized&#160;&#160;growth:&#160;&#160;(Section&#160;&#160;of&#160;&#160;Pathology).&#160;&#160;Proc&#160;&#160;R&#160;&#160;Soc&#160;&#160;Med&#160;&#160;1936;&#160;&#160;29:&#160;<br/>1577-626.&#160;</p>
<p style="position:absolute;top:1053px;left:496px;white-space:nowrap" class="ft127">[14]&#160;</p>
<p style="position:absolute;top:1053px;left:539px;white-space:nowrap" class="ft1215">Kasemeier-Kulesa&#160;&#160;JC,&#160;&#160;Teddy&#160;&#160;JM,&#160;&#160;Postovit&#160;&#160;LM,&#160;&#160;<i>et</i>&#160;&#160;<i>al</i>.&#160;&#160;Reprogram-<br/>ming&#160;&#160;multipotent&#160;&#160;tumor&#160;&#160;cells&#160;&#160;with&#160;&#160;the&#160;&#160;embryonic&#160;&#160;neural&#160;&#160;crest&#160;&#160;mi-<br/>croenvironment.&#160;Dev&#160;Dyn&#160;2008;&#160;237:&#160;2657-66.&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft130{font-size:9px;font-family:Times;color:#000000;}
	.ft131{font-size:9px;font-family:Times;color:#000000;}
	.ft132{font-size:9px;font-family:Times;color:#000000;}
	.ft133{font-size:9px;font-family:Times;color:#000000;}
	.ft134{font-size:9px;line-height:13px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page13-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft130"><i><b>Neurotransmitters&#160;and&#160;Electroceuticals&#160;in&#160;Cancer&#160;</b></i></p>
<p style="position:absolute;top:57px;left:560px;white-space:nowrap" class="ft130"><i><b>Current&#160;Pharmaceutical&#160;Design,&#160;</b></i><b>2017<i>, Vol.&#160;23, No. 32&#160; &#160;&#160;</i></b><b>4839<i>&#160;</i></b></p>
<p style="position:absolute;top:88px;left:96px;white-space:nowrap" class="ft132">[15]&#160;</p>
<p style="position:absolute;top:88px;left:138px;white-space:nowrap" class="ft134">Hendrix&#160;MJ,&#160;Seftor&#160;EA,&#160;Seftor&#160;RE,&#160;Kasemeier-Kulesa J,&#160;Kulesa&#160;<br/>PM, Postovit LM. Reprogramming&#160;metastatic&#160;tumour&#160;cells&#160;with&#160;<br/>embryonic microenvironments.&#160;Nat&#160;Rev Cancer&#160;2007;&#160;7:&#160;246-55.&#160;</p>
<p style="position:absolute;top:128px;left:96px;white-space:nowrap" class="ft132">[16]&#160;</p>
<p style="position:absolute;top:128px;left:138px;white-space:nowrap" class="ft134">Kulesa&#160;PM,&#160;Kasemeier-Kulesa JC,&#160;Teddy JM,&#160;<i>et&#160;al</i>.&#160;Reprogram-<br/>ming metastatic&#160;melanoma cells&#160;to&#160;assume&#160;a neural&#160;crest&#160;cell-like&#160;<br/>phenotype in&#160;an&#160;embryonic microenvironment.&#160;Proc Natl&#160;Acad Sci&#160;<br/>USA&#160;2006;&#160;103:&#160;3752-7.&#160;</p>
<p style="position:absolute;top:182px;left:96px;white-space:nowrap" class="ft132">[17]&#160;</p>
<p style="position:absolute;top:182px;left:138px;white-space:nowrap" class="ft134">Chernet&#160;B,&#160;Levin M.&#160;Endogenous&#160;voltage potentials&#160;and the micro-<br/>environment:&#160;bioelectric signals&#160;that&#160;reveal,&#160;induce and normalize&#160;<br/>cancer.&#160;J&#160;Clin&#160;Exp Oncol&#160;2013;&#160;Suppl&#160;1.&#160;</p>
<p style="position:absolute;top:222px;left:96px;white-space:nowrap" class="ft132">[18]&#160;</p>
<p style="position:absolute;top:222px;left:138px;white-space:nowrap" class="ft134">Levin M.&#160;Molecular&#160;bioelectricity:&#160;How&#160;endogenous&#160;voltage&#160;poten-<br/>tials&#160;control&#160;cell&#160;behavior&#160;and instruct&#160;pattern&#160;regulation&#160;<i>in&#160;vivo</i>.&#160;<br/>Mol&#160;Biol&#160;Cell&#160;2014;&#160;25:&#160;3835-50.&#160;</p>
<p style="position:absolute;top:263px;left:96px;white-space:nowrap" class="ft132">[19]&#160;</p>
<p style="position:absolute;top:263px;left:138px;white-space:nowrap" class="ft134">Levin M,&#160;Stevenson CG.&#160;Regulation of&#160;cell&#160;behavior&#160;and tissue&#160;<br/>patterning&#160;by&#160;bioelectrical&#160;signals:&#160;Challenges&#160;and&#160;opportunities&#160;for&#160;<br/>biomedical&#160;engineering.&#160;Annu&#160;Rev Biomed Eng 2012;&#160;14:&#160;295-323.&#160;</p>
<p style="position:absolute;top:303px;left:96px;white-space:nowrap" class="ft132">[20]&#160;</p>
<p style="position:absolute;top:303px;left:138px;white-space:nowrap" class="ft134">Levin M.&#160;Molecular&#160;bioelectricity&#160;in&#160;developmental&#160;biology:&#160;New&#160;<br/>tools&#160;and recent&#160;discoveries:&#160;Control&#160;of&#160;cell&#160;behavior&#160;and pattern&#160;<br/>formation by transmembrane potential&#160;gradients.&#160;BioEssays&#160;2012;&#160;<br/>34:&#160;205-17.&#160;</p>
<p style="position:absolute;top:357px;left:96px;white-space:nowrap" class="ft132">[21]&#160;</p>
<p style="position:absolute;top:357px;left:138px;white-space:nowrap" class="ft134">Bates&#160;E.&#160;Ion channels&#160;in&#160;development&#160;and cancer.&#160;Annu Rev Cell&#160;<br/>Dev Biol&#160;2015;&#160;31:&#160;231-47.&#160;</p>
<p style="position:absolute;top:384px;left:96px;white-space:nowrap" class="ft132">[22]&#160;</p>
<p style="position:absolute;top:384px;left:138px;white-space:nowrap" class="ft134">Liebeskind&#160;BJ, Hillis&#160;DM, Zakon HH.&#160;Evolution&#160;of&#160;sodium&#160;chan-<br/>nels&#160;predates&#160;the&#160;origin&#160;of&#160;nervous&#160;systems&#160;in&#160;animals.&#160;Proc&#160;Natl&#160;<br/>Acad Sci&#160;USA&#160;2011;&#160;108:&#160;9154-9.&#160;</p>
<p style="position:absolute;top:425px;left:96px;white-space:nowrap" class="ft132">[23]&#160;</p>
<p style="position:absolute;top:425px;left:138px;white-space:nowrap" class="ft134">Keijzer&#160;F,&#160;van Duijn&#160;M,&#160;Lyon P.&#160;What&#160;nervous&#160;systems&#160;do:&#160;Early&#160;<br/>evolution,&#160;input-output,&#160;and the&#160;skin brain thesis.&#160;Adaptive&#160;Behav-<br/>ior&#160;2013;&#160;21:&#160;67-85.&#160;</p>
<p style="position:absolute;top:465px;left:96px;white-space:nowrap" class="ft132">[24]&#160;</p>
<p style="position:absolute;top:465px;left:138px;white-space:nowrap" class="ft134">Sundelacruz S,&#160;Levin M,&#160;Kaplan DL.&#160;Role&#160;of&#160;membrane potential&#160;<br/>in&#160;the regulation of&#160;cell&#160;proliferation and&#160;differentiation.&#160;Stem&#160;Cell&#160;<br/>Rev Rep 2009;&#160;5:&#160;231-46.&#160;</p>
<p style="position:absolute;top:506px;left:96px;white-space:nowrap" class="ft132">[25]&#160;</p>
<p style="position:absolute;top:506px;left:138px;white-space:nowrap" class="ft134">Adams DS,&#160;Uzel&#160;SG,&#160;Akagi&#160;J,&#160;<i>et&#160;al</i>. Bioelectric&#160;signalling<i>&#160;via</i>&#160;po-<br/>tassium channels:&#160;A mechanism for&#160;craniofacial&#160;dysmorphogenesis&#160;<br/>in&#160;KCNJ2-associated Andersen-Tawil&#160;Syndrome.&#160;J&#160;Physiol&#160;2016.&#160;</p>
<p style="position:absolute;top:546px;left:96px;white-space:nowrap" class="ft132">[26]&#160;</p>
<p style="position:absolute;top:546px;left:138px;white-space:nowrap" class="ft134">Vandenberg LN,&#160;Morrie RD,&#160;Adams&#160;DS.&#160;V-ATPase-dependent&#160;<br/>ectodermal&#160;voltage&#160;and&#160;pH regionalization&#160;are required for&#160;cranio-<br/>facial&#160;morphogenesis.&#160;Dev Dyn 2011;&#160;240:&#160;1889-904.&#160;</p>
<p style="position:absolute;top:587px;left:96px;white-space:nowrap" class="ft132">[27]&#160;</p>
<p style="position:absolute;top:587px;left:138px;white-space:nowrap" class="ft134">Emmons-Bell M, Durant&#160;F, Hammelman&#160;J,&#160;<i>et&#160;al</i>. Gap&#160;junctional&#160;<br/>blockade&#160;stochastically&#160;induces&#160;different&#160;species-specific&#160;head&#160;<br/>anatomies&#160;in&#160;genetically&#160;wild-type girardia&#160;dorotocephala&#160;flat-<br/>worms.&#160;Int&#160;J&#160;Mol&#160;Sci&#160;2015;&#160;16:&#160;27865-96.&#160;</p>
<p style="position:absolute;top:641px;left:96px;white-space:nowrap" class="ft132">[28]&#160;</p>
<p style="position:absolute;top:641px;left:138px;white-space:nowrap" class="ft134">Beane WS,&#160;Morokuma J,&#160;Adams&#160;DS,&#160;Levin M.&#160;A&#160;Chemical&#160;genet-<br/>ics&#160;approach&#160;reveals&#160;H,K-ATPase-mediated membrane&#160;voltage&#160;is&#160;<br/>required for&#160;planarian head&#160;regeneration.&#160;Chem Biol&#160;2011;&#160;18:&#160;77-<br/>89.&#160;</p>
<p style="position:absolute;top:695px;left:96px;white-space:nowrap" class="ft132">[29]&#160;</p>
<p style="position:absolute;top:695px;left:138px;white-space:nowrap" class="ft134">Pai&#160;VP,&#160;Lemire&#160;JM,&#160;Pare&#160;JF,&#160;Lin G,&#160;Chen Y,&#160;Levin M.&#160;Endogenous&#160;<br/>gradients&#160;of&#160;resting potential&#160;instructively pattern&#160;embryonic neural&#160;<br/>tissue<i>&#160;via</i>&#160;notch signaling and regulation of&#160;proliferation.&#160;J&#160;Neuro-<br/>sci&#160;2015;&#160;35:&#160;4366-85.&#160;</p>
<p style="position:absolute;top:749px;left:96px;white-space:nowrap" class="ft132">[30]&#160;</p>
<p style="position:absolute;top:749px;left:138px;white-space:nowrap" class="ft134">Perathoner&#160;S,&#160;Daane JM,&#160;Henrion U,&#160;<i>et&#160;al</i>.&#160;Bioelectric signaling&#160;<br/>regulates&#160;size in&#160;zebrafish&#160;fins.&#160;PLoS Genetics&#160;2014;&#160;10:&#160;e1004080.&#160;</p>
<p style="position:absolute;top:776px;left:96px;white-space:nowrap" class="ft132">[31]&#160;</p>
<p style="position:absolute;top:776px;left:138px;white-space:nowrap" class="ft134">Adams&#160;DS,&#160;Tseng AS,&#160;Levin&#160;M.&#160;Light-activation of&#160;the&#160;Archaer-<br/>hodopsin&#160;H(+)-pump reverses&#160;age-dependent&#160;loss&#160;of&#160;vertebrate&#160;re-<br/>generation:&#160;sparking&#160;system-level&#160;controls&#160;<i>in&#160;vivo</i>.&#160;Biology open&#160;<br/>2013;&#160;2:&#160;306-13.&#160;</p>
<p style="position:absolute;top:830px;left:96px;white-space:nowrap" class="ft132">[32]&#160;</p>
<p style="position:absolute;top:830px;left:138px;white-space:nowrap" class="ft134">Pai&#160;VP,&#160;Aw&#160;S,&#160;Shomrat&#160;T,&#160;Lemire&#160;JM,&#160;Levin M.&#160;Transmembrane&#160;<br/>voltage&#160;potential&#160;controls&#160;embryonic&#160;eye patterning in&#160;Xenopus&#160;<br/>laevis.&#160;Development&#160;2012;&#160;139:&#160;313-23.&#160;</p>
<p style="position:absolute;top:870px;left:96px;white-space:nowrap" class="ft132">[33]&#160;</p>
<p style="position:absolute;top:870px;left:138px;white-space:nowrap" class="ft134">Levin M,&#160;Buznikov GA,&#160;Lauder&#160;JM.&#160;Of&#160;minds&#160;and embryos:&#160;Left-<br/>right&#160;asymmetry&#160;and the serotonergic&#160;controls&#160;of&#160;pre-neural&#160;<br/>morphogenesis.&#160;Dev Neurosci&#160;2006;&#160;28:&#160;171-85.&#160;</p>
<p style="position:absolute;top:911px;left:96px;white-space:nowrap" class="ft132">[34]&#160;</p>
<p style="position:absolute;top:911px;left:138px;white-space:nowrap" class="ft134">Buznikov&#160;GA,&#160;Lambert&#160;HW,&#160;Lauder&#160;JM.&#160;Serotonin and serotonin-<br/>like substances&#160;as&#160;regulators&#160;of&#160;early&#160;embryogenesis&#160;and morpho-<br/>genesis.&#160;Cell&#160;Tissue Res&#160;2001;&#160;305:&#160;177-86.&#160;</p>
<p style="position:absolute;top:951px;left:96px;white-space:nowrap" class="ft132">[35]&#160;</p>
<p style="position:absolute;top:951px;left:138px;white-space:nowrap" class="ft134">Fukumoto T,&#160;Kema&#160;IP,&#160;Levin M.&#160;Serotonin signaling is&#160;a very&#160;early&#160;<br/>step in&#160;patterning of&#160;the left-right&#160;axis&#160;in&#160;chick and frog embryos.&#160;<br/>Curr&#160;Biol&#160;2005;&#160;15:&#160;794-803.&#160;</p>
<p style="position:absolute;top:992px;left:96px;white-space:nowrap" class="ft132">[36]&#160;</p>
<p style="position:absolute;top:992px;left:138px;white-space:nowrap" class="ft134">Fukumoto T,&#160;Blakely R,&#160;Levin M.&#160;Serotonin transporter&#160;function is&#160;<br/>an early&#160;step&#160;in left-right&#160;patterning in&#160;chick and&#160;frog&#160;embryos.&#160;Dev&#160;<br/>Neurosci&#160;2005;&#160;27:&#160;349-63.&#160;</p>
<p style="position:absolute;top:1032px;left:96px;white-space:nowrap" class="ft132">[37]&#160;</p>
<p style="position:absolute;top:1032px;left:138px;white-space:nowrap" class="ft134">Reisoli&#160;E,&#160;De Lucchini&#160;S,&#160;Nardi&#160;I,&#160;Ori&#160;M.&#160;Serotonin 2B&#160;receptor&#160;<br/>signaling is&#160;required for&#160;craniofacial&#160;morphogenesis&#160;and jaw&#160;joint&#160;<br/>formation in Xenopus.&#160;Development&#160;2010;&#160;137:&#160;2927-37.&#160;</p>
<p style="position:absolute;top:1073px;left:96px;white-space:nowrap" class="ft132">[38]&#160;</p>
<p style="position:absolute;top:1073px;left:138px;white-space:nowrap" class="ft134">Moiseiwitsch&#160;J.&#160;The&#160;role&#160;of&#160;serotonin&#160;and&#160;neurotransmitters&#160;during&#160;<br/>craniofacial&#160;development. Critic&#160;Rev&#160;Oral&#160;Biol&#160;Med&#160;2000;&#160;11:&#160;230-<br/>9.&#160;</p>
<p style="position:absolute;top:87px;left:496px;white-space:nowrap" class="ft132">[39]&#160;</p>
<p style="position:absolute;top:87px;left:538px;white-space:nowrap" class="ft134">Yavarone&#160;MS,&#160;Shuey DL,&#160;Tamir&#160;H,&#160;Sadler&#160;TW,&#160;Lauder&#160;JM.&#160;Sero-<br/>tonin and cardiac morphogenesis&#160;in&#160;the mouse embryo.&#160;Teratology&#160;<br/>1993;&#160;47:&#160;573-84.&#160;</p>
<p style="position:absolute;top:128px;left:496px;white-space:nowrap" class="ft132">[40]&#160;</p>
<p style="position:absolute;top:128px;left:539px;white-space:nowrap" class="ft134">Nebigil&#160;CG,&#160;Hickel&#160;P,&#160;Messaddeq N,&#160;<i>et&#160;al</i>.&#160;Ablation of&#160;serotonin 5-<br/>HT(2B)&#160;receptors&#160;in&#160;mice leads to&#160;abnormal&#160;cardiac structure&#160;and&#160;<br/>function.&#160;Circulation 2001;&#160;103:&#160;2973-9.&#160;</p>
<p style="position:absolute;top:168px;left:496px;white-space:nowrap" class="ft132">[41]&#160;</p>
<p style="position:absolute;top:168px;left:539px;white-space:nowrap" class="ft134">Choi&#160;DS,&#160;Ward&#160;SJ,&#160;Messaddeq N,&#160;Launay JM,&#160;Maroteaux L.&#160;5-<br/>HT2B&#160;receptor-mediated serotonin morphogenetic&#160;functions&#160;in&#160;<br/>mouse cranial&#160;neural&#160;crest&#160;and myocardiac cells.&#160;Development&#160;<br/>1997;&#160;124:&#160;1745-55.&#160;</p>
<p style="position:absolute;top:222px;left:496px;white-space:nowrap" class="ft132">[42]&#160;</p>
<p style="position:absolute;top:222px;left:539px;white-space:nowrap" class="ft134">Colas&#160;JF,&#160;Launay JM,&#160;Vonesch JL,&#160;Hickel&#160;P,&#160;Maroteaux L.&#160;Sero-<br/>tonin synchronises&#160;convergent&#160;extension&#160;of&#160;ectoderm&#160;with&#160;<br/>morphogenetic&#160;gastrulation&#160;movements&#160;in&#160;Drosophila.&#160;Mech&#160;Dev&#160;<br/>1999;&#160;87:&#160;77-91.&#160;</p>
<p style="position:absolute;top:276px;left:496px;white-space:nowrap" class="ft132">[43]&#160;</p>
<p style="position:absolute;top:276px;left:539px;white-space:nowrap" class="ft134">Adams DS,&#160;Masi&#160;A,&#160;Levin&#160;M.&#160;H+&#160;pump-dependent&#160;changes in&#160;<br/>membrane&#160;voltage are an&#160;early&#160;mechanism necessary&#160;and sufficient&#160;<br/>to&#160;induce Xenopus&#160;tail&#160;regeneration.&#160;Development&#160;2007;&#160;134:&#160;<br/>1323-35.&#160;</p>
<p style="position:absolute;top:330px;left:496px;white-space:nowrap" class="ft132">[44]&#160;</p>
<p style="position:absolute;top:330px;left:539px;white-space:nowrap" class="ft134">Tseng AS,&#160;Beane&#160;WS,&#160;Lemire&#160;JM,&#160;Masi&#160;A,&#160;Levin M.&#160;Induction of&#160;<br/>vertebrate&#160;regeneration by&#160;a&#160;transient&#160;sodium&#160;current.&#160;J&#160;Neurosci&#160;<br/>2010;&#160;30:&#160;13192-200.&#160;</p>
<p style="position:absolute;top:371px;left:496px;white-space:nowrap" class="ft132">[45]&#160;</p>
<p style="position:absolute;top:371px;left:539px;white-space:nowrap" class="ft134">Nogi&#160;T,&#160;Levin&#160;M.&#160;Characterization of&#160;innexin gene&#160;expression&#160;and&#160;<br/>functional&#160;roles&#160;of&#160;gap-junctional&#160;communication in&#160;planarian re-<br/>generation.&#160;Dev Biol&#160;2005;&#160;287:&#160;314-35.&#160;</p>
<p style="position:absolute;top:411px;left:496px;white-space:nowrap" class="ft132">[46]&#160;</p>
<p style="position:absolute;top:411px;left:539px;white-space:nowrap" class="ft134">Oviedo NJ,&#160;Morokuma J,&#160;Walentek P,&#160;<i>et&#160;al</i>.&#160;Long-range neural&#160;and&#160;<br/>gap junction&#160;protein-mediated&#160;cues&#160;control&#160;polarity&#160;during&#160;planar-<br/>ian regeneration.&#160;Dev Biol&#160;2010;&#160;339:&#160;188-99.&#160;</p>
<p style="position:absolute;top:452px;left:496px;white-space:nowrap" class="ft132">[47]&#160;</p>
<p style="position:absolute;top:452px;left:539px;white-space:nowrap" class="ft134">Blandino JK,&#160;Viglione MP,&#160;Bradley WA,&#160;Oie HK,&#160;Kim&#160;YI.&#160;Volt-<br/>age-dependent&#160;sodium channels&#160;in&#160;human&#160;small-cell&#160;lung cancer&#160;<br/>cells: role&#160;in&#160;action&#160;potentials&#160;and&#160;inhibition&#160;by&#160;Lambert-Eaton&#160;syn-<br/>drome IgG.&#160;J&#160;Membr&#160;Biol&#160;1995;&#160;143:&#160;153-63.&#160;</p>
<p style="position:absolute;top:506px;left:496px;white-space:nowrap" class="ft132">[48]&#160;</p>
<p style="position:absolute;top:506px;left:538px;white-space:nowrap" class="ft134">Grimes JA,&#160;Fraser&#160;SP,&#160;Stephens GJ,&#160;<i>et&#160;al</i>.&#160;Differential&#160;expression of&#160;<br/>voltage-activated&#160;Na+&#160;currents&#160;in&#160;two&#160;prostatic&#160;tumour&#160;cell lines:&#160;<br/>Contribution to&#160;invasiveness&#160;<i>in&#160;vitro</i>.&#160;FEBS&#160;letters&#160;1995;&#160;369:&#160;290-<br/>4.&#160;</p>
<p style="position:absolute;top:560px;left:496px;white-space:nowrap" class="ft132">[49]&#160;</p>
<p style="position:absolute;top:560px;left:539px;white-space:nowrap" class="ft134">Blackiston DJ,&#160;McLaughlin&#160;KA,&#160;Levin&#160;M.&#160;Bioelectric controls&#160;of&#160;<br/>cell&#160;proliferation:&#160;Ion channels,&#160;membrane voltage&#160;and the cell&#160;cy-<br/>cle.&#160;Cell&#160;Cycle 2009;&#160;8:&#160;3519-28.&#160;</p>
<p style="position:absolute;top:600px;left:496px;white-space:nowrap" class="ft132">[50]&#160;</p>
<p style="position:absolute;top:600px;left:539px;white-space:nowrap" class="ft134">Binggeli&#160;R,&#160;Weinstein RC,&#160;Stevenson&#160;D.&#160;Calcium&#160;ion&#160;and the&#160;<br/>membrane&#160;potential&#160;of&#160;tumor&#160;cells.&#160;Cancer&#160;Biochem Biophys&#160;1994;&#160;<br/>14:&#160;201-10.&#160;</p>
<p style="position:absolute;top:641px;left:496px;white-space:nowrap" class="ft132">[51]&#160;</p>
<p style="position:absolute;top:641px;left:539px;white-space:nowrap" class="ft134">Cone CD.&#160;Unified theory&#160;on the basic mechanism&#160;of&#160;normal&#160;mi-<br/>totic&#160;control&#160;and oncogenesis.&#160;J&#160;Theor&#160;Biol&#160;1971;&#160;30:&#160;151-81.&#160;</p>
<p style="position:absolute;top:668px;left:496px;white-space:nowrap" class="ft132">[52]&#160;</p>
<p style="position:absolute;top:668px;left:539px;white-space:nowrap" class="ft134">Cone CD,&#160;Jr.&#160;Variation of&#160;the transmembrane potential&#160;level&#160;as&#160;a&#160;<br/>basic mechanism of&#160;mitosis&#160;control.&#160;Oncology 1970;&#160;24:&#160;438-70.&#160;</p>
<p style="position:absolute;top:695px;left:496px;white-space:nowrap" class="ft132">[53]&#160;</p>
<p style="position:absolute;top:695px;left:539px;white-space:nowrap" class="ft134">Stuhmer&#160;W,&#160;Alves&#160;F,&#160;Hartung F,&#160;Zientkowska M,&#160;Pardo LA.&#160;Potas-<br/>sium channels&#160;as&#160;tumour&#160;markers.&#160;FEBS&#160;Lett&#160;2006;&#160;580:&#160;2850-2.&#160;</p>
<p style="position:absolute;top:722px;left:496px;white-space:nowrap" class="ft132">[54]&#160;</p>
<p style="position:absolute;top:722px;left:539px;white-space:nowrap" class="ft134">Diss JK,&#160;Stewart&#160;D,&#160;Pani&#160;F,&#160;<i>et&#160;al</i>.&#160;A&#160;potential&#160;novel&#160;marker&#160;for&#160;<br/>human prostate&#160;cancer:&#160;Voltage-gated&#160;sodium channel&#160;expression&#160;<br/><i>in&#160;vivo</i>.&#160;Prostate&#160;Cancer&#160;Prostatic Dis&#160;2005;&#160;8:&#160;266-73.&#160;</p>
<p style="position:absolute;top:762px;left:496px;white-space:nowrap" class="ft132">[55]&#160;</p>
<p style="position:absolute;top:762px;left:538px;white-space:nowrap" class="ft134">Arcangeli&#160;A,&#160;Becchetti A.&#160;New&#160;trends&#160;in&#160;cancer&#160;therapy: Targeting&#160;<br/>ion channels&#160;and transporters.&#160;Pharmaceuticals&#160;2010;&#160;3:&#160;1202.&#160;</p>
<p style="position:absolute;top:789px;left:496px;white-space:nowrap" class="ft132">[56]&#160;</p>
<p style="position:absolute;top:789px;left:539px;white-space:nowrap" class="ft134">Defamie N,&#160;Chepied A,&#160;Mesnil&#160;M.&#160;Connexins,&#160;gap junctions&#160;and&#160;<br/>tissue invasion.&#160;FEBS&#160;Lett&#160;2014;&#160;588:&#160;1331-8.&#160;</p>
<p style="position:absolute;top:816px;left:496px;white-space:nowrap" class="ft132">[57]&#160;</p>
<p style="position:absolute;top:816px;left:539px;white-space:nowrap" class="ft134">Yamasaki&#160;H,&#160;Mesnil&#160;M,&#160;Omori&#160;Y,&#160;Mironov N,&#160;Krutovskikh&#160;V.&#160;<br/>Intercellular&#160;communication and&#160;carcinogenesis.&#160;Mutation Res&#160;<br/>1995;&#160;333:&#160;181-8.&#160;</p>
<p style="position:absolute;top:857px;left:496px;white-space:nowrap" class="ft132">[58]&#160;</p>
<p style="position:absolute;top:857px;left:539px;white-space:nowrap" class="ft134">Shishido SN,&#160;Prasain K,&#160;Beck A,&#160;Nguyen TD,&#160;Hua DH,&#160;Nguyen&#160;<br/>TA. Bioavailability&#160;and&#160;efficacy&#160;of&#160;a gap junction enhancer&#160;(PQ7)&#160;<br/>in&#160;a mouse mammary&#160;tumor&#160;model.&#160;PLoS One 2013;&#160;8:&#160;e67174.&#160;</p>
<p style="position:absolute;top:897px;left:496px;white-space:nowrap" class="ft132">[59]&#160;</p>
<p style="position:absolute;top:897px;left:539px;white-space:nowrap" class="ft134">Ding Y,&#160;Nguyen TA.&#160;Gap&#160;junction enhancer&#160;potentiates&#160;cytotoxic-<br/>ity&#160;of&#160;cisplatin&#160;in&#160;breast&#160;cancer&#160;cells.&#160;J&#160;Cancer&#160;Sci&#160;Ther&#160;2012;&#160;4:&#160;<br/>371-8.&#160;</p>
<p style="position:absolute;top:938px;left:496px;white-space:nowrap" class="ft132">[60]&#160;</p>
<p style="position:absolute;top:938px;left:539px;white-space:nowrap" class="ft134">Lobikin M,&#160;Chernet&#160;B,&#160;Lobo&#160;D,&#160;Levin M.&#160;Resting&#160;potential,&#160;onco-<br/>gene-induced&#160;tumorigenesis,&#160;and metastasis:&#160;The bioelectric basis&#160;<br/>of&#160;cancer&#160;<i>in&#160;vivo</i>.&#160;Phys&#160;Biol&#160;2012;&#160;9:&#160;065002.&#160;</p>
<p style="position:absolute;top:978px;left:496px;white-space:nowrap" class="ft132">[61]&#160;</p>
<p style="position:absolute;top:978px;left:539px;white-space:nowrap" class="ft134">Blackiston D,&#160;Adams&#160;DS,&#160;Lemire&#160;JM,&#160;Lobikin M,&#160;Levin M.&#160;<br/>Transmembrane&#160;potential&#160;of&#160;GlyCl-expressing&#160;instructor&#160;cells&#160;in-<br/>duces&#160;a&#160;neoplastic-like conversion of&#160;melanocytes<i>&#160;via</i>&#160;a&#160;serotoner-<br/>gic pathway.&#160;Dis&#160;Model&#160;Mech 2011;&#160;4:&#160;67-85.&#160;</p>
<p style="position:absolute;top:1032px;left:496px;white-space:nowrap" class="ft132">[62]&#160;</p>
<p style="position:absolute;top:1032px;left:539px;white-space:nowrap" class="ft134">Lobikin M,&#160;Lobo D,&#160;Blackiston DJ,&#160;Martyniuk CJ,&#160;Tkachenko E,&#160;<br/>Levin M.&#160;Serotonergic&#160;regulation&#160;of&#160;melanocyte&#160;conversion:&#160;A&#160;<br/>bioelectrically&#160;regulated&#160;network for&#160;stochastic&#160;all-or-none&#160;<br/>hyperpigmentation.&#160;Sci&#160;Signal&#160;2015;&#160;8:&#160;ra99.&#160;</p>
<p style="position:absolute;top:1086px;left:496px;white-space:nowrap" class="ft132">[63]&#160;</p>
<p style="position:absolute;top:1086px;left:539px;white-space:nowrap" class="ft134">Chernet BT, Levin&#160;M. Transmembrane&#160;voltage&#160;potential is&#160;an&#160;<br/>essential cellular&#160;parameter&#160;for&#160;the&#160;detection&#160;and&#160;control of&#160;tumor&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft140{font-size:9px;font-family:Times;color:#000000;}
	.ft141{font-size:9px;font-family:Times;color:#000000;}
	.ft142{font-size:9px;font-family:Times;color:#000000;}
	.ft143{font-size:9px;font-family:Times;color:#000000;}
	.ft144{font-size:9px;line-height:13px;font-family:Times;color:#000000;}
	.ft145{font-size:9px;line-height:14px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page14-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft140"><b>4840 &#160; &#160;<i>Current&#160;Pharmaceutical&#160;Design,&#160;</i></b><b>2017<i>, Vol.&#160;23, No. 32&#160;</i></b></p>
<p style="position:absolute;top:57px;left:789px;white-space:nowrap" class="ft141"><i><b>Tuszynski&#160;et&#160;al.&#160;</b></i></p>
<p style="position:absolute;top:88px;left:138px;white-space:nowrap" class="ft144">development&#160;in&#160;a Xenopus model.&#160;Disease Model&#160;Mechanisms&#160;<br/>2013;&#160;6:&#160;595-607.&#160;</p>
<p style="position:absolute;top:115px;left:96px;white-space:nowrap" class="ft142">[64]&#160;</p>
<p style="position:absolute;top:115px;left:138px;white-space:nowrap" class="ft144">Chernet&#160;BT,&#160;Fields&#160;C,&#160;Levin&#160;M.&#160;Long-range gap junctional&#160;signal-<br/>ing controls&#160;oncogene-mediated tumorigenesis&#160;in Xenopus&#160;laevis&#160;<br/>embryos.&#160;Frontiers&#160;Physiol&#160;2015;&#160;5:&#160;519.&#160;</p>
<p style="position:absolute;top:155px;left:96px;white-space:nowrap" class="ft142">[65]&#160;</p>
<p style="position:absolute;top:155px;left:138px;white-space:nowrap" class="ft144">Chernet BT, Levin&#160;M. Transmembrane&#160;voltage&#160;potential of&#160;somatic&#160;<br/>cells&#160;controls&#160;oncogene-mediated tumorigenesis&#160;at&#160;long-range.&#160;On-<br/>cotarget&#160;2014;&#160;5:&#160;3287-306.&#160;</p>
<p style="position:absolute;top:195px;left:96px;white-space:nowrap" class="ft142">[66]&#160;</p>
<p style="position:absolute;top:195px;left:138px;white-space:nowrap" class="ft144">Chernet&#160;BT,&#160;Adams&#160;DS,&#160;Lobikin M,&#160;Levin M.&#160;Use of&#160;genetically&#160;<br/>encoded,&#160;light-gated ion translocators&#160;to&#160;control&#160;tumorigenesis.&#160;<br/>Oncotarget&#160;2016.&#160;</p>
<p style="position:absolute;top:236px;left:96px;white-space:nowrap" class="ft142">[67]&#160;</p>
<p style="position:absolute;top:236px;left:138px;white-space:nowrap" class="ft144">Sinha G.&#160;Charged&#160;by GSK&#160;investment,&#160;battery&#160;of&#160;electroceuticals&#160;<br/>advance.&#160;Nat&#160;Med 2013;&#160;19:&#160;654.&#160;</p>
<p style="position:absolute;top:263px;left:96px;white-space:nowrap" class="ft142">[68]&#160;</p>
<p style="position:absolute;top:263px;left:138px;white-space:nowrap" class="ft144">Famm K,&#160;Litt&#160;B,&#160;Tracey KJ,&#160;Boyden ES,&#160;Slaoui&#160;M.&#160;Drug discov-<br/>ery:&#160;A&#160;jump-start&#160;for&#160;electroceuticals.&#160;Nature&#160;2013;&#160;496:&#160;159-61.&#160;</p>
<p style="position:absolute;top:290px;left:96px;white-space:nowrap" class="ft142">[69]&#160;</p>
<p style="position:absolute;top:290px;left:138px;white-space:nowrap" class="ft144">Li&#160;C,&#160;Levin M,&#160;Kaplan&#160;DL.&#160;Bioelectric modulation of&#160;macrophage&#160;<br/>polarization.&#160;Sci&#160;Rep 2016;&#160;6:&#160;21044.&#160;</p>
<p style="position:absolute;top:317px;left:96px;white-space:nowrap" class="ft142">[70]&#160;</p>
<p style="position:absolute;top:317px;left:138px;white-space:nowrap" class="ft144">Tseng A,&#160;Levin M.&#160;Cracking&#160;the&#160;bioelectric code:&#160;Probing&#160;endoge-<br/>nous&#160;ionic controls&#160;of&#160;pattern&#160;formation.&#160;Commun Integrative Biol&#160;<br/>2013;&#160;6:&#160;1-8.&#160;</p>
<p style="position:absolute;top:357px;left:96px;white-space:nowrap" class="ft142">[71]&#160;</p>
<p style="position:absolute;top:357px;left:138px;white-space:nowrap" class="ft144">Sundelacruz S,&#160;Li&#160;C,&#160;Choi&#160;YJ,&#160;Levin M,&#160;Kaplan DL.&#160;Bioelectric&#160;<br/>modulation of&#160;wound healing in&#160;a 3D&#160;<i>in&#160;vitro</i>&#160;model&#160;of&#160;tissue-<br/>engineered&#160;bone.&#160;Biomaterials&#160;2013;&#160;34:&#160;6695-705.&#160;</p>
<p style="position:absolute;top:398px;left:96px;white-space:nowrap" class="ft142">[72]&#160;</p>
<p style="position:absolute;top:398px;left:138px;white-space:nowrap" class="ft144">Sundelacruz S,&#160;Levin M,&#160;Kaplan DL.&#160;Depolarization alters&#160;pheno-<br/>type, maintains&#160;plasticity&#160;of&#160;predifferentiated&#160;mesenchymal stem&#160;<br/>cells.&#160;Tissue engineering.&#160;Part&#160;A&#160;2013;&#160;19:&#160;1889-908.&#160;</p>
<p style="position:absolute;top:438px;left:96px;white-space:nowrap" class="ft142">[73]&#160;</p>
<p style="position:absolute;top:438px;left:138px;white-space:nowrap" class="ft144">Lobikin M,&#160;Pare&#160;JF,&#160;Kaplan&#160;DL,&#160;Levin M.&#160;Selective depolarization&#160;<br/>of&#160;transmembrane potential&#160;alters&#160;muscle&#160;patterning&#160;and&#160;muscle&#160;<br/>cell&#160;localization in&#160;Xenopus&#160;laevis&#160;embryos.&#160;Int&#160;J&#160;Develop Biol&#160;<br/>2015.&#160;</p>
<p style="position:absolute;top:492px;left:96px;white-space:nowrap" class="ft142">[74]&#160;</p>
<p style="position:absolute;top:492px;left:138px;white-space:nowrap" class="ft144">Schloss&#160;P, Williams&#160;DC. The&#160;serotonin&#160;transporter:&#160;A&#160;primary&#160;<br/>target&#160;for&#160;antidepressant&#160;drugs.&#160;J&#160;Psychopharmacol&#160;1998;&#160;12:&#160;115-<br/>21.&#160;</p>
<p style="position:absolute;top:533px;left:96px;white-space:nowrap" class="ft142">[75]&#160;</p>
<p style="position:absolute;top:533px;left:138px;white-space:nowrap" class="ft144">Buznikov G,&#160;Shmukler&#160;Y,&#160;Lauder&#160;J.&#160;From&#160;oocyte to&#160;neuron:&#160;do&#160;<br/>neurotransmitters&#160;function&#160;in&#160;the&#160;same&#160;way&#160;throughout develop-<br/>ment? Cell&#160;Mol&#160;Neurobiol&#160;1996;&#160;16:&#160;537-59.&#160;</p>
<p style="position:absolute;top:573px;left:96px;white-space:nowrap" class="ft142">[76]&#160;</p>
<p style="position:absolute;top:573px;left:138px;white-space:nowrap" class="ft144">Sullivan&#160;KG,&#160;Levin&#160;M. Neurotransmitter&#160;signaling&#160;pathways&#160;re-<br/>quired for&#160;normal&#160;development&#160;in&#160;Xenopus&#160;laevis&#160;embryos:&#160;A&#160;<br/>pharmacological&#160;survey&#160;screen.&#160;J&#160;Anat&#160;2016;&#160;229:&#160;483-502.&#160;</p>
<p style="position:absolute;top:614px;left:96px;white-space:nowrap" class="ft142">[77]&#160;</p>
<p style="position:absolute;top:614px;left:138px;white-space:nowrap" class="ft144">Stepulak A,&#160;Rola&#160;R,&#160;Polberg K,&#160;Ikonomidou&#160;C.&#160;Glutamate&#160;and&#160;its&#160;<br/>receptors&#160;in&#160;cancer.&#160;J&#160;Neural&#160;Transm&#160;(Vienna)&#160;2014;&#160;121:&#160;933-44.&#160;</p>
<p style="position:absolute;top:641px;left:96px;white-space:nowrap" class="ft142">[78]&#160;</p>
<p style="position:absolute;top:641px;left:138px;white-space:nowrap" class="ft144">Sachlos&#160;E,&#160;Risueno RM,&#160;Laronde S,&#160;<i>et&#160;al</i>.&#160;Identification of&#160;drugs&#160;<br/>including a&#160;dopamine receptor&#160;antagonist&#160;that&#160;selectively target&#160;<br/>cancer&#160;stem&#160;cells.&#160;Cell&#160;2012;&#160;149:&#160;1284-97.&#160;</p>
<p style="position:absolute;top:681px;left:96px;white-space:nowrap" class="ft142">[79]&#160;</p>
<p style="position:absolute;top:681px;left:138px;white-space:nowrap" class="ft144">Fitzgerald&#160;PJ.&#160;Beta&#160;blockers,&#160;norepinephrine,&#160;and&#160;cancer:&#160;An&#160;epi-<br/>demiological&#160;viewpoint.&#160;Clin&#160;Epidemiol&#160;2012;&#160;4:&#160;151-6.&#160;</p>
<p style="position:absolute;top:708px;left:96px;white-space:nowrap" class="ft142">[80]&#160;</p>
<p style="position:absolute;top:708px;left:138px;white-space:nowrap" class="ft144">Schuller&#160;HM, Al-Wadei&#160;HA.&#160;Neurotransmitter&#160;receptors&#160;as central&#160;<br/>regulators&#160;of&#160;pancreatic&#160;cancer.&#160;Future&#160;Oncol&#160;2010;&#160;6:&#160;221-8.&#160;</p>
<p style="position:absolute;top:735px;left:96px;white-space:nowrap" class="ft142">[81]&#160;</p>
<p style="position:absolute;top:735px;left:138px;white-space:nowrap" class="ft144">Sontheimer&#160;H.&#160;Malignant&#160;gliomas:&#160;Perverting glutamate and ion&#160;<br/>homeostasis&#160;for&#160;selective&#160;advantage.&#160;Trends&#160;Neurosci&#160;2003;&#160;26:&#160;<br/>543-9.&#160;</p>
<p style="position:absolute;top:776px;left:96px;white-space:nowrap" class="ft142">[82]&#160;</p>
<p style="position:absolute;top:776px;left:138px;white-space:nowrap" class="ft144">Sarrouilhe D,&#160;Clarhaut&#160;J,&#160;Defamie N,&#160;Mesnil&#160;M.&#160;Serotonin and&#160;<br/>cancer:&#160;what&#160;is&#160;the link? Curr&#160;Mol&#160;Med 2015;&#160;15:&#160;62-77.&#160;</p>
<p style="position:absolute;top:803px;left:96px;white-space:nowrap" class="ft142">[83]&#160;</p>
<p style="position:absolute;top:803px;left:138px;white-space:nowrap" class="ft144">Brandes&#160;LJ,&#160;Arron RJ,&#160;Bogdanovic RP,&#160;<i>et&#160;al</i>.&#160;Stimulation of&#160;malig-<br/>nant&#160;growth&#160;in&#160;rodents&#160;by antidepressant&#160;drugs&#160;at&#160;clinically&#160;relevant&#160;<br/>doses.&#160;Cancer&#160;Res&#160;1992;&#160;52:&#160;3796-800.&#160;</p>
<p style="position:absolute;top:843px;left:96px;white-space:nowrap" class="ft142">[84]&#160;</p>
<p style="position:absolute;top:843px;left:138px;white-space:nowrap" class="ft144">Kubera&#160;M,&#160;Grygier&#160;B,&#160;Wrona&#160;D,&#160;<i>et&#160;al</i>.&#160;Stimulatory effect&#160;of&#160;antide-<br/>pressant&#160;drug pretreatment&#160;on&#160;progression&#160;of&#160;B16F10&#160;melanoma in&#160;<br/>high-active male&#160;and female&#160;C57BL/6J&#160;mice.&#160;J&#160;Neuroimmunol&#160;<br/>2011;&#160;240-241:&#160;34-44.&#160;</p>
<p style="position:absolute;top:897px;left:96px;white-space:nowrap" class="ft142">[85]&#160;</p>
<p style="position:absolute;top:897px;left:138px;white-space:nowrap" class="ft144">Grygier&#160;B,&#160;Arteta&#160;B,&#160;Kubera&#160;M,&#160;<i>et&#160;al</i>.&#160;Inhibitory&#160;effect&#160;of&#160;antide-<br/>pressants&#160;on&#160;B16F10 melanoma tumor&#160;growth.&#160;Pharmacol&#160;Rep&#160;<br/>2013;&#160;65:&#160;672-81.&#160;</p>
<p style="position:absolute;top:938px;left:96px;white-space:nowrap" class="ft142">[86]&#160;</p>
<p style="position:absolute;top:938px;left:138px;white-space:nowrap" class="ft144">Kubera&#160;M,&#160;Grygier&#160;B,&#160;Arteta&#160;B,&#160;<i>et&#160;al</i>.&#160;Age-dependent&#160;stimulatory&#160;<br/>effect&#160;of&#160;desipramine and fluoxetine&#160;pretreatment&#160;on metastasis&#160;<br/>formation by&#160;B16F10&#160;melanoma in&#160;male&#160;C57BL/6 mice.&#160;Pharma-<br/>col&#160;Rep 2009;&#160;61:&#160;1113-26.&#160;</p>
<p style="position:absolute;top:992px;left:96px;white-space:nowrap" class="ft142">[87]&#160;</p>
<p style="position:absolute;top:992px;left:138px;white-space:nowrap" class="ft144">Ashbury JE,&#160;Levesque LE,&#160;Beck PA,&#160;Aronson&#160;KJ.&#160;A&#160;population-<br/>based case-control&#160;study of&#160;selective serotonin reuptake inhibitors&#160;<br/>(SSRIs)&#160;and&#160;breast&#160;cancer:&#160;The impact&#160;of&#160;duration of&#160;use,&#160;cumula-<br/>tive dose and latency.&#160;BMC&#160;Med 2010;&#160;8:&#160;90.&#160;</p>
<p style="position:absolute;top:1046px;left:96px;white-space:nowrap" class="ft142">[88]&#160;</p>
<p style="position:absolute;top:1046px;left:138px;white-space:nowrap" class="ft144">Xu&#160;W,&#160;Tamim H,&#160;Shapiro S,&#160;Stang MR,&#160;Collet&#160;JP.&#160;Use&#160;of&#160;antide-<br/>pressants and risk&#160;of&#160;colorectal&#160;cancer:&#160;A nested&#160;case-control&#160;study.&#160;<br/>Lancet&#160;Oncol&#160;2006;&#160;7:&#160;301-8.&#160;</p>
<p style="position:absolute;top:87px;left:496px;white-space:nowrap" class="ft142">[89]&#160;</p>
<p style="position:absolute;top:87px;left:538px;white-space:nowrap" class="ft144">Padala&#160;PR,&#160;Padala&#160;KP,&#160;Monga V,&#160;Ramirez DA,&#160;Sullivan&#160;DH.&#160;Re-<br/>versal&#160;of&#160;SSRI-associated apathy syndrome by discontinuation of&#160;<br/>therapy.&#160;Ann Pharmacother&#160;2012;&#160;46:&#160;e8.&#160;</p>
<p style="position:absolute;top:128px;left:496px;white-space:nowrap" class="ft142">[90]&#160;</p>
<p style="position:absolute;top:128px;left:539px;white-space:nowrap" class="ft144">Barnhart&#160;WJ,&#160;Makela&#160;EH,&#160;Latocha MJ.&#160;SSRI-induced apathy&#160;syn-<br/>drome:&#160;A&#160;clinical&#160;review.&#160;J&#160;Psychiatr&#160;Pract&#160;2004;&#160;10:&#160;196-9.&#160;</p>
<p style="position:absolute;top:155px;left:496px;white-space:nowrap" class="ft142">[91]&#160;</p>
<p style="position:absolute;top:155px;left:539px;white-space:nowrap" class="ft144">Cantiello&#160;HF. Role&#160;of&#160;the&#160;actin&#160;cytoskeleton&#160;on&#160;epithelial Na+&#160;<br/>channel&#160;regulation.&#160;Kidney Int&#160;1995;&#160;48:&#160;970-84.&#160;</p>
<p style="position:absolute;top:182px;left:496px;white-space:nowrap" class="ft142">[92]&#160;</p>
<p style="position:absolute;top:182px;left:539px;white-space:nowrap" class="ft145">Hamm-Alvarez SF,&#160;Sheetz&#160;MP.&#160;Microtubule-dependent&#160;vesicle&#160;<br/>transport:&#160;modulation of&#160;channel&#160;and transporter&#160;activity&#160;in&#160;liver&#160;<br/>and kidney.&#160;Physiol&#160;Rev 1998;&#160;78:&#160;1109-29.&#160;</p>
<p style="position:absolute;top:223px;left:496px;white-space:nowrap" class="ft142">[93]&#160;</p>
<p style="position:absolute;top:223px;left:539px;white-space:nowrap" class="ft144">Yuen EY,&#160;Jiang Q,&#160;Chen P,&#160;Gu&#160;Z,&#160;Feng J,&#160;Yan Z.&#160;Serotonin 5-<br/>HT1A receptors&#160;regulate NMDA receptor&#160;channels&#160;through a mi-<br/>crotubule-dependent&#160;mechanism.&#160;J&#160;Neurosci&#160;2005;&#160;25:&#160;5488-501.&#160;</p>
<p style="position:absolute;top:263px;left:496px;white-space:nowrap" class="ft142">[94]&#160;</p>
<p style="position:absolute;top:263px;left:539px;white-space:nowrap" class="ft144">Rostovtseva&#160;TK,&#160;Bezrukov&#160;SM.&#160;VDAC&#160;inhibition by tubulin and&#160;<br/>its&#160;physiological&#160;implications.&#160;Biochim&#160;Biophys&#160;Acta&#160;2012;&#160;1818:&#160;<br/>1526-35.&#160;</p>
<p style="position:absolute;top:303px;left:496px;white-space:nowrap" class="ft142">[95]&#160;</p>
<p style="position:absolute;top:303px;left:538px;white-space:nowrap" class="ft144">Huzil&#160;JT,&#160;Richard FL,&#160;Jack T.&#160;Comparative modelling of&#160;human β&#160;<br/>tubulin isotypes&#160;and implications&#160;for&#160;drug binding.&#160;Nanotechnology&#160;<br/>2006;&#160;17:&#160;S90.&#160;</p>
<p style="position:absolute;top:344px;left:496px;white-space:nowrap" class="ft142">[96]&#160;</p>
<p style="position:absolute;top:344px;left:539px;white-space:nowrap" class="ft144">Gajewski MM, Alisaraie&#160;L, Tuszynski&#160;JA.&#160;Peloruside,&#160;laulimalide,&#160;<br/>and&#160;noscapine interactions&#160;with&#160;beta-tubulin.&#160;Pharm&#160;Res&#160;2012;&#160;29:&#160;<br/>2985-93.&#160;</p>
<p style="position:absolute;top:384px;left:496px;white-space:nowrap" class="ft142">[97]&#160;</p>
<p style="position:absolute;top:384px;left:539px;white-space:nowrap" class="ft144">Craddock&#160;TJ,&#160;Hameroff&#160;SR,&#160;Ayoub AT,&#160;Klobukowski&#160;M,&#160;Tuszyn-<br/>ski&#160;JA.&#160;Anesthetics&#160;act&#160;in&#160;quantum&#160;channels&#160;in&#160;brain microtubules&#160;<br/>to&#160;prevent&#160;consciousness.&#160;Curr&#160;Topics&#160;Med Chem 2015;&#160;15:&#160;523-<br/>33.&#160;</p>
<p style="position:absolute;top:438px;left:496px;white-space:nowrap" class="ft142">[98]&#160;</p>
<p style="position:absolute;top:438px;left:539px;white-space:nowrap" class="ft144">Roth&#160;B, Driscol J.&#160;PDSP&#160;Ki&#160;Database. In: (PDSP)&#160;PDSP,&#160;ed.^eds.&#160;<br/>University&#160;of&#160;North&#160;Carolina&#160;at&#160;Chapel&#160;Hill and&#160;the&#160;United&#160;States&#160;<br/>National Institute&#160;of&#160;Mental&#160;Health&#160;2013.&#160;</p>
<p style="position:absolute;top:479px;left:496px;white-space:nowrap" class="ft142">[99]&#160;</p>
<p style="position:absolute;top:479px;left:538px;white-space:nowrap" class="ft144">Owens MJ,&#160;Knight&#160;DL,&#160;Nemeroff&#160;CB.&#160;Second-generation SSRIs:&#160;<br/>Human monoamine&#160;transporter&#160;binding&#160;profile&#160;of&#160;escitalopram&#160;and&#160;<br/>R-fluoxetine.&#160;Biol&#160;Psychiatry&#160;2001;&#160;50:&#160;345-50.&#160;</p>
<p style="position:absolute;top:519px;left:496px;white-space:nowrap" class="ft142">[100]&#160;</p>
<p style="position:absolute;top:519px;left:538px;white-space:nowrap" class="ft144">Altamura&#160;AC,&#160;Moro&#160;AR,&#160;Percudani&#160;M.&#160;Clinical&#160;pharmacokinetics&#160;<br/>of&#160;fluoxetine.&#160;Clin&#160;Pharmacokinet&#160;1994;&#160;26:&#160;201-14.&#160;</p>
<p style="position:absolute;top:546px;left:496px;white-space:nowrap" class="ft142">[101]&#160;</p>
<p style="position:absolute;top:546px;left:539px;white-space:nowrap" class="ft144">Lorber&#160;DM.&#160;Computational&#160;drug design.&#160;Chem&#160;Biol&#160;1999;&#160;6:&#160;R227-<br/>8.&#160;</p>
<p style="position:absolute;top:573px;left:496px;white-space:nowrap" class="ft142">[102]&#160;</p>
<p style="position:absolute;top:573px;left:539px;white-space:nowrap" class="ft144">Soto&#160;AM,&#160;Sonnenschein C.&#160;One hundred years&#160;of&#160;somatic&#160;mutation&#160;<br/>theory&#160;of&#160;carcinogenesis:&#160;Is&#160;it&#160;time to&#160;switch?&#160;BioEssays:&#160;News&#160;and&#160;<br/>reviews&#160;in&#160;molecular,&#160;cellular&#160;and&#160;developmental biology&#160;2014; 36:&#160;<br/>118-20.&#160;</p>
<p style="position:absolute;top:627px;left:496px;white-space:nowrap" class="ft142">[103]&#160;</p>
<p style="position:absolute;top:627px;left:539px;white-space:nowrap" class="ft144">Sonnenschein C,&#160;Soto&#160;AM,&#160;Rangarajan A,&#160;Kulkarni&#160;P.&#160;Competing&#160;<br/>views&#160;on cancer.&#160;J&#160;Biosci&#160;2014;&#160;39:&#160;281-302.&#160;</p>
<p style="position:absolute;top:654px;left:496px;white-space:nowrap" class="ft142">[104]&#160;</p>
<p style="position:absolute;top:654px;left:538px;white-space:nowrap" class="ft144">Mintz B,&#160;Illmensee K.&#160;Normal&#160;genetically&#160;mosaic&#160;mice&#160;produced&#160;<br/>from malignant&#160;teratocarcinoma cells.&#160;Proc Natl&#160;Acad Sci&#160;USA&#160;<br/>1975;&#160;72:&#160;3585-9.&#160;</p>
<p style="position:absolute;top:695px;left:496px;white-space:nowrap" class="ft142">[105]&#160;</p>
<p style="position:absolute;top:695px;left:539px;white-space:nowrap" class="ft144">Tarin D.&#160;Clinical&#160;and Biological&#160;Implications&#160;of&#160;the&#160;Tumor&#160;Micro-<br/>environment.&#160;Cancer&#160;Microenviron 2012.&#160;</p>
<p style="position:absolute;top:722px;left:496px;white-space:nowrap" class="ft142">[106]&#160;</p>
<p style="position:absolute;top:722px;left:539px;white-space:nowrap" class="ft144">Tarin D.&#160;Cell&#160;and tissue&#160;interactions&#160;in carcinogenesis&#160;and metasta-<br/>sis&#160;and their&#160;clinical&#160;significance.&#160;Seminars&#160;Cancer&#160;Biol&#160;2011;&#160;21:&#160;<br/>72-82.&#160;</p>
<p style="position:absolute;top:762px;left:496px;white-space:nowrap" class="ft142">[107]&#160;</p>
<p style="position:absolute;top:762px;left:538px;white-space:nowrap" class="ft144">Bizzarri&#160;M,&#160;Cucina A.&#160;Tumor&#160;and the microenvironment:&#160;A&#160;chance&#160;<br/>to&#160;reframe&#160;the paradigm&#160;of&#160;carcinogenesis?&#160;BioMed&#160;Res&#160;Int&#160;2014;&#160;<br/>2014:&#160;934038.&#160;</p>
<p style="position:absolute;top:803px;left:496px;white-space:nowrap" class="ft142">[108]&#160;</p>
<p style="position:absolute;top:803px;left:538px;white-space:nowrap" class="ft144">D'Anselmi&#160;F,&#160;Masiello&#160;MG,&#160;Cucina A,&#160;<i>et&#160;al</i>.&#160;Microenvironment&#160;<br/>promotes&#160;tumor&#160;cell&#160;reprogramming&#160;in&#160;human breast&#160;cancer&#160;cell&#160;<br/>lines.&#160;PloS&#160;one 2013;&#160;8:&#160;e83770.&#160;</p>
<p style="position:absolute;top:843px;left:496px;white-space:nowrap" class="ft142">[109]&#160;</p>
<p style="position:absolute;top:843px;left:539px;white-space:nowrap" class="ft144">Onkal&#160;R,&#160;Djamgoz&#160;MB.&#160;Molecular&#160;pharmacology of&#160;voltage-gated&#160;<br/>sodium channel&#160;expression in&#160;metastatic&#160;disease:&#160;Clinical&#160;potential&#160;<br/>of&#160;neonatal&#160;Nav1.5&#160;in&#160;breast&#160;cancer.&#160;Eur&#160;J Pharmacol&#160;2009;&#160;625:&#160;<br/>206-19.&#160;</p>
<p style="position:absolute;top:897px;left:496px;white-space:nowrap" class="ft142">[110]&#160;</p>
<p style="position:absolute;top:897px;left:538px;white-space:nowrap" class="ft144">House CD,&#160;Vaske CJ,&#160;Schwartz&#160;AM,&#160;<i>et&#160;al</i>.&#160;Voltage-gated Na+&#160;<br/>channel&#160;SCN5A&#160;is&#160;a key regulator&#160;of&#160;a gene transcriptional&#160;network&#160;<br/>that&#160;controls&#160;colon cancer&#160;invasion.&#160;Cancer&#160;Res&#160;2010;&#160;70:&#160;6957-67.&#160;</p>
<p style="position:absolute;top:938px;left:496px;white-space:nowrap" class="ft142">[111]&#160;&#160;Perez-Neut&#160;M,&#160;Rao VR,&#160;Gentile&#160;S. hERG1/Kv11.1 activation&#160;</p>
<p style="position:absolute;top:951px;left:539px;white-space:nowrap" class="ft144">stimulates&#160;transcription of&#160;p21waf/cip&#160;in&#160;breast&#160;cancer&#160;cells<i>&#160;via</i>&#160;a&#160;<br/>calcineurin-dependent&#160;mechanism.&#160;Oncotarget&#160;2015.&#160;</p>
<p style="position:absolute;top:978px;left:496px;white-space:nowrap" class="ft142">[112]&#160;</p>
<p style="position:absolute;top:978px;left:539px;white-space:nowrap" class="ft144">Lansu K,&#160;Gentile&#160;S.&#160;Potassium&#160;channel activation&#160;inhibits&#160;prolifera-<br/>tion of&#160;breast&#160;cancer&#160;cells&#160;by activating a senescence program.&#160;Cell&#160;<br/>Death Dis&#160;2013;&#160;4:&#160;E652.&#160;</p>
<p style="position:absolute;top:1019px;left:496px;white-space:nowrap" class="ft142">[113]&#160;</p>
<p style="position:absolute;top:1019px;left:539px;white-space:nowrap" class="ft144">Lin H,&#160;Xiao J,&#160;Luo X,&#160;<i>et&#160;al</i>.&#160;Overexpression&#160;HERG&#160;K(+)&#160;channel&#160;<br/>gene mediates&#160;cell-growth signals&#160;on activation of&#160;oncoproteins&#160;<br/>SP1&#160;and&#160;NF-kappaB&#160;and&#160;inactivation&#160;of&#160;tumor&#160;suppressor&#160;Nkx3.1.&#160;<br/>J&#160;Cell&#160;Physiol&#160;2007;&#160;212:&#160;137-47.&#160;</p>
<p style="position:absolute;top:1073px;left:496px;white-space:nowrap" class="ft142">[114]&#160;</p>
<p style="position:absolute;top:1073px;left:539px;white-space:nowrap" class="ft144">Pei&#160;L,&#160;Wiser&#160;O,&#160;Slavin&#160;A,&#160;<i>et&#160;al</i>.&#160;Oncogenic potential&#160;of&#160;TASK3&#160;<br/>(Kcnk9)&#160;depends&#160;on&#160;K+&#160;channel&#160;function.&#160;Proc Natl&#160;Acad Sci&#160;USA&#160;<br/>2003;&#160;100:&#160;7803-7.&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>ac7cb9debdd356e3a4a2a2f56ecaa0d6-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft150{font-size:9px;font-family:Times;color:#000000;}
	.ft151{font-size:9px;font-family:Times;color:#000000;}
	.ft152{font-size:9px;font-family:Times;color:#000000;}
	.ft153{font-size:9px;font-family:Times;color:#000000;}
	.ft154{font-size:9px;line-height:13px;font-family:Times;color:#000000;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page15-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:57px;left:96px;white-space:nowrap" class="ft150"><i><b>Neurotransmitters&#160;and&#160;Electroceuticals&#160;in&#160;Cancer&#160;</b></i></p>
<p style="position:absolute;top:57px;left:560px;white-space:nowrap" class="ft150"><i><b>Current&#160;Pharmaceutical&#160;Design,&#160;</b></i><b>2017<i>, Vol.&#160;23, No. 32&#160; &#160;&#160;</i></b><b>4841<i>&#160;</i></b></p>
<p style="position:absolute;top:88px;left:96px;white-space:nowrap" class="ft152">[115]&#160;</p>
<p style="position:absolute;top:88px;left:138px;white-space:nowrap" class="ft154">Saito&#160;T,&#160;Schlegel&#160;R,&#160;Andresson T,&#160;Yuge L,&#160;Yamamoto&#160;M,&#160;Yama-<br/>saki&#160;H.&#160;Induction&#160;of&#160;cell&#160;transformation by&#160;mutated&#160;16K&#160;vacuolar&#160;<br/>H+-atpase (ductin)&#160;is&#160;accompanied by down-regulation of&#160;gap junc-<br/>tional intercellular&#160;communication&#160;and&#160;translocation&#160;of&#160;connexin&#160;<br/>43 in&#160;NIH3T3&#160;cells.&#160;Oncogene 1998;&#160;17:&#160;1673-80.&#160;</p>
<p style="position:absolute;top:155px;left:96px;white-space:nowrap" class="ft152">[116]&#160;&#160;Gupta N,&#160;Martin&#160;PM,&#160;Prasad PD,&#160;Ganapathy V.&#160;SLC5A8&#160;</p>
<p style="position:absolute;top:168px;left:138px;white-space:nowrap" class="ft154">(SMCT1)-mediated transport&#160;of&#160;butyrate forms&#160;the basis&#160;for&#160;the&#160;<br/>tumor&#160;suppressive&#160;function&#160;of&#160;the&#160;transporter.&#160;Life Sci&#160;2006;&#160;78:&#160;<br/>2419-25.&#160;</p>
<p style="position:absolute;top:209px;left:96px;white-space:nowrap" class="ft152">[117]&#160;</p>
<p style="position:absolute;top:209px;left:138px;white-space:nowrap" class="ft154">Roepke TK,&#160;Purtell&#160;K,&#160;King EC,&#160;<i>et&#160;al</i>.&#160;Targeted deletion of&#160;Kcne2&#160;<br/>causes&#160;gastritis&#160;cystica&#160;profunda and gastric neoplasia.&#160;PLoS&#160;One&#160;<br/>2010;&#160;5:&#160;e11451.&#160;</p>
<p style="position:absolute;top:249px;left:96px;white-space:nowrap" class="ft152">[118]&#160;</p>
<p style="position:absolute;top:249px;left:138px;white-space:nowrap" class="ft154">Weksberg&#160;R,&#160;Nishikawa J,&#160;Caluseriu O,&#160;<i>et&#160;al</i>.&#160;Tumor&#160;development&#160;<br/>in&#160;the Beckwith-Wiedemann syndrome is&#160;associated&#160;with&#160;a variety&#160;<br/>of&#160;constitutional molecular&#160;11p15&#160;alterations&#160;including&#160;imprinting&#160;<br/>defects&#160;of&#160;KCNQ1OT1.&#160;Hum Mol&#160;Genet&#160;2001;&#160;10:&#160;2989-3000.&#160;</p>
<p style="position:absolute;top:303px;left:96px;white-space:nowrap" class="ft152">[119]&#160;</p>
<p style="position:absolute;top:303px;left:138px;white-space:nowrap" class="ft154">Lee&#160;MP,&#160;Hu RJ,&#160;Johnson LA,&#160;Feinberg AP.&#160;Human KVLQT1 gene&#160;<br/>shows tissue-specific&#160;imprinting&#160;and&#160;encompasses Beckwith-<br/>Wiedemann&#160;syndrome&#160;chromosomal&#160;rearrangements.&#160;Nat&#160;Genet&#160;<br/>1997;&#160;15:&#160;181-5.&#160;</p>
<p style="position:absolute;top:357px;left:96px;white-space:nowrap" class="ft152">[120]&#160;</p>
<p style="position:absolute;top:357px;left:138px;white-space:nowrap" class="ft154">Than BL,&#160;Goos&#160;JA,&#160;Sarver&#160;AL,&#160;<i>et&#160;al</i>.&#160;The role&#160;of&#160;KCNQ1&#160;in&#160;mouse&#160;<br/>and human gastrointestinal&#160;cancers.&#160;Oncogene 2013.&#160;</p>
<p style="position:absolute;top:384px;left:96px;white-space:nowrap" class="ft152">[121]&#160;</p>
<p style="position:absolute;top:384px;left:138px;white-space:nowrap" class="ft154">House CD,&#160;Vaske CJ,&#160;Schwartz&#160;A,&#160;<i>et&#160;al</i>.&#160;Voltage-gated Na+ chan-<br/>nel&#160;SCN5A&#160;is&#160;a key&#160;regulator&#160;of&#160;a&#160;gene&#160;transcriptional&#160;network that&#160;<br/>controls&#160;colon cancer&#160;invasion.&#160;Cancer&#160;Res&#160;2010.&#160;</p>
<p style="position:absolute;top:425px;left:96px;white-space:nowrap" class="ft152">[122]&#160;</p>
<p style="position:absolute;top:425px;left:138px;white-space:nowrap" class="ft154">Martino JJ,&#160;Wall&#160;BA,&#160;Mastrantoni&#160;E,&#160;<i>et&#160;al</i>.&#160;Metabotropic&#160;glutamate&#160;<br/>receptor&#160;1 (Grm1)&#160;is&#160;an&#160;oncogene in&#160;epithelial&#160;cells.&#160;Oncogene&#160;<br/>2012.&#160;</p>
<p style="position:absolute;top:465px;left:96px;white-space:nowrap" class="ft152">[123]&#160;</p>
<p style="position:absolute;top:465px;left:138px;white-space:nowrap" class="ft154">Speyer&#160;CL,&#160;Smith&#160;JS,&#160;Banda M,&#160;DeVries&#160;JA,&#160;Mekani&#160;T,&#160;Gorski&#160;<br/>DH.&#160;Metabotropic glutamate receptor-1:&#160;A&#160;potential&#160;therapeutic&#160;<br/>target&#160;for&#160;the treatment&#160;of&#160;breast&#160;cancer.&#160;Breast&#160;cancer&#160;research&#160;and&#160;<br/>treatment&#160;2012;&#160;132:&#160;565-73.&#160;</p>
<p style="position:absolute;top:519px;left:96px;white-space:nowrap" class="ft152">[124]&#160;</p>
<p style="position:absolute;top:519px;left:138px;white-space:nowrap" class="ft154">Song Z,&#160;He&#160;CD,&#160;Liu J,&#160;<i>et&#160;al</i>.&#160;Blocking glutamate-mediated signal-<br/>ling inhibits&#160;human melanoma&#160;growth&#160;and migration.&#160;Exp Derma-<br/>tol&#160;2012;&#160;21:&#160;926-31.&#160;</p>
<p style="position:absolute;top:560px;left:96px;white-space:nowrap" class="ft152">[125]&#160;</p>
<p style="position:absolute;top:560px;left:138px;white-space:nowrap" class="ft154">Zhang JT,&#160;Jiang XH,&#160;Xie&#160;C,&#160;<i>et&#160;al</i>.&#160;Downregulation of&#160;CFTR&#160;pro-<br/>motes&#160;epithelial-to-mesenchymal transition&#160;and&#160;is&#160;associated&#160;with&#160;<br/>poor&#160;prognosis&#160;of&#160;breast&#160;cancer.&#160;Biochim Biophys&#160;Acta&#160;2013;&#160;<br/>1833:&#160;2961-9.&#160;</p>
<p style="position:absolute;top:614px;left:96px;white-space:nowrap" class="ft152">[126]&#160;</p>
<p style="position:absolute;top:614px;left:138px;white-space:nowrap" class="ft154">Xie C,&#160;Jiang XH,&#160;Zhang JT,&#160;<i>et&#160;al</i>.&#160;CFTR&#160;suppresses&#160;tumor&#160;progres-<br/>sion through miR-193b targeting&#160;urokinase&#160;plasminogen activator&#160;<br/>(uPA)&#160;in&#160;prostate&#160;cancer.&#160;Oncogene 2013;&#160;32:&#160;2282-91,&#160;2291 e1-7.&#160;</p>
<p style="position:absolute;top:654px;left:96px;white-space:nowrap" class="ft152">[127]&#160;</p>
<p style="position:absolute;top:654px;left:138px;white-space:nowrap" class="ft154">Sirnes&#160;S,&#160;Bruun J,&#160;Kolberg M,&#160;<i>et&#160;al</i>.&#160;Connexin43&#160;acts&#160;as&#160;a&#160;colorec-<br/>tal&#160;cancer&#160;tumor&#160;suppressor&#160;and&#160;predicts&#160;disease&#160;outcome.&#160;Int&#160;J&#160;<br/>Cancer&#160;2012;&#160;131:&#160;570-81.&#160;</p>
<p style="position:absolute;top:695px;left:96px;white-space:nowrap" class="ft152">[128]&#160;</p>
<p style="position:absolute;top:695px;left:138px;white-space:nowrap" class="ft154">Schickling BM,&#160;England SK,&#160;Aykin-Burns&#160;N,&#160;Norian LA,&#160;Leslie&#160;<br/>KK,&#160;Frieden-Korovkina VP.&#160;BKCa&#160;channel&#160;inhibitor&#160;modulates&#160;the&#160;<br/>tumorigenic&#160;ability&#160;of&#160;hormone-independent breast cancer&#160;cells<i>&#160;via</i>&#160;<br/>the Wnt&#160;pathway.&#160;Oncol&#160;Rep 2015;&#160;33:&#160;533-8.&#160;</p>
<p style="position:absolute;top:749px;left:96px;white-space:nowrap" class="ft152">[129]&#160;</p>
<p style="position:absolute;top:749px;left:138px;white-space:nowrap" class="ft154">Felder&#160;CC,&#160;MacArthur&#160;L,&#160;Ma&#160;AL,&#160;Gusovsky F,&#160;Kohn&#160;EC.&#160;Tumor-<br/>suppressor&#160;function&#160;of&#160;muscarinic&#160;acetylcholine receptors&#160;is&#160;associ-<br/>ated with&#160;activation of&#160;receptor-operated calcium&#160;influx.&#160;Proc&#160;Natl&#160;<br/>Acad Sci&#160;USA&#160;1993;&#160;90:&#160;1706-10.&#160;</p>
<p style="position:absolute;top:803px;left:96px;white-space:nowrap" class="ft152">[130]&#160;</p>
<p style="position:absolute;top:803px;left:138px;white-space:nowrap" class="ft154">Illmensee K,&#160;Mintz B.&#160;Totipotency and normal&#160;differentiation of&#160;<br/>single&#160;teratocarcinoma&#160;cells&#160;cloned&#160;by&#160;injection&#160;into&#160;blastocysts.&#160;<br/>Proc Natl&#160;Acad Sci&#160;USA&#160;1976;&#160;73:&#160;549-53.&#160;</p>
<p style="position:absolute;top:843px;left:96px;white-space:nowrap" class="ft152">[131]&#160;</p>
<p style="position:absolute;top:843px;left:138px;white-space:nowrap" class="ft154">Seilern-Aspang F,&#160;Kratochwill L. Relation&#160;between&#160;regeneration&#160;<br/>and tumor&#160;growth.&#160;In:&#160;ed.^eds.,&#160;Regeneration in&#160;animals&#160;and related&#160;<br/>problems.&#160;North-Holland&#160;Publishing Company:&#160;Amsterdam&#160;1965;&#160;<br/>pp.&#160;452-73.&#160;</p>
<p style="position:absolute;top:897px;left:96px;white-space:nowrap" class="ft152">[132]&#160;</p>
<p style="position:absolute;top:897px;left:138px;white-space:nowrap" class="ft154">Donaldson DJ,&#160;Mason&#160;JM.&#160;Cancer-related&#160;aspects&#160;of&#160;regeneration&#160;<br/>research:&#160;A&#160;review.&#160;Growth&#160;1975;&#160;39:&#160;475-96.&#160;</p>
<p style="position:absolute;top:924px;left:96px;white-space:nowrap" class="ft152">[133]&#160;</p>
<p style="position:absolute;top:924px;left:138px;white-space:nowrap" class="ft154">Del&#160;Rio-Tsonis&#160;K,&#160;Tsonis&#160;PA.&#160;Amphibian tissue&#160;regeneration -&#160;a&#160;<br/>model&#160;for&#160;cancer&#160;regulation.&#160;Int&#160;J&#160;Oncol&#160;1992;&#160;1:&#160;161-4.&#160;</p>
<p style="position:absolute;top:951px;left:96px;white-space:nowrap" class="ft152">[134]&#160;</p>
<p style="position:absolute;top:951px;left:138px;white-space:nowrap" class="ft154">Brockes&#160;JP.&#160;Regeneration and cancer.&#160;Biochimica et&#160;Biophysica&#160;<br/>Acta&#160;1998;&#160;1377:&#160;M1-11.&#160;</p>
<p style="position:absolute;top:87px;left:496px;white-space:nowrap" class="ft152">[135]&#160;</p>
<p style="position:absolute;top:87px;left:538px;white-space:nowrap" class="ft152">Smithers&#160;DW.&#160;An&#160;attack on cytologism.&#160;Lancet&#160;1962;&#160;1:&#160;493-9.&#160;</p>
<p style="position:absolute;top:101px;left:496px;white-space:nowrap" class="ft152">[136]&#160;</p>
<p style="position:absolute;top:101px;left:538px;white-space:nowrap" class="ft154">O'Brien J.&#160;The ever-changing electrical&#160;synapse.&#160;Curr&#160;Opin&#160;Neuro-<br/>biol&#160;2014;&#160;29C:&#160;64-72.&#160;</p>
<p style="position:absolute;top:128px;left:496px;white-space:nowrap" class="ft152">[137]&#160;</p>
<p style="position:absolute;top:128px;left:538px;white-space:nowrap" class="ft154">Connors&#160;BW,&#160;Long MA.&#160;Electrical&#160;synapses&#160;in&#160;the mammalian&#160;<br/>brain.&#160;Annu Rev Neurosci&#160;2004;&#160;27:&#160;393-418.&#160;</p>
<p style="position:absolute;top:155px;left:496px;white-space:nowrap" class="ft152">[138]&#160;</p>
<p style="position:absolute;top:155px;left:538px;white-space:nowrap" class="ft154">Bennett&#160;MV.&#160;Gap&#160;junctions&#160;as&#160;electrical&#160;synapses.&#160;J&#160;Neurocytol&#160;<br/>1997;&#160;26:&#160;349-66.&#160;</p>
<p style="position:absolute;top:182px;left:496px;white-space:nowrap" class="ft152">[139]&#160;</p>
<p style="position:absolute;top:182px;left:539px;white-space:nowrap" class="ft154">Kandouz M,&#160;Batist&#160;G.&#160;Gap junctions&#160;and connexins&#160;as&#160;therapeutic&#160;<br/>targets&#160;in&#160;cancer.&#160;Expert&#160;Opin&#160;Ther&#160;Targets&#160;2010;&#160;14:&#160;681-92.&#160;</p>
<p style="position:absolute;top:209px;left:496px;white-space:nowrap" class="ft152">[140]&#160;</p>
<p style="position:absolute;top:209px;left:539px;white-space:nowrap" class="ft154">Trosko JE.&#160;Gap&#160;junctional&#160;intercellular&#160;communication&#160;as&#160;a&#160;bio-<br/>logical&#160;&#34;Rosetta&#160;stone&#34;&#160;in&#160;understanding,&#160;in&#160;a systems&#160;biological&#160;<br/>manner,&#160;stem&#160;cell&#160;behavior,&#160;mechanisms&#160;of&#160;epigenetic&#160;toxicology,&#160;<br/>chemoprevention and chemotherapy.&#160;J&#160;Membr&#160;Biol&#160;2007;&#160;218:&#160;93-<br/>100.&#160;</p>
<p style="position:absolute;top:276px;left:496px;white-space:nowrap" class="ft152">[141]&#160;</p>
<p style="position:absolute;top:276px;left:539px;white-space:nowrap" class="ft154">Trosko JE.&#160;The&#160;role&#160;of&#160;stem&#160;cells&#160;and gap junctions&#160;as&#160;targets&#160;for&#160;<br/>cancer&#160;chemoprevention and chemotherapy.&#160;Biomed&#160;Pharmacother&#160;<br/>2005;&#160;59 Suppl&#160;2:&#160;S326-31.&#160;</p>
<p style="position:absolute;top:317px;left:496px;white-space:nowrap" class="ft152">[142]&#160;</p>
<p style="position:absolute;top:317px;left:538px;white-space:nowrap" class="ft154">Mesnil&#160;M,&#160;Crespin S,&#160;Avanzo&#160;JL,&#160;Zaidan-Dagli&#160;ML.&#160;Defective&#160;gap&#160;<br/>junctional&#160;intercellular&#160;communication in&#160;the&#160;carcinogenic&#160;process.&#160;<br/>Biochim&#160;Biophys&#160;Acta&#160;2005;&#160;1719:&#160;125-45.&#160;</p>
<p style="position:absolute;top:357px;left:496px;white-space:nowrap" class="ft152">[143]&#160;</p>
<p style="position:absolute;top:357px;left:539px;white-space:nowrap" class="ft154">Mandala&#160;M,&#160;Serck-Hanssen G,&#160;Martino G,&#160;Helle&#160;KB.&#160;The fluores-<br/>cent&#160;cationic&#160;dye rhodamine 6G&#160;as&#160;a probe for&#160;membrane potential&#160;<br/>in&#160;bovine aortic&#160;endothelial&#160;cells.&#160;Anal&#160;Biochem&#160;1999;&#160;274:&#160;1-6.&#160;</p>
<p style="position:absolute;top:398px;left:496px;white-space:nowrap" class="ft152">[144]&#160;</p>
<p style="position:absolute;top:398px;left:539px;white-space:nowrap" class="ft154">Joshi&#160;PG,&#160;Pant&#160;HC.&#160;Depolarization of&#160;synaptosomal&#160;membranes:&#160;a&#160;<br/>study of&#160;mechanism by which rhodamine 6G&#160;measures&#160;membrane&#160;<br/>potential.&#160;Indian J&#160;Biochem Biophys&#160;1991;&#160;28:&#160;140-5.&#160;</p>
<p style="position:absolute;top:438px;left:496px;white-space:nowrap" class="ft152">[145]&#160;&#160;Nieuwkoop PD,&#160;Faber&#160;J.&#160;Normal&#160;Table of&#160;Xenopus&#160;laevis&#160;</p>
<p style="position:absolute;top:452px;left:539px;white-space:nowrap" class="ft152">(Daudin).&#160;North-Holland:&#160;Amsterdam 1967.&#160;</p>
<p style="position:absolute;top:465px;left:496px;white-space:nowrap" class="ft152">[146]&#160;</p>
<p style="position:absolute;top:465px;left:539px;white-space:nowrap" class="ft154">Dahal&#160;GR,&#160;Rawson J,&#160;Gassaway B,&#160;<i>et&#160;al</i>. An&#160;inwardly&#160;rectifying&#160;<br/>K+&#160;channel&#160;is&#160;required for&#160;patterning.&#160;Development&#160;2012;&#160;139:&#160;<br/>3653-64.&#160;</p>
<p style="position:absolute;top:506px;left:496px;white-space:nowrap" class="ft152">[147]&#160;</p>
<p style="position:absolute;top:506px;left:538px;white-space:nowrap" class="ft154">Pai&#160;VP,&#160;Martyniuk CJ,&#160;Echeverri&#160;K,&#160;Sundelacruz S,&#160;Kaplan DL,&#160;<br/>Levin M.&#160;Genome-wide analysis&#160;reveals conserved transcriptional&#160;<br/>responses&#160;downstream of&#160;resting&#160;potential&#160;change in&#160;Xenopus&#160;em-<br/>bryos,&#160;axolotl&#160;regeneration,&#160;and&#160;human mesenchymal&#160;cell&#160;differen-<br/>tiation.&#160;Regeneration 2015;&#160;3(1):&#160;3-25.&#160;</p>
<p style="position:absolute;top:573px;left:496px;white-space:nowrap" class="ft152">[148]&#160;</p>
<p style="position:absolute;top:573px;left:539px;white-space:nowrap" class="ft154">Gradinaru V,&#160;Thompson KR,&#160;Zhang F,&#160;<i>et&#160;al</i>.&#160;Targeting and readout&#160;<br/>strategies&#160;for fast optical&#160;neural&#160;control&#160;<i>in&#160;vitro</i>&#160;and&#160;<i>in&#160;vivo</i>.&#160;J Neu-<br/>rosci&#160;2007;&#160;27:&#160;14231-8.&#160;</p>
<p style="position:absolute;top:614px;left:496px;white-space:nowrap" class="ft152">[149]&#160;</p>
<p style="position:absolute;top:614px;left:539px;white-space:nowrap" class="ft154">Binggeli&#160;R,&#160;Weinstein R.&#160;Membrane&#160;potentials&#160;and sodium&#160;chan-<br/>nels:&#160;hypotheses&#160;for&#160;growth&#160;regulation and cancer&#160;formation based&#160;<br/>on changes&#160;in&#160;sodium channels&#160;and gap junctions.&#160;J&#160;Theoretical&#160;<br/>Biol&#160;1986;&#160;123:&#160;377-401.&#160;</p>
<p style="position:absolute;top:668px;left:496px;white-space:nowrap" class="ft152">[150]&#160;</p>
<p style="position:absolute;top:668px;left:538px;white-space:nowrap" class="ft154">Olivotto&#160;M,&#160;Arcangeli&#160;A,&#160;Carla M,&#160;Wanke E.&#160;Electric fields&#160;at&#160;the&#160;<br/>plasma membrane level:&#160;A neglected&#160;element&#160;in&#160;the mechanisms of&#160;<br/>cell&#160;signalling.&#160;Bioessays&#160;1996;&#160;18:&#160;495-504.&#160;</p>
<p style="position:absolute;top:708px;left:496px;white-space:nowrap" class="ft152">[151]&#160;</p>
<p style="position:absolute;top:708px;left:539px;white-space:nowrap" class="ft154">Cone CD,&#160;Tongier&#160;M.&#160;Control&#160;of&#160;somatic&#160;cell&#160;mitosis&#160;by&#160;simulated&#160;<br/>changes&#160;in&#160;the&#160;transmembrane&#160;potential level. Oncology&#160;1971; 25:&#160;<br/>168-82.&#160;</p>
<p style="position:absolute;top:749px;left:496px;white-space:nowrap" class="ft152">[152]&#160;</p>
<p style="position:absolute;top:749px;left:538px;white-space:nowrap" class="ft154">Morokuma J,&#160;Blackiston D,&#160;Adams&#160;DS,&#160;Seebohm&#160;G,&#160;Trimmer&#160;B,&#160;<br/>Levin M.&#160;Modulation of&#160;potassium channel&#160;function confers&#160;a hy-<br/>perproliferative invasive phenotype on&#160;embryonic&#160;stem cells.&#160;Proc&#160;<br/>Natl&#160;Acad Sci&#160;USA&#160;2008;&#160;105:&#160;16608-13.&#160;</p>
<p style="position:absolute;top:803px;left:496px;white-space:nowrap" class="ft152">[153]&#160;&#160;Cohen AE,&#160;Venkatachalam&#160;V.&#160;Bringing&#160;bioelectricity&#160;to&#160;light.&#160;</p>
<p style="position:absolute;top:816px;left:539px;white-space:nowrap" class="ft152">Annu Rev Biophys&#160;2014;&#160;43:&#160;211-32.&#160;</p>
<p style="position:absolute;top:830px;left:496px;white-space:nowrap" class="ft152">[154]&#160;</p>
<p style="position:absolute;top:830px;left:538px;white-space:nowrap" class="ft154">Fenno L,&#160;Yizhar&#160;O,&#160;Deisseroth&#160;K.&#160;The development&#160;and application&#160;<br/>of&#160;optogenetics.&#160;Annual&#160;review&#160;of&#160;neuroscience 2011;&#160;34:&#160;389-412.&#160;</p>
<p style="position:absolute;top:857px;left:496px;white-space:nowrap" class="ft152">[155]&#160;</p>
<p style="position:absolute;top:857px;left:538px;white-space:nowrap" class="ft154">Adams&#160;DS,&#160;Lemire&#160;JM,&#160;Kramer&#160;RH,&#160;Levin&#160;M.&#160;Optogenetics&#160;in&#160;<br/>Developmental&#160;Biology:&#160;Using light&#160;to control&#160;ion flux-dependent&#160;<br/>signals&#160;in Xenopus&#160;embryos.&#160;Int&#160;J&#160;Develop Biol&#160;2014;&#160;58:&#160;851-61.&#160;</p>
<p style="position:absolute;top:897px;left:496px;white-space:nowrap" class="ft152">[156]&#160;</p>
<p style="position:absolute;top:897px;left:539px;white-space:nowrap" class="ft154">Tochitsky I,&#160;Polosukhina&#160;A,&#160;Degtyar&#160;VE,&#160;<i>et&#160;al</i>.&#160;Restoring visual&#160;<br/>function to&#160;blind&#160;mice with&#160;a&#160;photoswitch that&#160;exploits&#160;electro-<br/>physiological&#160;remodeling&#160;of&#160;retinal&#160;ganglion cells.&#160;Neuron&#160;2014;&#160;<br/>81:&#160;800-13.&#160;</p>
<p style="position:absolute;top:951px;left:496px;white-space:nowrap" class="ft152">[157]&#160;</p>
<p style="position:absolute;top:951px;left:538px;white-space:nowrap" class="ft154">Fortin&#160;DL,&#160;Dunn TW,&#160;Kramer&#160;RH.&#160;Engineering light-regulated ion&#160;<br/>channels.&#160;Cold Spring Harb Protoc 2011;&#160;2011:&#160;579-85.&#160;</p>
<p style="position:absolute;top:978px;left:96px;white-space:nowrap" class="ft154">&#160;<br/>&#160;<br/>&#160;</p>
</div>
</body>
</html>
